Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (599 citations).

Chirality in metal-based anticancer agents
Yi Wang, Huaiyi Huang, Qianling Zhang and Pingyu Zhang
Dalton Trans., 2018, 47, 4017
DOI: 10.1039/C8DT00089A

Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes
Thangavel Sathiya Kamatchi, Mohamed Kasim Mohamed Subarkhan, Rengan Ramesh, Hangxiang Wang and Jan Grzegorz Małecki
Dalton Trans., 2020, 49, 11385
DOI: 10.1039/D0DT01476A

A hypoxia efficient imidazole-based Ru(ii) arene anticancer agent resistant to deactivation by glutathione
Kallol Purkait, Subhendu Karmakar, Sudipta Bhattacharyya, Saptarshi Chatterjee, Suman Kr Dey and Arindam Mukherjee
Dalton Trans., 2015, 44, 5969
DOI: 10.1039/C4DT03983A

Novel cyclometalated iridium(iii) phosphine-imine (P^N) complexes: highly efficient anticancer and anti-lung metastasis agents in vivo
Zhishan Xu, Yuliang Yang, Xianglei Jia, Lihua Guo, Xingxing Ge, Genshen Zhong, Shujiao Chen and Zhe Liu
Inorg. Chem. Front., 2020, 7, 1273
DOI: 10.1039/C9QI01492F

Albumin binding and ligand-exchange processes of the Ru(iii) anticancer agent NAMI-A and its bis-DMSO analogue determined by ENDOR spectroscopy
Michael I. Webb and Charles J. Walsby
Dalton Trans., 2015, 44, 17482
DOI: 10.1039/C5DT02021B

Triazole appending ruthenium(ii) polypyridine complex for selective sensing of phosphate anions through C–H–anion interaction and copper(ii) ions via cancer cells
Mohanraj Ramachandran and Sambandam Anandan
New J. Chem., 2020, 44, 6186
DOI: 10.1039/D0NJ00273A

Mitochondria-targeted half-sandwich rutheniumII diimine complexes: anticancer and antimetastasis via ROS-mediated signalling
Zhishan Xu, Deliang Kong, Xiangdong He, Lihua Guo, Xingxing Ge, Xicheng Liu, Hairong Zhang, Juanjuan Li, Yuliang Yang and Zhe Liu
Inorg. Chem. Front., 2018, 5, 2100
DOI: 10.1039/C8QI00476E

Hypoxia-targeted drug delivery
Amit Sharma, Jonathan F. Arambula, Seyoung Koo, Rajesh Kumar, Hardev Singh, Jonathan L. Sessler and Jong Seung Kim
Chem. Soc. Rev., 2019, 48, 771
DOI: 10.1039/C8CS00304A

Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research
Ronald F. S. Lee, Sarah Theiner, Anders Meibom, Gunda Koellensperger, Bernhard K. Keppler and Paul J. Dyson
Metallomics, 2017, 9, 365
DOI: 10.1039/C6MT00231E

The straightforward synthesis of N-coordinated ruthenium 4-aryl-1,2,3-triazolato complexes by [3 + 2] cycloaddition reactions of a ruthenium azido complex with terminal phenylacetylenes and non-covalent aromatic interactions in structures
Chao-Wan Chang, Chi-Rung Lee, Gene-Hsiang Lee and Kuang-Lieh Lu
RSC Adv., 2022, 12, 24830
DOI: 10.1039/D2RA04835C

Rationally designed Ru(ii)-metallacycle chemo-phototheranostic that emits beyond 1000 nm
Chonglu Li, Yuling Xu, Le Tu, Minhyeok Choi, Yifan Fan, Xiaoqiang Chen, Jonathan L. Sessler, Jong Seung Kim and Yao Sun
Chem. Sci., 2022, 13, 6541
DOI: 10.1039/D2SC01518H

In vivoanti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
Andrea Weiss, Robert H. Berndsen, Maxime Dubois, Cristina Müller, Roger Schibli, Arjan W. Griffioen, Paul J. Dyson and Patrycja Nowak-Sliwinska
Chem. Sci., 2014, 5, 4742
DOI: 10.1039/C4SC01255K

Arene ruthenium(ii) complexes with chalcone, aminoantipyrine and aminopyrimidine based ligands: synthesis, structure and preliminary evaluation of anti-leukemia activity
Jayaraman Pitchaimani, Mamilla R. Charan Raja, Srinivasan Sujatha, Santanu Kar Mahapatra, Dohyun Moon, Savarimuthu Philip Anthony and Vedichi Madhu
RSC Adv., 2016, 6, 90982
DOI: 10.1039/C6RA18504E

Structural and solution equilibrium studies on half-sandwich organorhodium complexes of (N,N) donor bidentate ligands
János P. Mészáros, Orsolya Dömötör, Carmen M. Hackl, Alexander Roller, Bernhard K. Keppler, Wolfgang Kandioller and Éva A. Enyedy
New J. Chem., 2018, 42, 11174
DOI: 10.1039/C8NJ01681J

Transition metal compounds as cancer radiosensitizers
Martin R. Gill and Katherine A. Vallis
Chem. Soc. Rev., 2019, 48, 540
DOI: 10.1039/C8CS00641E

Effective PDT/PTT dual-modal phototherapeutic killing of pathogenic bacteria by using ruthenium nanoparticles
Xiaoquan Huang, Gengjia Chen, Jiali Pan, Xu Chen, Na Huang, Xin Wang and Jie Liu
J. Mater. Chem. B, 2016, 4, 6258
DOI: 10.1039/C6TB01122E

An iridium(iii)-based irreversible protein–protein interaction inhibitor of BRD4 as a potent anticancer agent
Hai-Jing Zhong, Lihua Lu, Ka-Ho Leung, Catherine C. L. Wong, Chao Peng, Siu-Cheong Yan, Dik-Lung Ma, Zongwei Cai, Hui-Min David Wang and Chung-Hang Leung
Chem. Sci., 2015, 6, 5400
DOI: 10.1039/C5SC02321A

A camphor based 1,3-diamine Ru(ii) terpyridine complex: synthesis, characterization, kinetic investigation and DNA binding
Milan M. Milutinović, Živadin D. Bugarčić and René Wilhelm
New J. Chem., 2018, 42, 7607
DOI: 10.1039/C7NJ04674J

Metal complexes in medicine: structural scaffolds vs. functional centres
Nicolás Montesdeoca and Johannes Karges
Chem. Sci., 2026, 17, 7340
DOI: 10.1039/D6SC01182A

A general strategy to add diversity to ruthenium arene complexes with bioactive organic compounds via a coordinated (4-hydroxyphenyl)diphenylphosphine ligand
Lorenzo Biancalana, Lucinda K. Batchelor, Alice De Palo, Stefano Zacchini, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Dalton Trans., 2017, 46, 12001
DOI: 10.1039/C7DT02062G

Design and synthesis of a DNA intercalative half-sandwich organoruthenium(ii)–chromone complex: cytotoxicity evaluation and topoisomerase Iα inhibition assay
Imtiyaz Yousuf, Farukh Arjmand, Sartaj Tabassum and Musheer Ahmad
New J. Chem., 2019, 43, 5475
DOI: 10.1039/C9NJ00042A

Selectively inhibiting malignant melanoma migration and invasion in an engineered skin model using actin-targeting dinuclear RuII-complexes
Ahtasham Raza, Stuart A. Archer, Jim A. Thomas, Sheila MacNeil and John W. Haycock
RSC Med. Chem., 2023, 14, 65
DOI: 10.1039/D2MD00280A

New half-sandwich ruthenium(ii) complexes as proteosynthesis inhibitors in cancer cells
Francisco J. Ballester, Enrique Ortega, Vanesa Porto, Hana Kostrhunova, Nerea Davila-Ferreira, Delia Bautista, Viktor Brabec, Fernando Domínguez, M. Dolores Santana and José Ruiz
Chem. Commun., 2019, 55, 1140
DOI: 10.1039/C8CC09211G

Exploring the cytotoxicity of dinuclear Ru(ii) p-cymene complexes appended N,N′-bis(4-substituted benzoyl)hydrazines: insights into the mechanism of apoptotic cell death
Arunachalam Abirami, Umapathy Devan, Rengan Ramesh, Arockiam Antony Joseph Velanganni and Jan Grzegorz Małecki
Dalton Trans., 2024, 53, 5167
DOI: 10.1039/D3DT04234K

Necrosis inducing tetranuclear Ru(ii)–Re(i) metal complex for anticancer therapy
Julia Schleisiek, Eleni Michaltsis, Stephan Mayer, Nicolás Montesdeoca and Johannes Karges
Dalton Trans., 2025, 54, 942
DOI: 10.1039/D4DT02992E

Synthesis, structures, and DNA and protein binding of ruthenium(ii)-p-cymene complexes of substituted pyridylimidazo[1,5-a]pyridine: enhanced cytotoxicity of complexes of ligands appended with a carbazole moiety
Themmila Khamrang, Radhakrishnan Kartikeyan, Marappan Velusamy, Venugopal Rajendiran, Rajakumar Dhivya, Balaji Perumalsamy, Mohammad Abdulkadher Akbarsha and Mallayan Palaniandavar
RSC Adv., 2016, 6, 114143
DOI: 10.1039/C6RA23663D

Investigation of enzyme inhibition, serum protein protective effects, and molecular docking studies of mixed-ligand ruthenium(ii) polypyridyl complexes
Sunita Khatkar, Santosh Kumar Dubey, Manoj Trivedi, Chanchal Vashisth, Neeru Devi, Neera Raghav, Meenakshi Sharma and Jagan Rajamoni
New J. Chem., 2025, 49, 1440
DOI: 10.1039/D4NJ04773G

Ruthenium(ii) polypyridyl complexes with visible light-enhanced anticancer activity and multimodal cell imaging
Yan Kang, Yao Zhao, Yuanyuan Wei, Yang Zhang, Zhaoying Wang, Qun Luo, Jun Du and Fuyi Wang
Dalton Trans., 2023, 52, 12478
DOI: 10.1039/D3DT01661G

Ruthenium(ii) complex containing cinnamic acid derivative inhibits cell cycle progression at G0/G1 and induces apoptosis in melanoma cells
Amanda Alvim Negreti, Guilherme Álvaro Ferreira-Silva, Carolina Girotto Pressete, Rafael Fonseca, Caio C. Candido, Angelica E. Graminha, Antonio Carlos Doriguetto, Ester Siqueira Caixeta, João Adolfo Costa Hanemann, Angel Mauricio Castro-Gamero, Marilia I. F. Barbosa, Marta Miyazawa and Marisa Ionta
New J. Chem., 2022, 46, 3325
DOI: 10.1039/D1NJ04291B

Novel organo-osmium(ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth inCaenorhabditis elegans
Enrique Ortega, Francisco J. Ballester, Alba Hernández-García, Samanta Hernández-García, M. Alejandra Guerrero-Rubio, Delia Bautista, M. Dolores Santana, Fernando Gandía-Herrero and José Ruiz
Inorg. Chem. Front., 2021, 8, 141
DOI: 10.1039/C9QI01704F

Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy
Yu Lu, Di Zhu, Quynh Le, Yuji Wang and Wei Wang
Nanoscale, 2022, 14, 16339
DOI: 10.1039/D2NR02994D

Synthesis and molecular structure of arene ruthenium(ii) benzhydrazone complexes: impact of substitution at the chelating ligand and arene moiety on antiproliferative activity
Mohamed Kasim Mohamed Subarkhan, Rengan Ramesh and Yu Liu
New J. Chem., 2016, 40, 9813
DOI: 10.1039/C6NJ01936F

Positive and negative nano-electrospray mass spectrometry of ruthenated serum albumin supported by docking studies: an integrated approach towards defining metallodrug binding sites on proteins
Marija Nišavić, Goran V. Janjić, Amela Hozić, Marijana Petković, Miloš K. Milčić, Zoran Vujčić and Mario Cindrić
Metallomics, 2018, 10, 587
DOI: 10.1039/C7MT00330G

Antiproliferative activity of ruthenium(ii) arene complexes with mono- and bidentate pyridine-based ligands
Stefan Richter, Sushma Singh, Dijana Draca, Anup Kate, Anupa Kumbhar, Avinash S. Kumbhar, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Peter Lönnecke and Evamarie Hey-Hawkins
Dalton Trans., 2016, 45, 13114
DOI: 10.1039/C6DT01782G

Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies
Lorenzo Biancalana, Lucinda K. Batchelor, Gianluca Ciancaleoni, Stefano Zacchini, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Dalton Trans., 2018, 47, 9367
DOI: 10.1039/C8DT01555D

Synthesis and structure of nickel(ii) thiocarboxamide complexes: effect of ligand substitutions on DNA/protein binding, antioxidant and cytotoxicity
Ramasamy Raj Kumar, Mohamed Kasim Mohamed Subarkhan and Rengan Ramesh
RSC Adv., 2015, 5, 46760
DOI: 10.1039/C5RA06112A

Piano-stool ruthenium(ii) complexes with maleimide and phosphine or phosphite ligands: synthesis and activity against normal and cancer cells
Michał Juszczak, Sujoy Das, Aneta Kosińska, Agnieszka J. Rybarczyk-Pirek, Kinga Wzgarda-Raj, Paulina Tokarz, Saranya Vasudevan, Arkadiusz Chworos, Katarzyna Woźniak and Bogna Rudolf
Dalton Trans., 2023, 52, 4237
DOI: 10.1039/D2DT04083B

Chloride-to-(radio)iodide exchange on NHC–metal complexes
Ginevra Giobbio, Killian Henault, Gauthier Foucras, Anaïs Prigent, Sylvain Gaillard and Thomas Cailly
Dalton Trans., 2025, 54, 11817
DOI: 10.1039/D5DT01364J

Rhodium complexes as therapeutic agents
Dik-Lung Ma, Modi Wang, Zhifeng Mao, Chao Yang, Chan-Tat Ng and Chung-Hang Leung
Dalton Trans., 2016, 45, 2762
DOI: 10.1039/C5DT04338G

Role of the (pseudo)halido ligand in ruthenium(ii) p-cymene α-amino acid complexes in speciation, protein reactivity and cytotoxicity
Lorenzo Biancalana, Emanuele Zanda, Mouna Hadiji, Stefano Zacchini, Alessandro Pratesi, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Dalton Trans., 2021, 50, 15760
DOI: 10.1039/D1DT03274G

Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential
P.-S. Kuhn, V. Pichler, A. Roller, M. Hejl, M. A. Jakupec, W. Kandioller and B. K. Keppler
Dalton Trans., 2015, 44, 659
DOI: 10.1039/C4DT01645A

Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines
Poulami Mandal, Bidyut Kumar Kundu, Komal Vyas, Vidya Sabu, A. Helen, Sandeep Singh Dhankhar, C. M. Nagaraja, Debojit Bhattacherjee, Krishna Pada Bhabak and Suman Mukhopadhyay
Dalton Trans., 2018, 47, 517
DOI: 10.1039/C7DT03637J

Metal-based strategies for the fight against COVID-19
Hongyan Li, Shuofeng Yuan, Xueying Wei and Hongzhe Sun
Chem. Commun., 2022, 58, 7466
DOI: 10.1039/D2CC01772E

Hyphenation of lipophilic ruthenium(ii)-diphosphine core with 5-fluorouracil: an effective metallodrug against glioblastoma brain cancer cells
Abhijit Saha, Indranil Mondal, Anuj Kumari, Avinash Kumar Sonkar, Ramranjan Mishra, Ritu Kulshreshtha and Ashis K. Patra
Dalton Trans., 2024, 53, 1551
DOI: 10.1039/D3DT02941G

Use of a fluorinated probe to quantitatively monitor amino acid binding preferences of ruthenium(ii) arene complexes
George S. Biggs, Michael J. O'Neill, Pablo Carames Mendez, Thomas G. Scrase, Yulu Lin, Amzar Muzani Bin-Maarof, Andrew D. Bond, Sally R. Boss and Paul D. Barker
Dalton Trans., 2019, 48, 6910
DOI: 10.1039/C8DT05159C

Aminophosphine ligands as a privileged platform for development of antitumoral ruthenium(ii) arene complexes
L. M. Broomfield, C. Alonso-Moreno, E. Martin, A. Shafir, I. Posadas, V. Ceña and J. A. Castro-Osma
Dalton Trans., 2017, 46, 16113
DOI: 10.1039/C7DT03369A

Syntheses and structural and serum protein protecting activity of ruthenium(ii)–DMSO complexes containing a mercapto ligand
Santosh Kumar Dubey, Sunita Khatkar, Manoj Trivedi, Shikha Gulati, Sanjay Kumar, Nigam P. Rath, Satish Kumar, Raman Lakhia, Neera Ragav and Sumanjeet Kaur
New J. Chem., 2022, 46, 11669
DOI: 10.1039/D2NJ01363K

The non-innocent nature of graphene oxide as a theranostic platform for biomedical applications and its reactivity towards metal-based anticancer drugs
Audrey Mokdad, Konstantinos Dimos, Giorgio Zoppellaro, Jiri Tucek, Jason A. Perman, Ondrej Malina, K. Kristoffer Andersson, Kasibhatta Kumara Ramanatha Datta, Jens Peter Froning and Radek Zboril
RSC Adv., 2015, 5, 76556
DOI: 10.1039/C5RA13831K

Leucine aminopeptidase may contribute to the intrinsic resistance of cancer cells toward cisplatin as revealed by an ultrasensitive fluorescent probe
Qiuyu Gong, Wen Shi, Lihong Li and Huimin Ma
Chem. Sci., 2016, 7, 788
DOI: 10.1039/C5SC03600C

The development of ruthenium(ii) polypyridyl complexes and conjugates forin vitrocellular andin vivoapplications
Fergus E. Poynton, Sandra A. Bright, Salvador Blasco, D. Clive Williams, John M. Kelly and Thorfinnur Gunnlaugsson
Chem. Soc. Rev., 2017, 46, 7706
DOI: 10.1039/C7CS00680B

Comparison of KP1019 and NAMI-A in tumour-mimetic environments
Gemma K. Gransbury, Peter Kappen, Chris J. Glover, James N. Hughes, Aviva Levina, Peter A. Lay, Ian F. Musgrave and Hugh H. Harris
Metallomics, 2016, 8, 762
DOI: 10.1039/C6MT00145A

Impact of the central atom and halido ligand on the structure, antiproliferative activity and selectivity of half-sandwich Ru(ii) and Ir(iii) complexes with a 1,3,4-thiadiazole-based ligand
Radka Křikavová, Michaela Romanovová, Zuzana Jendželovská, Martin Majerník, Lukáš Masaryk, Pavel Zoufalý, David Milde, Jan Moncol, Radovan Herchel, Rastislav Jendželovský and Ivan Nemec
Dalton Trans., 2023, 52, 12717
DOI: 10.1039/D3DT01696J

Synthesis and C–H activation reactions of cyclometalated copper(i) complexes with NCN pincer and 1,3,5-triaza-7-phosphaadamantane derivatives: in vitro antimicrobial and cytotoxic activity
Leila Tabrizi and Hossein Chiniforoshan
New J. Chem., 2017, 41, 10972
DOI: 10.1039/C7NJ02500A

Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer
Maria C Ruiz, Jakob Kljun, Iztok Turel, Ana L Di Virgilio and Ignacio E León
Metallomics, 2019, 11, 666
DOI: 10.1039/c8mt00369f

Combination of Ru(ii) complexes and light: new frontiers in cancer therapy
Cristina Mari, Vanessa Pierroz, Stefano Ferrari and Gilles Gasser
Chem. Sci., 2015, 6, 2660
DOI: 10.1039/C4SC03759F

Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice
Alexander E. Egger, Sarah Theiner, Christoph Kornauth, Petra Heffeter, Walter Berger, Bernhard K. Keppler and Christian G. Hartinger
Metallomics, 2014, 6, 1616
DOI: 10.1039/C4MT00072B

GSH-resistant and highly cytoselective ruthenium(ii)-p-cymene-(imidazo[4,5-f][1,10]phenanthrolin-2-yl)phenol complexes as potential anticancer agents
Binoy Kar, Utpal Das, Sourav De, Sudhindra Pete, Ajay Sharma S, Nilmadhab Roy, Ashok Kumar S. K., Debashis Panda and Priyankar Paira
Dalton Trans., 2021, 50, 10369
DOI: 10.1039/D1DT01604K

Synthesis, structure and N–N bonding character of 1,1-disubstituted indazolium hexafluorophosphate
Yingtang Ning, Masatoshi Kawahata, Kentaro Yamaguchi, Yuko Otani and Tomohiko Ohwada
Chem. Commun., 2018, 54, 1881
DOI: 10.1039/C8CC00183A

Pyrithione-based ruthenium complexes as inhibitors of aldo–keto reductase 1C enzymes and anticancer agents
Jakob Kljun, Maja Anko, Katja Traven, Maša Sinreih, Renata Pavlič, Špela Peršič, Žiga Ude, Elisa Esteve Codina, Jure Stojan, Tea Lanišnik Rižner and Iztok Turel
Dalton Trans., 2016, 45, 11791
DOI: 10.1039/C6DT00668J

Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
Samuel M. Meier-Menches, Christopher Gerner, Walter Berger, Christian G. Hartinger and Bernhard K. Keppler
Chem. Soc. Rev., 2018, 47, 909
DOI: 10.1039/C7CS00332C

Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand
Lorenzo Biancalana, Stefano Zacchini, Nicola Ferri, Maria Giovanna Lupo, Guido Pampaloni and Fabio Marchetti
Dalton Trans., 2017, 46, 16589
DOI: 10.1039/C7DT03385K

Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate
Alexander Rosner, Lukas Skos, Theresa Mendrina, Dina Baier, Michaela Hejl, Yasmin Borutzki, Mathias Gradl, Heiko Geisler, Thomas Mohr, Anton Legin, Michael A. Jakupec, Andrea Bileck, Christopher Gerner, Gunda Koellensperger, Petra Heffeter, Walter Berger, Bernhard K. Keppler, Wolfgang Kandioller and Samuel M. Meier-Menches
Chem. Sci., 2025, 16, 15652
DOI: 10.1039/D5SC00735F

Clioquinol–ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity
Ana Mitrović, Jakob Kljun, Izidor Sosič, Stanislav Gobec, Iztok Turel and Janko Kos
Dalton Trans., 2016, 45, 16913
DOI: 10.1039/C6DT02369J

New ruthenium(ii) coordination compounds possessing bidentate aminomethylphosphane ligands: synthesis, characterization and preliminary biological study in vitro
Michał Płotek, Radosław Starosta, Urszula K. Komarnicka, Agnieszka Skórska-Stania, Małgorzata Jeżowska-Bojczuk, Grażyna Stochel and Agnieszka Kyzioł
Dalton Trans., 2015, 44, 13969
DOI: 10.1039/C5DT01119A

Degradable polyprodrugs: design and therapeutic efficiency
Farzad Seidi, Yajie Zhong, Huining Xiao, Yongcan Jin and Daniel Crespy
Chem. Soc. Rev., 2022, 51, 6652
DOI: 10.1039/D2CS00099G

Antitumor and biological investigation of doubly cyclometalated ruthenium(ii) organometallics derived from benzimidazolyl derivatives
Palani Elumalai, Yong Joon Jeong, Dae Won Park, Dong Hwan Kim, Hyunuk Kim, Se Chan Kang and Ki-Whan Chi
Dalton Trans., 2016, 45, 6667
DOI: 10.1039/C5DT04400F

New organometallic ruthenium(ii) complexes with purine analogs – a wide perspective on their biological application
Marzena Fandzloch, Tomasz Jędrzejewski, Liliana Dobrzańska, Ginés M. Esteban-Parra, Joanna Wiśniewska, Agata Paneth, Piotr Paneth and Jerzy Sitkowski
Dalton Trans., 2021, 50, 5557
DOI: 10.1039/D0DT03974H

Modification of multiwalled carbon nanotubes with a ruthenium drug candidate—indazolium[tetrachlorobis(1H-indazole)ruthenate(iii)] (KP1019 )
Monika Richert, Grzegorz Trykowski, Mariusz Walczyk, Marcin J. Cieślak, Julia Kaźmierczak-Barańska, Karolina Królewska-Golińska, Janusz W. Sobczak and Stanisław Biniak
Dalton Trans., 2020, 49, 16791
DOI: 10.1039/D0DT03528A

Endoplasmic reticulum stress: an arising target for metal-based anticancer agents
A. Paden King and Justin J. Wilson
Chem. Soc. Rev., 2020, 49, 8113
DOI: 10.1039/D0CS00259C

Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds
Ricardo G. Teixeira, Dimas C. Belisario, Xavier Fontrodona, Isabel Romero, Ana Isabel Tomaz, M. Helena Garcia, Chiara Riganti and Andreia Valente
Inorg. Chem. Front., 2021, 8, 1983
DOI: 10.1039/D0QI01344G

Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS
Matthias H. M. Klose, Sarah Theiner, Christoph Kornauth, Samuel M. Meier-Menches, Petra Heffeter, Walter Berger, Gunda Koellensperger and Bernhard K. Keppler
Metallomics, 2018, 10, 388
DOI: 10.1039/C8MT00012C

Metal-based immunogenic cell death inducers for cancer immunotherapy
Jiao Xia Zou, Meng Rui Chang, Nikita A. Kuznetsov, Jia Xuan Kee, Maria V. Babak and Wee Han Ang
Chem. Sci., 2025, 16, 6160
DOI: 10.1039/D4SC08495K

Copper(ii) complexes of the CuN4S core: selective cytotoxicity to cancerous cells, ROS generation and induction of apoptosis
Kakoli Malakar, Balasubramaniam Selvakumaran, Mariappan Murali, Pitchan Arul Prakash, Somasundaram Sangeetha, Winaki P. Sohtun, Mohamed Sultan Mohamed Jaabir and Marappan Velusamy
New J. Chem., 2023, 47, 20070
DOI: 10.1039/D2NJ06170H

Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(iv) complex: better stability yet equipotent to the Pt(ii) analogue
Subhendu Karmakar, Saptarshi Chatterjee, Kallol Purkait and Arindam Mukherjee
Dalton Trans., 2016, 45, 11710
DOI: 10.1039/C6DT00831C

Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer–lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells
Samara R. Alves Rico, Azhar Z. Abbasi, Geise Ribeiro, Taksim Ahmed, Xiao Yu Wu and Denise de Oliveira Silva
Nanoscale, 2017, 9, 10701
DOI: 10.1039/C7NR01582H

Catalytic transfer hydrogenation and anticancer activity of arene–ruthenium compounds incorporating bi-dentate precursors
Yu-Hsiang Chang, Wohn-Jenn Leu, Amitabha Datta, Hung-Chang Hsiao, Chia-Her Lin, Jih-Hwa Guh and Jui-Hsien Huang
Dalton Trans., 2015, 44, 16107
DOI: 10.1039/C5DT01310K

Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos
O. A. Lenis-Rojas, A. R. Fernandes, C. Roma-Rodrigues, P. V. Baptista, F. Marques, D. Pérez-Fernández, J. Guerra-Varela, L. Sánchez, D. Vázquez-García, M. López Torres, A. Fernández and J. J. Fernández
Dalton Trans., 2016, 45, 19127
DOI: 10.1039/C6DT03591D

Near-infrared metal agents assisting precision medicine: from strategic design to bioimaging and therapeutic applications
Chonglu Li, Yida Pang, Yuling Xu, Mengjiao Lu, Le Tu, Qian Li, Amit Sharma, Zhenzhong Guo, Xiangyang Li and Yao Sun
Chem. Soc. Rev., 2023, 52, 4392
DOI: 10.1039/D3CS00227F

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103
B. Happl, T. Balber, P. Heffeter, C. Denk, J. M. Welch, U. Köster, C. Alliot, A.-C. Bonraisin, M. Brandt, F. Haddad, J. H. Sterba, W. Kandioller, M. Mitterhauser, M. Hacker, B. K. Keppler and T. L. Mindt
Dalton Trans., 2024, 53, 6031
DOI: 10.1039/D4DT00118D

{Ru(CO)x}-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo
Gabriella Tamasi, Antonello Merlino, Federica Scaletti, Petra Heffeter, Anton A. Legin, Michael A. Jakupec, Walter Berger, Luigi Messori, Bernhard K. Keppler and Renzo Cini
Dalton Trans., 2017, 46, 3025
DOI: 10.1039/C6DT04295C

Interactions of arene ruthenium metallaprisms with human proteins
Lydia E. H. Paul, Bruno Therrien and Julien Furrer
Org. Biomol. Chem., 2015, 13, 946
DOI: 10.1039/C4OB02194K

Hypoxia efficient and glutathione-resistant cytoselective ruthenium(ii)-p-cymene-arylimidazophenanthroline complexes: biomolecular interaction and live cell imaging
Ashaparna Mondal and Priyankar Paira
Dalton Trans., 2020, 49, 12865
DOI: 10.1039/D0DT02069A

The ruthenium complex assists in nuclear targeting and selective killing of tumor cells
Yu Lu, Di Zhu, Liujia Chan, Bo Hu, MarMar Tuohan, Li Li, Wei Wang and Yuji Wang
Nanoscale, 2023, 15, 11529
DOI: 10.1039/D3NR02707D

DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes
Dejan Lazić, Aleksandar Arsenijević, Ralph Puchta, Živadin D. Bugarčić and Ana Rilak
Dalton Trans., 2016, 45, 4633
DOI: 10.1039/C5DT04132E

A new bis-pyrazolylpyridine ruthenium(iii) complex as a potential anticancer drug:in vitroandin vivoactivity in murine colon cancer
Dejan Lazić, Andreas Scheurer, Dušan Ćoćić, Jelena Milovanović, Aleksandar Arsenijević, Bojana Stojanović, Nebojša Arsenijević, Marija Milovanović and Ana Rilak Simović
Dalton Trans., 2021, 50, 7686
DOI: 10.1039/D1DT00185J

Mitochondrial targeted osmium polypyridyl probe shows concentration dependent uptake, localisation and mechanism of cell death
Karmel Sofia Gkika, Aisling Byrne and Tia E. Keyes
Dalton Trans., 2019, 48, 17461
DOI: 10.1039/C9DT02967B

Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related RuII-p-cymene complexes
Kallol Purkait, Saptarshi Chatterjee, Subhendu Karmakar and Arindam Mukherjee
Dalton Trans., 2016, 45, 8541
DOI: 10.1039/C5DT04781A

Induction of transferrin aggregation by indazolium [tetrachlorobis(1H-indazole)ruthenate(iii)] (KP1019) and its biological function
Klaudyna Śpiewak, Sylwia Świątek, Barbara Jachimska and Małgorzata Brindell
New J. Chem., 2019, 43, 11296
DOI: 10.1039/C9NJ01342C

Potential apoptosis inducing agents based on a new benzimidazole schiff base ligand and its dicopper(ii) complex
Anup Paul, Rakesh Kumar Gupta, Mrigendra Dubey, Gunjan Sharma, Biplob Koch, Geeta Hundal, Maninderjeet Singh Hundal and Daya Shankar Pandey
RSC Adv., 2014, 4, 41228
DOI: 10.1039/C4RA08680E

Investigating the anticancer potential of 4-phenylthiazole derived Ru(ii) and Os(ii) metalacycles
Paul Getreuer, Laura Marretta, Emine Toyoglu, Orsolya Dömötör, Michaela Hejl, Alexander Prado-Roller, Klaudia Cseh, Anton A. Legin, Michael A. Jakupec, Giampaolo Barone, Alessio Terenzi, Bernhard K. Keppler and Wolfgang Kandioller
Dalton Trans., 2024, 53, 5567
DOI: 10.1039/D4DT00245H

Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety
Salah S. Massoud, Febee R. Louka, Madison T. Dial, Andrew J. Malek, Roland C. Fischer, Franz A. Mautner, Ján Vančo, Tomáš Malina, Zdeněk Dvořák and Zdeněk Trávníček
Dalton Trans., 2021, 50, 11521
DOI: 10.1039/D1DT01724A

Ruthenium(ii)–arene complexes as anti-metastatic agents, and related techniques
Chanchal Sonkar, Sayantan Sarkar and Suman Mukhopadhyay
RSC Med. Chem., 2022, 13, 22
DOI: 10.1039/D1MD00220A

Combining a Ru(ii)-arene complex with a NO-releasing nitrate-ester ligand generates cytotoxic activity
Jian Zhao, Kathleen E. Prosser, Stephanie W. Chang, Shradha P. Zakharia and Charles J. Walsby
Dalton Trans., 2016, 45, 18079
DOI: 10.1039/C6DT03661A

Hydrolytic behaviour of mono- and dithiolato-bridged dinuclear arene ruthenium complexes and their interactions with biological ligands
David Stíbal, Lennart Geiser, Georg Süss-Fink and Julien Furrer
RSC Adv., 2016, 6, 38332
DOI: 10.1039/C6RA07701C

Proteomic analysis of the S. cerevisiae response to the anticancer ruthenium complex KP1019
Laura K Stultz, Alexandra Hunsucker, Sydney Middleton, Evan Grovenstein, Jacob O’Leary, Eliot Blatt, Mary Miller, James Mobley and Pamela K Hanson
Metallomics, 2020, 12, 876
DOI: 10.1039/d0mt00008f

Exploring the potential of ruthenium(ii)–phosphine–mercapto complexes as new anticancer agents
Marcos V. Palmeira-Mello, Analu R. Costa, Leticia P. de Oliveira, Olivier Blacque, Gilles Gasser and Alzir A. Batista
Dalton Trans., 2024, 53, 10947
DOI: 10.1039/D4DT01191K

Increasing the cytotoxicity of Ru(ii) polypyridyl complexes by tuning the electron-donating ability of 1,10-phenanthroline ligands
Yang Lu, Zhiying Hou, Mengshan Li, Ning Wang, Jinhui Wang, Feng Ni, Yufen Zhao, Bin Zhang and Ning Xi
Dalton Trans., 2022, 51, 16224
DOI: 10.1039/D2DT02332F

Synthesis of a half-sandwich complex of ruthenium(ii) with a nonsymmetric bis-nitrogen donor ligand: biological investigations
Sana Yarahmadi, Elham Jokar, Zahra Shamsi, Dalia Nahieh, Mehrnoosh Moosavi, Masood Fereidoonnezhad and Hamid R. Shahsavari
New J. Chem., 2023, 47, 6266
DOI: 10.1039/D2NJ06075B

Comparative solution equilibrium studies of antitumor ruthenium(η6-p-cymene) and rhodium(η5-C5Me5) complexes of 8-hydroxyquinolines
Orsolya Dömötör, Veronika F. S. Pape, Nóra V. May, Gergely Szakács and Éva A. Enyedy
Dalton Trans., 2017, 46, 4382
DOI: 10.1039/C7DT00439G

Synthesis, characterization and anticancer mechanism studies of fluorinated cyclometalated ruthenium(ii) complexes
Ya Wen, Cheng Ouyang, Quanwen Li, Thomas W. Rees, Kangqiang Qiu, Liangnian Ji and Hui Chao
Dalton Trans., 2020, 49, 7044
DOI: 10.1039/D0DT01412E

Cytotoxicity and preliminary mode of action studies of novel 2-aryl-4-thiopyrone-based organometallics
Melanie Schmidlehner, Lea S. Flocke, Alexander Roller, Michaela Hejl, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Dalton Trans., 2016, 45, 724
DOI: 10.1039/C5DT02722E

Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates
Anna Notaro and Gilles Gasser
Chem. Soc. Rev., 2017, 46, 7317
DOI: 10.1039/C7CS00356K

Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity
Mickaël Marloye, Haider Inam, Connor J. Moore, Tyler R. Mertens, Aude Ingels, Marilin Koch, Michal O. Nowicki, Véronique Mathieu, Justin R. Pritchard, Samuel G. Awuah, Sean E. Lawler, Franck Meyer, François Dufrasne and Gilles Berger
Inorg. Chem. Front., 2022, 9, 2594
DOI: 10.1039/D2QI00423B

Cellular and cell-free studies of catalytic DNA cleavage by ruthenium polypyridyl complexes containing redox-active intercalating ligands
Cynthia Griffith, Adam S. Dayoub, Thamara Jaranatne, Nagham Alatrash, Ali Mohamedi, Kenneth Abayan, Zachary S. Breitbach, Daniel W. Armstrong and Frederick M. MacDonnell
Chem. Sci., 2017, 8, 3726
DOI: 10.1039/C6SC04094B

Cytotoxic RuII-p-cymene complexes of an anthraimidazoledione: halide dependent solution stability, reactivity and resistance to hypoxia deactivation
Amrita Sarkar, Sourav Acharya, Kumar Khushvant, Kallol Purkait and Arindam Mukherjee
Dalton Trans., 2019, 48, 7187
DOI: 10.1039/C8DT04687E

Glutathione activation of an organometallic half-sandwich anticancer drug candidate by ligand attack
Xin Zhang, Fortuna Ponte, Elisa Borfecchia, Andrea Martini, Carlos Sanchez-Cano, Emilia Sicilia and Peter J. Sadler
Chem. Commun., 2019, 55, 14602
DOI: 10.1039/C9CC06725F

Ru(iii)–TMSO complexes containing azole-based ligands: synthesis and cytotoxicity study
Victoria Meiklejohn, Dilip Depan, Seth P. Boudreaux, Siva Murru, Richard S. Perkins, Frank. R. Fronczek and Radhey S. Srivastava
New J. Chem., 2018, 42, 6858
DOI: 10.1039/C7NJ03267F

Ruthenium–arene complexes bearing naphthyl-substituted 1,3-dioxoindan-2-carboxamides ligands for G-quadruplex DNA recognition
Laura A. Hager, Stephan Mokesch, Claudia Kieler, Silvia Alonso-de Castro, Dina Baier, Alexander Roller, Wolfgang Kandioller, Bernhard K. Keppler, Walter Berger, Luca Salassa and Alessio Terenzi
Dalton Trans., 2019, 48, 12040
DOI: 10.1039/C9DT02078K

Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells
Jun Du, Erlong Zhang, Yao Zhao, Wei Zheng, Yang Zhang, Yu Lin, Zhaoying Wang, Qun Luo, Kui Wu and Fuyi Wang
Metallomics, 2015, 7, 1573
DOI: 10.1039/C5MT00122F

Synthesis, characterization and cytotoxicity of arene–ruthenium(ii) complexes with acylpyrazolones functionalized with aromatic groups in the acyl moiety
Fabio Marchetti, Riccardo Pettinari, Corrado Di Nicola, Claudio Pettinari, Jessica Palmucci, Rosario Scopelliti, Tina Riedel, Bruno Therrien, Agustín Galindo and Paul J. Dyson
Dalton Trans., 2018, 47, 868
DOI: 10.1039/C7DT04249C

Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies
Sudipta Bhattacharyya, Kallol Purkait and Arindam Mukherjee
Dalton Trans., 2017, 46, 8539
DOI: 10.1039/C7DT00938K

Making organoruthenium complexes of 8-hydroxyquinolines more hydrophilic: impact of a novel l-phenylalanine-derived arene ligand on the biological activity
Sanam Movassaghi, Muhammad Hanif, Hannah U. Holtkamp, Tilo Söhnel, Stephen M. F. Jamieson and Christian G. Hartinger
Dalton Trans., 2018, 47, 2192
DOI: 10.1039/C7DT04451H

Synthesis and structure of new binuclear ruthenium(ii) arene benzil bis(benzoylhydrazone) complexes: investigation on antiproliferative activity and apoptosis induction
Mohamed Subarkhan Mohamed Kasim, Saranya Sundar and Ramesh Rengan
Inorg. Chem. Front., 2018, 5, 585
DOI: 10.1039/C7QI00761B

Spatial characterization of redox processes and speciation of Ru(iii) anticancer complexes by 19F magnetic resonance imaging
Gregory A. MacNeil, Stephanie W. Chang, Kathleen E. Prosser, Eric Ye, Devon Heroux, Andrew R. Lewis, Marcel Bally and Charles J. Walsby
Chem. Commun., 2023, 59, 623
DOI: 10.1039/D2CC04830B

Ruthenium arene complexes with triphenylphosphane ligands: cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution
Lorenzo Biancalana, Alessandro Pratesi, Federica Chiellini, Stefano Zacchini, Tiziana Funaioli, Chiara Gabbiani and Fabio Marchetti
New J. Chem., 2017, 41, 14574
DOI: 10.1039/C7NJ02300F

Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(ii) and rhodium(iii) thiosemicarbazone complexes
Muneebah Adams, Carmen de Kock, Peter J. Smith, Kirkwood M. Land, Nicole Liu, Melissa Hopper, Allyson Hsiao, Andrew R. Burgoyne, Tameryn Stringer, Mervin Meyer, Lubbe Wiesner, Kelly Chibale and Gregory S. Smith
Dalton Trans., 2015, 44, 2456
DOI: 10.1039/C4DT03234A

A new C,N-cyclometalated osmium(ii) arene anticancer scaffold with a handle for functionalization and antioxidative properties
Enrique Ortega, Jyoti G. Yellol, Matthias Rothemund, Francisco J. Ballester, Venancio Rodríguez, Gorakh Yellol, Christoph Janiak, Rainer Schobert and José Ruiz
Chem. Commun., 2018, 54, 11120
DOI: 10.1039/C8CC06427J

Bifunctional ruthenium(ii) polypyridyl complexes of curcumin as potential anticancer agents
Shuang Li, Gang Xu, Yuhua Zhu, Jian Zhao and Shaohua Gou
Dalton Trans., 2020, 49, 9454
DOI: 10.1039/D0DT01040E

Synthesis, characterization, and anticancer activity of Ru(p-cymene) complexes bearing pyrazolyl–pyridine type ligands
Arangasamy Mounica, Arumugam Madan Kumar, Nattamai S. P. Bhuvanesh and Mani Ganeshpandian
New J. Chem., 2024, 48, 6392
DOI: 10.1039/D4NJ00259H

Design of an anticancer organoruthenium complex as the guest and polydiacetylene-coated fluorogenic nanocarrier as the host: engineering nanocarrier using ene-yne conjugation for sustained guest release, enhanced anticancer activity and reduced in vivo toxicity
Chezhiyan Sumithaa, Przemyslaw Gajda-Morszewski, Wickneswaran Ishaniya, Themmila Khamrang, Marappan Velusamy, Nattamai Bhuvanesh, Malgorzata Brindell, Olga Mazuryk and Mani Ganeshpandian
Dalton Trans., 2024, 53, 966
DOI: 10.1039/D3DT03358A

Synthesis, characterization, biological activity, DNA and BSA binding study: novel copper(ii) complexes with 2-hydroxy-4-aryl-4-oxo-2-butenoate
Nenad Joksimović, Dejan Baskić, Suzana Popović, Milan Zarić, Marijana Kosanić, Branislav Ranković, Tatjana Stanojković, Sladjana B. Novaković, Goran Davidović, Zorica Bugarčić and Nenad Janković
Dalton Trans., 2016, 45, 15067
DOI: 10.1039/C6DT02257J

Kinetic and mechanistic study on the reactions of ruthenium(ii) chlorophenyl terpyridine complexes with nucleobases, oligonucleotides and DNA
Milan M. Milutinović, Sofi K. C. Elmroth, Goran Davidović, Ana Rilak, Olivera R. Klisurić, Ioannis Bratsos and Živadin D. Bugarčić
Dalton Trans., 2017, 46, 2360
DOI: 10.1039/C6DT04254F

Ruthenium(iii) complexes containing thiazole-based ligands that modulate amyloid-β aggregation
Samantha E Huffman, Gideon K Yawson, Samuel S Fisher, Paige J Bothwell, David C Platt, Marjorie A Jones, Christopher G Hamaker and Michael I Webb
Metallomics, 2020, 12, 491
DOI: 10.1039/d0mt00054j

RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A
Alberta Bergamo, Marco Gerdol, Marianna Lucafò, Chiara Pelillo, Marilena Battaglia, Alberto Pallavicini and Gianni Sava
Metallomics, 2015, 7, 1439
DOI: 10.1039/C5MT00081E

Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes
Zhishan Xu, Yujiao Zhang, Shumiao Zhang, Xianglei Jia, Genshen Zhong, Yuliang Yang, Qing Du, Juanjuan Li and Zhe Liu
Cancer Letters, 2019, 447, 75
DOI: 10.1016/j.canlet.2019.01.018

Development of Piano-Stool ruthenium(II) complexes: Synthesis, characterization, DNA/BSA binding affinity, in vitro cytotoxic and wound healing activity
Hagar E. Badr, Shadia A. Elsayed, Abdel-Nasser Kawde and Ahmed M. El-Hendawy
Inorganic Chemistry Communications, 2025, 181, 115287
DOI: 10.1016/j.inoche.2025.115287

Aspirin-inspired organometallic compounds: Structural characterization and cytotoxicity
Adnan Ashraf, Muhammad Hanif, Mario Kubanik, Tilo Söhnel, Stephen M.F. Jamieson, Arindam Bhattacharyya and Christian G. Hartinger
Journal of Organometallic Chemistry, 2017, 839, 31
DOI: 10.1016/j.jorganchem.2017.01.016

A Proteomic Platform Enables to Test for AML Normalization In Vitro
Samuel M. Meier-Menches, Benjamin Neuditschko, Lukas Janker, Marlene C. Gerner, Klaus G. Schmetterer, Albrecht Reichle and Christopher Gerner
Front. Chem., 2022, 10
DOI: 10.3389/fchem.2022.826346

Metallic elements and their molecular roles in gastric cancer: Pathogenic mechanisms and therapeutic implications
Li-Baihe Jing, Jie Liu, Zi-Hai Yang, Fei-Fei Yang, De-Gui Wang and Yu-Min Li
World J Gastrointest Oncol, 2026, 18
DOI: 10.4251/wjgo.v18.i2.114351

Reactivity and Transformation of Antimetastatic and Cytotoxic Rhodium(III)–Dimethyl Sulfoxide Complexes in Biological Fluids: An XAS Speciation Study
Jun Liang, Aviva Levina, Junteng Jia, Peter Kappen, Chris Glover, Bernt Johannessen and Peter A. Lay
Inorg. Chem., 2019, 58, 4880
DOI: 10.1021/acs.inorgchem.8b03477

Chiral metallic anticancer drugs: A brief-review
Sofi Danish Mukhtar and Mohammad Suhail
Eur. J. Chem., 2022, 13, 483
DOI: 10.5155/eurjchem.13.4.483-490.2312

Cytotoxicity of ruthenium-N,N-disubstituted-N′-acylthioureas complexes
Tamires D. de Oliveira, Ana M. Plutín, Liany Luna-Dulcey, Eduardo E. Castellano, Márcia R. Cominetti and Alzir A. Batista
Materials Science and Engineering: C, 2020, 115, 111106
DOI: 10.1016/j.msec.2020.111106

Binding and Photocleavage Studies of Ru (II) Polypyridyl Complexes with DNA: An In Silico and Antibacterial activity
Navaneetha Nambigari, Aruna Kodipaka, Ravi Kumar Vuradi, Praveen Kumar Airva and Satyanarayana Sirasani
Analytical Chemistry Letters, 2022, 12, 266
DOI: 10.1080/22297928.2021.2021110

ChemInform Abstract: NKP‐1339, the First Ruthenium‐Based Anticancer Drug on the Edge to Clinical Application
Robert Trondl, Petra Heffeter, Christian R. Kowol, Michael A. Jakupec, Walter Berger and Bernhard K. Keppler
ChemInform, 2014, 45
DOI: 10.1002/chin.201436281

Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand
Moumita Maji, Sourav Acharya, Saptarshi Maji, Kallol Purkait, Arnab Gupta and Arindam Mukherjee
Inorg. Chem., 2020, 59, 10262
DOI: 10.1021/acs.inorgchem.0c01433

Half-sandwich ruthenium–arene thiosemicarbazones complexes: Synthesis, characterization, biological evaluation and DFT calculations
Kavita Dhariyal, Shama Parveen, Saurabh Kumar, Monisha Banerjee, Princi Sharma, Sudheer Kumar Singh and Ashok K. Singh
Inorganic Chemistry Communications, 2023, 152, 110678
DOI: 10.1016/j.inoche.2023.110678

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)
K. Jagathesan and Sovan Roy
ChemMedChem, 2024, 19
DOI: 10.1002/cmdc.202400127

Rational Design of Enzyme-Responsive Fluorescent Organoruthenium Prodrug for Real-Time Tracking of Cargo Release and Cytotoxicity
Karnan Sugantharam, Vadde Ramu, Chezhiyan Sumithaa, Aswathy Karanath-Anilkumar, Ganesh Munuswamy-Ramanujam, Nattamai Bhuvanesh, Nils Metzler-Nolte and Mani Ganeshpandian
Inorg. Chem., 2026
DOI: 10.1021/acs.inorgchem.5c04797

Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes
Manpreet Kaur, Loveleen and Raj Kumar
Bioorganic Chemistry, 2020, 105, 104396
DOI: 10.1016/j.bioorg.2020.104396

Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)–p-Cymene Complexes: Influence of Pendant Perfluorous Chains
Patrycja Nowak-Sliwinska, Catherine M. Clavel, Emilia Păunescu, Marije T. te Winkel, Arjan W. Griffioen and Paul J. Dyson
Mol. Pharmaceutics, 2015, 12, 3089
DOI: 10.1021/acs.molpharmaceut.5b00417

Development of highly potent Arene-Ru (II)-ninhydrin complexes for inhibition of cancer cell growth
Sourav De and S.K. Ashok Kumar
Inorganica Chimica Acta, 2020, 508, 119641
DOI: 10.1016/j.ica.2020.119641

Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity
Priyaranjan Kumar, Srikanth Dasari and Ashis K. Patra
European Journal of Medicinal Chemistry, 2017, 136, 52
DOI: 10.1016/j.ejmech.2017.04.076

Biodistribution of the novel anticancer drug sodium trans-[tetrachloridobis(1H-indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
Anna K. Bytzek, Gunda Koellensperger, Bernhard K. Keppler and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2016, 160, 250
DOI: 10.1016/j.jinorgbio.2016.02.037

Ruthenium(II) piano stool coordination compounds with aminomethylphosphanes: Synthesis, characterisation and preliminary biological study in vitro
Michał Płotek, Radosław Starosta, Urszula K. Komarnicka, Agnieszka Skórska-Stania, Przemysław Kołoczek and Agnieszka Kyzioł
Journal of Inorganic Biochemistry, 2017, 170, 178
DOI: 10.1016/j.jinorgbio.2017.02.017

Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes
Lucinda K. Batchelor, Emilia Păunescu, Mylène Soudani, Rosario Scopelliti and Paul J. Dyson
Inorg. Chem., 2017, 56, 9617
DOI: 10.1021/acs.inorgchem.7b01082

Multinuclear biologically active Ru, Rh, Os and Ir arene complexes
Pavel Štarha
Coordination Chemistry Reviews, 2021, 431, 213690
DOI: 10.1016/j.ccr.2020.213690

Four new ruthenium(II) coordination compounds bearing coumarin derivatives as anticancer agents
Qi-Pin Qin, Xiao-Feng Zhou, Ling-Qi Du, Yue-Jiao Liang, Jin-Yuan Cai, Song Sun and Yan Yang
Polyhedron, 2024, 263, 117192
DOI: 10.1016/j.poly.2024.117192

New Ru(III) 2,6‐Bis(2‐Benzimidazolyl)Pyridine Complexes Bearing P‐Sub‐Benzyl Thiosemicarbazones Schiff Base: Synthesis, Characterization, DNA Binding and Anti‐cancer Activity
Ashok K. Singh, Ravindra K. Singh, Kumud Pandav, Swaila Bano, Farha Arshi, Amarendra Kumar, Sudheer Kumar Singh and Ramesh Chandra
Chemistry — An Asian Journal, 2025, 20
DOI: 10.1002/asia.202500059

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer
Elena Domínguez-Jurado, Francisco J. Cimas, José Antonio Castro-Osma, Alberto Juan, Agustín Lara-Sánchez, Antonio Rodríguez-Diéguez, Alexandr Shafir, Alberto Ocaña and Carlos Alonso-Moreno
Pharmaceutics, 2021, 13, 1559
DOI: 10.3390/pharmaceutics13101559

Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines
Zahid Riaz, Betty Y.T. Lee, Julia Stjärnhage, Sanam Movassaghi, Tilo Söhnel, Stephen M.F. Jamieson, Muhammad Ashraf Shaheen, Muhammad Hanif and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2023, 241, 112115
DOI: 10.1016/j.jinorgbio.2022.112115

Ruthenium (II) complex cis-[RuII(ŋ2-O2CC7H7O2)(dppm)2]PF6-hmxbato induces ROS-mediated apoptosis in lung tumor cells producing selective cytotoxicity
Mônica Soares Costa, Yasmim Garcia Gonçalves, Bruna Cristina Borges, Marcelo José Barbosa Silva, Martin Krähenbühl Amstalden, Tássia Rafaella Costa, Lusânia Maria Greggi Antunes, Renata Santos Rodrigues, Veridiana de Melo Rodrigues, Eduardo de Faria Franca, Mariana Alves Pereira Zoia, Thaise Gonçalves de Araújo, Luiz Ricardo Goulart, Gustavo Von Poelhsitz and Kelly Aparecida Geraldo Yoneyama
Sci Rep, 2020, 10
DOI: 10.1038/s41598-020-72420-w

High Ground State Overlap via Quantum Embedding Methods
Mihael Erakovic, Freek Witteveen, Dylan Harley, Jakob Günther, Moritz Bensberg, Oinam Romesh Meitei, Minsik Cho, Troy Van Voorhis, Markus Reiher and Matthias Christandl
PRX Life, 2025, 3
DOI: 10.1103/PRXLife.3.013003

Silica-Based Materials Containing Inorganic Red/NIR Emitters and Their Application in Biomedicine
Yuri A. Vorotnikov, Natalya A. Vorotnikova and Michael A. Shestopalov
Materials, 2023, 16, 5869
DOI: 10.3390/ma16175869

Designing biotin-human serum albumin nanoparticles to enhance the targeting ability of binuclear ruthenium(III) compound
Ming Jiang, Shanhe Li, Junmiao Wu, Wenjuan Li, Xiao-an Wen, Hong Liang and Feng Yang
Journal of Inorganic Biochemistry, 2021, 215, 111318
DOI: 10.1016/j.jinorgbio.2020.111318

Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity
Huzaifa Yasir Khan, Azeem Ahmad, Md Nadir Hassan, Yassir Hasan Khan, Farukh Arjmand and Rizwan Hasan Khan
Coordination Chemistry Reviews, 2024, 501, 215580
DOI: 10.1016/j.ccr.2023.215580

Biological evaluation of nitrile containing Ru(II) polypyridyl complexes as potential photodynamic therapy agents
C. Mari, R. Rubbiani and G. Gasser
Inorganica Chimica Acta, 2017, 454, 21
DOI: 10.1016/j.ica.2015.10.010

The Antitumor and Toxicity Effects of Ruthenium(II) Complexes on Heterotopic Murine Colon Carcinoma Model
Maja Savic, Marija Milovanovic, Vesna Stankovic, Katarina Mihajlovic, Tamara Nikolic Turnic, Ana Rilak Simovic, Nebojsa Arsenijevic and Vladimir Jakovljevic
Experimental and Applied Biomedical Research (EABR), 2025, 26, 233
DOI: 10.2478/sjecr-2022-0028

Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment
Tina Riedel, Olivier Demaria, Olivier Zava, Ana Joncic, Michel Gilliet and Paul J. Dyson
Mol. Pharmaceutics, 2018, 15, 116
DOI: 10.1021/acs.molpharmaceut.7b00764

Anticancer Activity of Bifunctional Organometallic Ru(II) Arene Complexes Containing a 7-Hydroxycoumarin Group
Jian Zhao, Dingyi Zhang, Wuyang Hua, Wanchun Li, Gang Xu and Shaohua Gou
Organometallics, 2018, 37, 441
DOI: 10.1021/acs.organomet.7b00842

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Sang Yeul Lee, Chul Young Kim and Tae-Gyu Nam
DDDT, 2020, Volume 14, 5375
DOI: 10.2147/DDDT.S275007

Coligand-Dependent Cellular Effects and DNA/BSA Binding of Ruthenium(II) Tris(pyrazolylmethane) Complexes
Alberto Gobbo, Ján Vančo, Sara Benetti, Tomáš Malina, Zdeněk Dvořák, Christian Castelli, Alessio Chiappa, Massimo Guelfi, Stefano Zacchini, Tarita Biver, Zdeněk Trávníček and Fabio Marchetti
Inorg. Chem., 2025, 64, 24615
DOI: 10.1021/acs.inorgchem.5c04198

The water soluble ruthenium(II) organometallic compound [Ru( p -cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells
Maura Montani, Gretta V. Badillo Pazmay, Albana Hysi, Giulio Lupidi, Riccardo Pettinari, Valentina Gambini, Martina Tilio, Fabio Marchetti, Claudio Pettinari, Stefano Ferraro, Manuela Iezzi, Cristina Marchini and Augusto Amici
Pharmacological Research, 2016, 107, 282
DOI: 10.1016/j.phrs.2016.03.032

Activation by Oxidation: Ferrocene-Functionalized Ru(II)-Arene Complexes with Anticancer, Antibacterial, and Antioxidant Properties
Changhua Mu, Kathleen E. Prosser, Shane Harrypersad, Gregory A. MacNeil, Rikesh Panchmatia, John R. Thompson, Soumalya Sinha, Jeffrey J. Warren and Charles J. Walsby
Inorg. Chem., 2018, 57, 15247
DOI: 10.1021/acs.inorgchem.8b02542

Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells
Marijana Pavlović, Ana Tadić, Nevenka Gligorijević, Jelena Poljarević, Tamara Petrović, Biljana Dojčinović, Aleksandar Savić, Siniša Radulović, Sanja Grgurić-Šipka and Sandra Aranđelović
Journal of Inorganic Biochemistry, 2020, 210, 111155
DOI: 10.1016/j.jinorgbio.2020.111155

Bioactive ruthenium(II)-arene complexes containing modified 18β-glycyrrhetinic acid ligands
Yaqiong Kong, Feng Chen, Zhi Su, Yong Qian, Fang-xin Wang, Xiuxiu Wang, Jing Zhao, Zong-Wan Mao and Hong-Ke Liu
Journal of Inorganic Biochemistry, 2018, 182, 194
DOI: 10.1016/j.jinorgbio.2018.02.004

The aqueous stability and interactions of organoruthenium compounds with serum proteins, cell culture medium, and human serum
Mie Riisom, Liam Eade, William D J Tremlett and Christian G Hartinger
Metallomics, 2022, 14
DOI: 10.1093/mtomcs/mfac043

Enhanced Cytotoxicity of Half-Sandwich Ruthenium(II) Complex Containing Nitro-Substituted Salicyllimidazo[1,5-a]pyridine toward Hormone-Independent Triple-Negative Breast Cancer Cells
Ibanpynhunlang Passi, Liji Muthirakalayil Abraham, Acily Skadon Worral Wilfred Raj, Manikandan Varadhan, Surya Muthuraman, Madhuri Priya Sivaramakrishnan, Prabha Vadivelu, Ravi Manoharan, Marappan Velusamy and Venugopal Rajendiran
Inorg. Chem., 2025, 64, 14073
DOI: 10.1021/acs.inorgchem.5c00090

Additional functionality for plecstatin-1-analogous anticancer Ru(η6-p-cymene)Cl complexes
Shahid Iqbal, Adnan Ashraf, Anne Dill, Zexiong Lin, Sanam Movassaghi, Muhammad Hanif, Waseeq Ahmad Siddiqui, Stephen M.F. Jamieson and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2026, 276, 113168
DOI: 10.1016/j.jinorgbio.2025.113168

The Differential Distribution of RAPTA-T in Non-Invasive and Invasive Breast Cancer Cells Correlates with Its Anti-Invasive and Anti-Metastatic Effects
Ronald Lee, Stéphane Escrig, Catherine Maclachlan, Graham Knott, Anders Meibom, Gianni Sava and Paul Dyson
IJMS, 2017, 18, 1869
DOI: 10.3390/ijms18091869

An Amphiphilic Ruthenium Polymetallodrug for Combined Photodynamic Therapy and Photochemotherapy In Vivo
Wen Sun, Shuyi Li, Bernhard Häupler, Juan Liu, Shubin Jin, Werner Steffen, Ulrich S. Schubert, Hans‐Jürgen Butt, Xing‐Jie Liang and Si Wu
Advanced Materials, 2017, 29
DOI: 10.1002/adma.201603702

Design and Anticancer Properties of New Water-Soluble Ruthenium–Cyclopentadienyl Complexes
Tânia S. Morais, Fernanda Marques, Paulo J. Amorim Madeira, Maria Paula Robalo and Maria Helena Garcia
Pharmaceuticals, 2022, 15, 862
DOI: 10.3390/ph15070862

Biodegradable Polymeric Delivery Systems of Ruthenium(II) Polypyridyl Complexes for the Treatment of High-Grade Epithelial Ovarian Cancer
Marta Redrado, Kanokon Upitak, Fariba Nemati, Pierre Mesdom, Giulia Salluce, Fan Sun, Carine Robert, Olivier Blacque, Didier Decaudin, Christophe M. Thomas and Gilles Gasser
Chem. Mater., 2025, 37, 9231
DOI: 10.1021/acs.chemmater.5c02113

Review of the Most Important Research Trends in Potential Chemotherapeutics Based on Coordination Compounds of Ruthenium, Rhodium and Iridium
Agnieszka Gilewska, Barbara Barszcz and Joanna Masternak
Pharmaceuticals, 2025, 18, 1728
DOI: 10.3390/ph18111728

DNA condensation induced by metal complexes
Guan-Ying Li, Rui-Lin Guan, Liang-Nian Ji and Hui Chao
Coordination Chemistry Reviews, 2014, 281, 100
DOI: 10.1016/j.ccr.2014.09.005

β‐Diketones as Scaffolds for Anticancer Drug Design – From Organic Building Blocks to Natural Products and Metallodrug Components
Jakob Kljun and Iztok Turel
Eur J Inorg Chem, 2017, 2017, 1655
DOI: 10.1002/ejic.201601314

Oral ruthenium-based PAD4 inhibitor modulates immunogenic cell death and neutrophil extracellular traps in triple-negative breast cancer
Bo Hu, Di Zhu, Liujia Chan, Marmar Tuohan, Wenjing Wang, Yu Lu and Yuji Wang
Journal of Controlled Release, 2025, 386, 114133
DOI: 10.1016/j.jconrel.2025.114133

Dinuclear RuII(bipy)2Derivatives: Structural, Biological, and in Vivo Zebrafish Toxicity Evaluation
Oscar A. Lenis-Rojas, Catarina Roma-Rodrigues, Alexandra R. Fernandes, Fernanda Marques, David Pérez-Fernández, Jorge Guerra-Varela, Laura Sánchez, Digna Vázquez-García, Margarita López-Torres, Alberto Fernández and Jesús J. Fernández
Inorg. Chem., 2017, 56, 7127
DOI: 10.1021/acs.inorgchem.7b00790

Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs
Julien Furrer and Georg Süss-Fink
Coordination Chemistry Reviews, 2016, 309, 36
DOI: 10.1016/j.ccr.2015.10.007

Ionic mononuclear [Fe] and heterodinuclear [Fe,Ru] bis(diphenylphosphino)alkane complexes: Synthesis, spectroscopy, DFT structures, cytotoxicity, and biomolecular interactions
Matylda Odachowski, Robin Neven, Giuditta Perversi, Dario Romano, Cathryn A. Slabber, Mouna Hadiji, Maarten Honing, Yuandi Zhao, Orde Q. Munro and Burgert Blom
Journal of Inorganic Biochemistry, 2023, 242, 112156
DOI: 10.1016/j.jinorgbio.2023.112156

Anticancer Organometallic Osmium(II)‐p‐cymene Complexes
Emilia Păunescu, Patrycja Nowak‐Sliwinska, Catherine M. Clavel, Rosario Scopelliti, Arjan W. Griffioen and Paul J. Dyson
ChemMedChem, 2015, 10, 1539
DOI: 10.1002/cmdc.201500221

Ruthenium Complex HB324 Induces Apoptosis via Mitochondrial Pathway with an Upregulation of Harakiri and Overcomes Cisplatin Resistance in Neuroblastoma Cells In Vitro
Nicola L. Wilke, Hilke Burmeister, Corazon Frias, Ingo Ott and Aram Prokop
IJMS, 2023, 24, 952
DOI: 10.3390/ijms24020952

Half-Sandwich Ru(II) and Os(II) Bathophenanthroline Complexes Containing a Releasable Dichloroacetato Ligand
Pavel Štarha, Zdeněk Trávníček, Ján Vančo and Zdeněk Dvořák
Molecules, 2018, 23, 420
DOI: 10.3390/molecules23020420

Synthesis, Structure, and Antiproliferative Activity of Ruthenium(II) Arene Complexes of Indenoisoquinoline Derivatives
Nathalie Wambang, Nadège Schifano-Faux, Alain Martoriati, Natacha Henry, Brigitte Baldeyrou, Christine Bal-Mahieu, Till Bousquet, Sylvain Pellegrini, Samuel Meignan, Katia Cailliau, Jean-François Goossens, Jean-François Bodart, Peter T. Ndifon and Lydie Pélinski
Organometallics, 2016, 35, 2868
DOI: 10.1021/acs.organomet.6b00440

Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs
Ekaterina Schreiber-Brynzak, Erik Klapproth, Christine Unger, Irene Lichtscheidl-Schultz, Simone Göschl, Sarah Schweighofer, Robert Trondl, Helmut Dolznig, Michael A. Jakupec and Bernhard K. Keppler
Invest New Drugs, 2015, 33, 835
DOI: 10.1007/s10637-015-0260-4

Anticancer Ru(η6-p-cymene) complexes of 2-pyridinecarbothioamides: A structure–activity relationship study
Jahanzaib Arshad, Muhammad Hanif, Sanam Movassaghi, Mario Kubanik, Amir Waseem, Tilo Söhnel, Stephen M.F. Jamieson and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2017, 177, 395
DOI: 10.1016/j.jinorgbio.2017.08.034

Insights into the in vitro Anticancer Effects of Diruthenium‐1
Aneta Koceva‐Chyła, Karolina Matczak, Msc. Paweł Hikisz, Msc. Kamil Durka, Msc. Krzysztof Kochel, Georg Süss‐Fink, Julien Furrer and Konrad Kowalski
ChemMedChem, 2016, 11, 2171
DOI: 10.1002/cmdc.201600315

Synthesis and Preclinical Evaluation of Radiolabeled [103Ru]BOLD-100
Barbara Happl, Marie Brandt, Theresa Balber, Katarína Benčurová, Zeynep Talip, Alexander Voegele, Petra Heffeter, Wolfgang Kandioller, Nicholas P. Van der Meulen, Markus Mitterhauser, Marcus Hacker, Bernhard K. Keppler and Thomas L. Mindt
Pharmaceutics, 2023, 15, 2626
DOI: 10.3390/pharmaceutics15112626

1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)
Hedvika Primasová, Lydia E. H. Paul, Gaëlle Diserens, Ester Primasová, Peter Vermathen, Martina Vermathen and Julien Furrer
Metabolites, 2019, 9, 146
DOI: 10.3390/metabo9070146

Design of a Tris-Heteroleptic Ru(II) Complex with Red-Light Excitation and Remarkably Improved Photobiological Activity
Shuang Li, Jian Zhao, Xinyi Wang, Gang Xu, Shaohua Gou and Qiang Zhao
Inorg. Chem., 2020, 59, 11193
DOI: 10.1021/acs.inorgchem.0c01860

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
Claudia Riccardi, Domenica Musumeci, Marco Trifuoggi, Carlo Irace, Luigi Paduano and Daniela Montesarchio
Pharmaceuticals, 2019, 12, 146
DOI: 10.3390/ph12040146

Positively-charged, chalcone-hydroxypyrone hybrid ruthenium(II)-arene complexes functionalized with ethacrynic acid: Synthesis, characterizaion, and antitumor effect
Yuxin Xuan, Yuxi Yan, Xiaonan Wei, Shuxiang Wang, Jinchao Zhang, Yonghe Tang and Shenghui Li
Journal of Inorganic Biochemistry, 2025, 263, 112778
DOI: 10.1016/j.jinorgbio.2024.112778

Tuning the in vitro cell cytotoxicity of dinuclear arene ruthenium trithiolato complexes: Influence of the arene ligand
Federico Giannini, Lennart Geiser, Lydia E.H. Paul, Thomas Roder, Bruno Therrien, Georg Süss-Fink and Julien Furrer
Journal of Organometallic Chemistry, 2015, 783, 40
DOI: 10.1016/j.jorganchem.2015.02.010

Study on antitumor activity of three ruthenium arene complexes in vitro
Xiaolong Peng, Qiang Tang, Huiyun Zhu, Lijuan Bai, Hua Zhao and Yongjie Chen
Journal of Inorganic Biochemistry, 2023, 247, 112310
DOI: 10.1016/j.jinorgbio.2023.112310

Characterizing guanine’s binding modes with potential Ru(II) monofunctional adducts: A local vibrational mode study
Hunter La Force and Elfi Kraka
Chemical Physics Letters, 2023, 828, 140733
DOI: 10.1016/j.cplett.2023.140733

Heteroleptic ruthenium bioflavonoid complexes: from synthesis to in vitro biological activity
Adnan Zahirović, Emira Kahrović, Marina Cindrić, Sandra Kraljević Pavelić, Mirsada Hukić, Anja Harej and Emir Turkušić
Journal of Coordination Chemistry, 2017, 70, 4030
DOI: 10.1080/00958972.2017.1409893

Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer
Marialuisa Piccolo, Gabriella Misso, Maria Grazia Ferraro, Claudia Riccardi, Antonella Capuozzo, Mayra Rachele Zarone, Francesco Maione, Marco Trifuoggi, Paola Stiuso, Gerardino D’Errico, Michele Caraglia, Luigi Paduano, Daniela Montesarchio, Carlo Irace and Rita Santamaria
Sci Rep, 2019, 9
DOI: 10.1038/s41598-019-43411-3

Combining [Arene–Ru] with Azocarboxamide to Generate a Complex with Cytotoxic Properties
Michael G. Sommer, Petra Kureljak, Damijana Urankar, David Schweinfurth, Nikolina Stojanović, Martina Bubrin, Martin Gazvoda, Maja Osmak, Biprajit Sarkar and Janez Košmrlj
Chemistry A European J, 2014, 20, 17296
DOI: 10.1002/chem.201404448

Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity
Salah S. Massoud, Febee R. Louka, Gerard T. Ducharme, Roland C. Fischer, Franz A. Mautner, Ján Vančo, Radovan Herchel, Zdeněk Dvořák and Zdeněk Trávníček
Journal of Inorganic Biochemistry, 2018, 180, 39
DOI: 10.1016/j.jinorgbio.2017.11.023

First insights into the novel class of organometallic compounds bearing a bidentate selenopyridone coordination motif: Synthesis, characterization, stability and biological investigations
Sophia Harringer, Manuel Matzinger, Natalie Gajic, Michaela Hejl, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Inorganica Chimica Acta, 2020, 513, 119919
DOI: 10.1016/j.ica.2020.119919

Half-Sandwich Ru(p-cymene) Compounds with Diphosphanes: In Vitro and In Vivo Evaluation As Potential Anticancer Metallodrugs
Oscar A. Lenis-Rojas, M. Paula Robalo, Ana Isabel Tomaz, Alexandra R. Fernandes, Catarina Roma-Rodrigues, Ricardo G. Teixeira, Fernanda Marques, Mónica Folgueira, Julián Yáñez, Anabel Alba Gonzalez, Martín Salamini-Montemurri, Dawrin Pech-Puch, Digna Vázquez-García, Margarita López Torres, Alberto Fernández and Jesús J. Fernández
Inorg. Chem., 2021, 60, 2914
DOI: 10.1021/acs.inorgchem.0c02768

Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes
Dandan Zhang, Mengshan Li, A.F.M. Motiur Rahman, Zhongyang Liu and Yang Lu
Journal of Molecular Structure, 2025, 1321, 140044
DOI: 10.1016/j.molstruc.2024.140044

The 1,3-diaryltriazenido(p-cymene)ruthenium(II) complexes with a high in vitro anticancer activity
Jure Vajs, Ivana Steiner, Anamaria Brozovic, Andrej Pevec, Andreja Ambriović-Ristov, Marija Matković, Ivo Piantanida, Damijana Urankar, Maja Osmak and Janez Košmrlj
Journal of Inorganic Biochemistry, 2015, 153, 42
DOI: 10.1016/j.jinorgbio.2015.09.005

New Nanostructured Materials Based on Mesoporous Silica Loaded with Ru(II)/Ru(III) Complexes with Anticancer and Antimicrobial Properties
Gabriela Marinescu, Daniela C. Culita, Teodora Mocanu, Raul-Augustin Mitran, Simona Petrescu, Miruna S. Stan, Mariana C. Chifiriuc and Marcela Popa
Pharmaceutics, 2023, 15, 1458
DOI: 10.3390/pharmaceutics15051458

Repurposing sunscreen as an antibiotic: zinc-activated avobenzone inhibits methicillin-resistant Staphylococcus aureus
Rachel M Andrews, Gretchen E Bollar, A Sophia Giattina, Alex G Dalecki, John R Wallace Jr, Leah Frantz, Kayla Eschliman, Obdulia Covarrubias-Zambrano, Johnathan D Keith, Alexandra Duverger, Frederic Wagner, Frank Wolschendorf, Stefan H Bossmann, Susan E Birket and Olaf Kutsch
Metallomics, 2023, 15
DOI: 10.1093/mtomcs/mfad049

BODIPY-based Ir(III) rectangles containing bis-benzimidazole ligands with highly selective toxicity obtained through self-assembly
Gajendra Gupta, Abhishek Das, Seon Woong Lee, Ji Yeon Ryu, Junseong Lee, Narayana Nagesh, Nripendranath Mandal and Chang Yeon Lee
Journal of Organometallic Chemistry, 2018, 868, 86
DOI: 10.1016/j.jorganchem.2018.04.034

Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review
Alexandra-Cristina Munteanu and Valentina Uivarosi
Pharmaceutics, 2021, 13, 874
DOI: 10.3390/pharmaceutics13060874

Synthesis, characterisation and biological activity of the ruthenium(II) complexes of the N4-tetradentate (N4-TL), 1,6-di(2′-pyridyl)-2,5-dibenzyl-2,5-diazahexane (picenBz2)
Aleksandra Bjelosevic, Jennette Sakoff, Jayne Gilbert, Yingjie Zhang, Brondwyn McGhie, Christopher Gordon and Janice R. Aldrich-Wright
Journal of Inorganic Biochemistry, 2022, 226, 111629
DOI: 10.1016/j.jinorgbio.2021.111629

Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections
Aviva Levina, Debbie Crans and Peter Lay
Pharmaceutics, 2022, 14, 790
DOI: 10.3390/pharmaceutics14040790

Biological applications of Ru(II) polypyridyl complexes
Mariusz Mital and Zyta Ziora
Coordination Chemistry Reviews, 2018, 375, 434
DOI: 10.1016/j.ccr.2018.02.013

RuIII–Morpholine-Derived Thiosemicarbazone-Based Metallodrugs: Lysosome-Targeted Anticancer Agents
Monalisa Mohanty, Sanchita Das, Pratikshya Das Pattanayak, Sudhir Lima, Werner Kaminsky and Rupam Dinda
ACS Appl. Bio Mater., 2025, 8, 1210
DOI: 10.1021/acsabm.4c01536

Thirty Years of the Drug Candidate NAMI‐A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
Enzo Alessio
Eur J Inorg Chem, 2017, 2017, 1549
DOI: 10.1002/ejic.201600986

CuAAC “Click”-Derived Luminescent 2-(2-(4-(4-(Pyridin-2-yl)-1H-1,2,3-triazol-1-yl)butoxy)phenyl)benzo[d]thiazole-Based Ru(II)/Ir(III)/Re(I) Complexes as Anticancer Agents
Lavanya Thilak Babu and Priyankar Paira
ACS Omega, 2023, 8, 32382
DOI: 10.1021/acsomega.3c01639

Oxovanadium(IV) and ruthenium(II) carbonyl complexes of ONS‐donor ligands derived from dehydroacetic acid and dithiocarbazate: Synthesis, characterization, antioxidant activity, DNA binding and in vitro cytotoxicity
Amira M. Sarhan, Shadia A. Elsayed, Mohammad M. Mashaly and Ahmed M. El‐Hendawy
Applied Organom Chemis, 2019, 33
DOI: 10.1002/aoc.4655

Iridium complexes in cancer treatment: a promising complement to Cis-platin –A mini review
Arup Mandal
Journal of Organometallic Chemistry, 2025, 1040, 123814
DOI: 10.1016/j.jorganchem.2025.123814

Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts
Georgi Momekov, Iva Ugrinova, Evdokia Pasheva, Daniela Tsekova and Galina Gencheva
IJMS, 2018, 19, 2451
DOI: 10.3390/ijms19082451

A Biophysical Study of Ru(II) Polypyridyl Complex, Properties and its Interaction with DNA
Navaneetha Nambigari, Aruna Kodipaka, Ravi Kumar Vuradi, Praveen Kumar Airva and Satyanarayana Sirasani
J Fluoresc, 2022, 32, 1211
DOI: 10.1007/s10895-021-02879-x

Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand
Muhammad Hanif, Sally Moon, Matthew P. Sullivan, Sanam Movassaghi, Mario Kubanik, David C. Goldstone, Tilo Söhnel, Stephen M.F. Jamieson and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2016, 165, 100
DOI: 10.1016/j.jinorgbio.2016.06.025

Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation
Orsolya Dömötör, Ricardo G. Teixeira, Gabriella Spengler, Fernando Avecilla, Fernanda Marques, Oscar A. Lenis-Rojas, Cristina P. Matos, Rodrigo F.M. de Almeida, Éva A. Enyedy and Ana Isabel Tomaz
Journal of Inorganic Biochemistry, 2023, 238, 112058
DOI: 10.1016/j.jinorgbio.2022.112058

Azaindoles: Suitable ligands of cytotoxic transition metal complexes
Pavel Štarha and Zdeněk Trávníček
Journal of Inorganic Biochemistry, 2019, 197, 110695
DOI: 10.1016/j.jinorgbio.2019.110695

Palladium analogues as complementary of Cis-platin- a mini review
Arup Mandal
Polyhedron, 2025, 277, 117585
DOI: 10.1016/j.poly.2025.117585

Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process
L. Brescacin, A. Masi, G. Sava and A. Bergamo
J Biol Inorg Chem, 2015, 20, 1163
DOI: 10.1007/s00775-015-1297-8

Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives
Dragiša Obradović, Stefan Nikolić, Ivana Milenković, Marina Milenković, Predrag Jovanović, Vladimir Savić, Alexander Roller, Marija Đorđić Crnogorac, Tatjana Stanojković and Sanja Grgurić-Šipka
Journal of Inorganic Biochemistry, 2020, 210, 111164
DOI: 10.1016/j.jinorgbio.2020.111164

The Anticancer Activity of Indazole Compounds: A Mini Review
Congshan Shang, Yani Hou, Tingting Meng, Min Shi and Guoyan Cui
CTMC, 2021, 21, 363
DOI: 10.2174/1568026620999201124154231

Singlet Oxygen Formation vs Photodissociation for Light-Responsive Protic Ruthenium Anticancer Compounds: The Oxygenated Substituent Determines Which Pathway Dominates
Fengrui Qu, Robert W. Lamb, Colin G. Cameron, Seungjo Park, Olaitan Oladipupo, Jessica L. Gray, Yifei Xu, Houston D. Cole, Marco Bonizzoni, Yonghyun Kim, Sherri A. McFarland, Charles Edwin Webster and Elizabeth T. Papish
Inorg. Chem., 2021, 60, 2138
DOI: 10.1021/acs.inorgchem.0c02027

Tuning In Vitro Cytotoxicity in Diruthenium(I) bis‐Cyclopentadienyl Complexes
Benedetta Bertoncini, Kseniya Glinkina, Stefano Zacchini, Paul J. Dyson, Lorenzo Biancalana and Fabio Marchetti
Applied Organom Chemis, 2025, 39
DOI: 10.1002/aoc.70133

Thermodynamic Genome-Scale Metabolic Modeling of Metallodrug Resistance in Colorectal Cancer
Helena A. Herrmann, Mate Rusz, Dina Baier, Michael A. Jakupec, Bernhard K. Keppler, Walter Berger, Gunda Koellensperger and Jürgen Zanghellini
Cancers, 2021, 13, 4130
DOI: 10.3390/cancers13164130

Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation
Beatriz N. Cunha, Liany Luna-Dulcey, Ana M. Plutin, Rafael G. Silveira, João Honorato, Raúl R. Cairo, Tamires D. de Oliveira, Marcia R. Cominetti, Eduardo E. Castellano and Alzir A. Batista
Inorg. Chem., 2020, 59, 5072
DOI: 10.1021/acs.inorgchem.0c00319

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
Robert H. Berndsen, U. Kulsoom Abdul, Andrea Weiss, Marloes Zoetemelk, Marije T. te Winkel, Paul J. Dyson, Arjan W. Griffioen and Patrycja Nowak-Sliwinska
Angiogenesis, 2017, 20, 245
DOI: 10.1007/s10456-017-9551-z

Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
Vincent H.S. van Rixel, Anja Busemann, Adrien J. Göttle and Sylvestre Bonnet
Journal of Inorganic Biochemistry, 2015, 150, 174
DOI: 10.1016/j.jinorgbio.2015.05.010

Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways
Souvik Roy, Anil Kumar Mondru, Tania Chakraborty, Abhijit Das and Sandipan Dasgupta
Toxicology and Applied Pharmacology, 2022, 434, 115822
DOI: 10.1016/j.taap.2021.115822

Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis
Francyelli Mello-Andrade, Adriana P.M. Guedes, Wanessa C. Pires, Vivianne S. Velozo-Sá, Kezia A. Delmond, Davi Mendes, Matheus S. Molina, Larissa Matuda, Maria Alice Montes de Sousa, Paulo Melo-Reis, Clever C. Gomes, Carlos Henrique Castro, Márcio Aurélio P. Almeida, Carlos F.M. Menck, Alzir A. Batista, Ravshan Burikhanov, Vivek M. Rangnekar and Elisângela Silveira-Lacerda
Journal of Inorganic Biochemistry, 2022, 226, 111625
DOI: 10.1016/j.jinorgbio.2021.111625

Metal Complexes as Promising Matrix Metalloproteinases Regulators
Yen Thi Nguyen, Namdoo Kim and Hyuck Jin Lee
IJMS, 2023, 24, 1258
DOI: 10.3390/ijms24021258

Machine Learning-Enhanced Calculation of Quantum-Classical Binding Free Energies
Moritz Bensberg, Marco Eckhoff, F. Emil Thomasen, William Bro-Jørgensen, Matthew S. Teynor, Valentina Sora, Thomas Weymuth, Raphael T. Husistein, Frederik E. Knudsen, Anders Krogh, Kresten Lindorff-Larsen, Markus Reiher and Gemma C. Solomon
J. Chem. Theory Comput., 2025, 21, 8182
DOI: 10.1021/acs.jctc.5c00388

Coordination-Driven Self-Assembly of Triazole-Based Apoptosis-Inducible Metallomacrocycles
Jatinder Singh, Dae Won Park, Dong Hwan Kim, Nem Singh, Se Chan Kang and Ki-Whan Chi
ACS Omega, 2019, 4, 10810
DOI: 10.1021/acsomega.9b00093

Heteroleptic Copper(I) Complexes of “Scorpionate” Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode
Rais Ahmad Khan, Mohammad Usman, Rajakumar Dhivya, Perumalsamy Balaji, Ali Alsalme, Hamad AlLohedan, Farukh Arjmand, Khalid AlFarhan, Mohammad Abdulkader Akbarsha, Fabio Marchetti, Claudio Pettinari and Sartaj Tabassum
Sci Rep, 2017, 7
DOI: 10.1038/srep45229

Cationic Ru(η6‐p‐cymene) Complexes of 3‐Hydroxy‐4‐pyr(id)ones – Lipophilic Triphenylphosphine as Co‐Ligand Is Key to Highly Stable and Cytotoxic Anticancer Agents
Shahida Parveen, Muhammad Hanif, Sanam Movassaghi, Matthew P. Sullivan, Mario Kubanik, Muhammad Ashraf Shaheen, Tilo Söhnel, Stephen M. F. Jamieson and Christian G. Hartinger
Eur J Inorg Chem, 2017, 2017, 1721
DOI: 10.1002/ejic.201601163

Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, Francesco Maione, Daniela Montesarchio, Michele Caraglia, Luigi Paduano, Rita Santamaria and Carlo Irace
Cells, 2020, 9, 1412
DOI: 10.3390/cells9061412

The medicinal chemistry of ferrocene and its derivatives
Malay Patra and Gilles Gasser
Nat Rev Chem, 2017, 1
DOI: 10.1038/s41570-017-0066

Partially Solvated Dinuclear Ruthenium Compounds Bridged by Quinoxaline-Functionalized Ligands as Ru(II) Photocage Architectures for Low-Energy Light Absorption
Sayan Saha, Bruno Peña and Kim R. Dunbar
Inorg. Chem., 2019, 58, 14568
DOI: 10.1021/acs.inorgchem.9b02232

Synthesis, structure, cytotoxicity, photodynamic reactivities and molecular simulation studies of three [RuNO(Qn)(Pro)Cl] isomeric complexes
Chenyang Liu, Shuxiang Jiao, Yuhua Liu, Tao Wu, Leilei Xie, Lijuan Zhang, Yun Zhang, Wenming Wang and Hongfei Wang
Journal of Molecular Structure, 2025, 1321, 140243
DOI: 10.1016/j.molstruc.2024.140243

Tripodal Half‐Sandwich Rhodium and Iridium Complexes Containing Sulfonate and Pyridinyl Entities as Antitumor Agents
Andrew R. Burgoyne, Catherine H. Kaschula, M. Iqbal Parker and Gregory S. Smith
Eur J Inorg Chem, 2017, 2017, 5379
DOI: 10.1002/ejic.201700704

Rux largely restores lungs in Iraq PM-exposed mice, Up-regulating regulatory T-cells (Tregs)
David Lin, Jonathan Li, Rabail Razi, Niha Qamar, Laurie Levine, Thomas Zimmerman, Sayyed A. Hamidi, Millicent Schmidt, Marc G. Golightly, Todd Rueb, Andrea Harrington, Merrill Garnett, Frank Antonawich, Steven McClain, Edmund Miller, Courtney Cox, Po Hsuan Huang and Anthony M. Szema
Experimental Lung Research, 2018, 44, 153
DOI: 10.1080/01902148.2018.1459957

Synthesis, characterization, in vitro cytotoxicity and anticancer effects of ruthenium(II) complexes on BEL-7402 cells
Cheng Zhang, Bing-Jie Han, Chuan-Chuan Zeng, Shang-Hai Lai, Wei Li, Bing Tang, Dan Wan, Guang-Bin Jiang and Yun-Jun Liu
Journal of Inorganic Biochemistry, 2016, 157, 62
DOI: 10.1016/j.jinorgbio.2016.01.003

Organometallic Glutathione S-Transferase Inhibitors
Emilia Păunescu, Mylène Soudani, Paloma Martin, Rosario Scopelliti, Mario Lo Bello and Paul J. Dyson
Organometallics, 2017, 36, 3313
DOI: 10.1021/acs.organomet.7b00468

Synthesis and characterization of triruthenium carbonyl incorporating 4-pyridones as potential antitumor agents
V.D. Reddy, Divya Dayal, David J. Szalda, Stephen C. Cosenza and M.V. Ramana Reddy
Journal of Organometallic Chemistry, 2018, 872, 102
DOI: 10.1016/j.jorganchem.2018.07.023

Synthesis, Structure, and Antiproliferative Activity of Ruthenium(II) Arene Complexes with N,O-Chelating Pyrazolone-Based β-Ketoamine Ligands
Riccardo Pettinari, Fabio Marchetti, Claudio Pettinari, Agnese Petrini, Rosario Scopelliti, Catherine M. Clavel and Paul J. Dyson
Inorg. Chem., 2014, 53, 13105
DOI: 10.1021/ic502274b

Ruthenium carbonyl containing 4-pyrones as potent anticancer agents
V.D. Reddy, Divya Dayal, David J. Szalda, Stephen C. Cosenza and M.V. Ramana Reddy
Journal of Organometallic Chemistry, 2018, 872, 135
DOI: 10.1016/j.jorganchem.2018.04.014

Investigation of the Relationship between Electronic Structures and Bioactivities of Polypyridyl Ru(II) Complexes
Zhiying Hou, Yang Lu, Bin Zhang, A. F. M. Motiur Rahman, Yufen Zhao, Ning Xi, Ning Wang and Jinhui Wang
Molecules, 2023, 28, 5035
DOI: 10.3390/molecules28135035

Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay
Christian Artner, Hannah U. Holtkamp, Christian G. Hartinger and Samuel M. Meier-Menches
Journal of Inorganic Biochemistry, 2017, 177, 322
DOI: 10.1016/j.jinorgbio.2017.07.010

Synthesis, cytotoxicity and docking studies (with SARS-CoV-2) of water-soluble binuclear Ru-p-cymene complex holding indole thiosemicarbazone ligand
Jebiti Haribabu, Nithya Balakrishnan, Srividya Swaminathan, Jerome Peter, Dasararaju Gayathri, Cesar Echeverria, Nattamai Bhuvanesh and Ramasamy Karvembu
Inorganic Chemistry Communications, 2021, 134, 109029
DOI: 10.1016/j.inoche.2021.109029

Coordination-driven self-assembly and anticancer studies of thiophene-derived donor and arene ruthenium acceptors
Taegeun Kim, Hae Seong Song, Jatinder Singh, Donghyuk Kim, Hyunuk Kim, Se Chan Kang and Ki-Whan Chi
Inorganica Chimica Acta, 2018, 482, 179
DOI: 10.1016/j.ica.2018.05.035

Construction of homo and heteronuclear Ru(II), Ir(III) and Re(I) complexes for target specific cancer therapy
Sudhindra Pete, Nilmadhab Roy, Binoy Kar and Priyankar Paira
Coordination Chemistry Reviews, 2022, 460, 214462
DOI: 10.1016/j.ccr.2022.214462

Induction of Cytotoxicity in Pyridine Analogues of the Anti-metastatic Ru(III) Complex NAMI-A by Ferrocene Functionalization
Changhua Mu, Stephanie W. Chang, Kathleen E. Prosser, Ada W. Y. Leung, Stephanie Santacruz, Thalia Jang, John R. Thompson, Donald T. T. Yapp, Jeffrey J. Warren, Marcel B. Bally, Timothy V. Beischlag and Charles J. Walsby
Inorg. Chem., 2016, 55, 177
DOI: 10.1021/acs.inorgchem.5b02109

Ruthenium(II)–arene complexes of diimines: Effect of diimine intercalation and hydrophobicity on DNA and protein binding and cytotoxicity
Mani Ganeshpandian, Mallayan Palaniandavar, Amsaveni Muruganantham, Swapan K. Ghosh, Anvarbatcha Riyasdeen and Mohammad Abdulkader Akbarsha
Applied Organom Chemis, 2018, 32
DOI: 10.1002/aoc.4154

Synthesis and Antiparasitic Activity of New Conjugates—Organic Drugs Tethered to Trithiolato-Bridged Dinuclear Ruthenium(II)–Arene Complexes
Oksana Desiatkina, Serena K. Johns, Nicoleta Anghel, Ghalia Boubaker, Andrew Hemphill, Julien Furrer and Emilia Păunescu
Inorganics, 2021, 9, 59
DOI: 10.3390/inorganics9080059

Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as a Potential Chemotherapeutic Agent: From Synthesis toIn VivoStudies
Anna Notaro, Angelo Frei, Riccardo Rubbiani, Marta Jakubaszek, Uttara Basu, Severin Koch, Cristina Mari, Mazzarine Dotou, Olivier Blacque, Jérémie Gouyon, Fethi Bedioui, Nils Rotthowe, Rainer F. Winter, Bruno Goud, Stefano Ferrari, Mickaël Tharaud, Martina Řezáčová, Jana Humajová, Pavel Tomšík and Gilles Gasser
J. Med. Chem., 2020, 63, 5568
DOI: 10.1021/acs.jmedchem.0c00431

Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse
Amir Blazevic, Alfred A. Hummer, Petra Heffeter, Walter Berger, Martin Filipits, Giannantonio Cibin, Bernhard K. Keppler and Annette Rompel
Sci Rep, 2017, 7
DOI: 10.1038/srep40966

Synthesis, Structural Characterization, and Catalytic Activity of Indenyl Tris(N‐pyrrolyl)phosphine Complexes of Ruthenium
Matthew J. Stark, Michael J. Shaw, Nigam P. Rath and Eike B. Bauer
Eur J Inorg Chem, 2016, 2016, 1093
DOI: 10.1002/ejic.201501381

Synthesis, characterization, and biological investigation of thiosemicarbazone-ruthenium(II) complexes
Atif Ahmad, Angelica Ellen Graminha, Anam, Saulo H. Mendes Abe, Marcos V. Palmeira-Mello, Sabir Khan, Alzir Azevedo Batista, Wladimir P.D. Badaró, Thales Reggiani de Moura, Ana Maria Romão Polez, Adelino Vieira de Godoy Netto and José Clayston Melo Pereira
Journal of Inorganic Biochemistry, 2026, 113346
DOI: 10.1016/j.jinorgbio.2026.113346

Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos
Golara Golbaghi, Irène Pitard, Matthieu Lucas, Mohammad Mehdi Haghdoost, Yossef López de los Santos, Nicolas Doucet, Shunmoogum A. Patten, J. Thomas Sanderson and Annie Castonguay
European Journal of Medicinal Chemistry, 2020, 188, 112030
DOI: 10.1016/j.ejmech.2019.112030

BODIPY-based Ru(II) and Ir(III) organometallic complexes of avobenzone, a sunscreen material: Potent anticancer agents
Gajendra Gupta, Shirisha Cherukommu, Gunda Srinivas, Seon Woong Lee, Sung Hwan Mun, Jaehoon Jung, Narayana Nagesh and Chang Yeon Lee
Journal of Inorganic Biochemistry, 2018, 189, 17
DOI: 10.1016/j.jinorgbio.2018.08.009

Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells
Fengrui Qu, Seungjo Park, Kristina Martinez, Jessica L. Gray, Fathima Shazna Thowfeik, John A. Lundeen, Ashley E. Kuhn, David J. Charboneau, Deidra L. Gerlach, Molly M. Lockart, James A. Law, Katherine L. Jernigan, Nicole Chambers, Matthias Zeller, Nicholas A. Piro, W. Scott Kassel, Russell H. Schmehl, Jared J. Paul, Edward J. Merino, Yonghyun Kim and Elizabeth T. Papish
Inorg. Chem., 2017, 56, 7519
DOI: 10.1021/acs.inorgchem.7b01065

Varying the metal to ethacrynic acid ratio in ruthenium(ii)/osmium(ii)-p-cymene conjugates
Emilia Păunescu, Mylène Soudani, Catherine M. Clavel and Paul J. Dyson
Journal of Inorganic Biochemistry, 2017, 175, 198
DOI: 10.1016/j.jinorgbio.2017.07.027

Theoretical Determination of Influence of the Metallic State of Oxidation toward Cytotoxic Activity: Case of Ruthenium Complexes
Bamba Kafoumba, Ouattara Wawohinlin Patrice, Diarrassouba Fatogoma, Lamoussa Ouattara, Massapihanhoro Pierre Ouattara, Kouakou Nobel N’guessan, Ehouman Ahissan Donatien and Ziao Nahossé
CC, 2021, 09, 97
DOI: 10.4236/cc.2021.92006

An Experimental and Molecular modelling Study of Ruthenium(II) Polypyridyl Complexes with a Thiazole-Imidazo-Phenanthroline Ligand and their DNA Affinity
Navaneetha Nambigari, Sravani Gudikandula and Satyanarayana Sirasani
J Fluoresc, 2026, 36, 2923
DOI: 10.1007/s10895-026-04723-6

Enhanced DNA damage and anti-proliferative activity of a novel ruthenium complex with a chlorambucil-decorated ligand
Alberto Gobbo, Feihong Chen, Stefano Zacchini, Shaohua Gou and Fabio Marchetti
Journal of Inorganic Biochemistry, 2024, 260, 112703
DOI: 10.1016/j.jinorgbio.2024.112703

NIR‐II Emissive Ru(II) Metallacycle Assisting Fluorescence Imaging and Cancer Therapy
Yifan Fan, Chonglu Li, Suya Bai, Xin Ma, Jingfang Yang, Xiaofang Guan and Yao Sun
Small, 2022, 18
DOI: 10.1002/smll.202201625

The determination of the potential anticancer effects of ruthenium (Ru) arene complexes in PC-3, Du-145, and LNCaP prostate cancer cell lines
Seda Sabah Özcan, Serdar Batıkan Kavukcu, Rehime Yapar, Levent Elmas, İsmail Değerli, Sinem Çakır, Mehmet Korkmaz and Hayati Türkmen
Inorganic Chemistry Communications, 2026, 184, 115999
DOI: 10.1016/j.inoche.2025.115999

Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
Nur Aininie Yusoh, Haslina Ahmad and Martin R. Gill
ChemMedChem, 2020, 15, 2121
DOI: 10.1002/cmdc.202000391

Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment
Kazi Mustafa Mahmud, Mahruba Sultana Niloy, Md Salman Shakil and Md Asiful Islam
Pharmaceutics, 2021, 13, 1295
DOI: 10.3390/pharmaceutics13081295

Toward a new avenue in ruthenium-sulphur chemistry of binuclear μ-sulphido bridged (μ-S)2 complexes having Ru2S2 core: Targeted synthesis, crystal structure, biomolecules interaction and their in vitro anticancer activities
Paranthaman Vijayan, Periasamy Viswanathamurthi, Paramasivam Sugumar, Mondikalipudur Nanjappagounder Ponnuswamy, Krishnaswamy Velmurugan, Raju Nandhakumar, Manickam Dakshinamoorthi Balakumaran and Pudupalayam Thangavelu Kalaichelvan
Inorganica Chimica Acta, 2016, 453, 596
DOI: 10.1016/j.ica.2016.09.024

Transition metals, their organic complexes, and radionuclides promising for medical use
A. P. Orlov, T. P. Trofimova and M. A. Orlova
Russ Chem Bull, 2022, 71, 415
DOI: 10.1007/s11172-022-3429-y

Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates asligands: Loading into nanocarriers and preliminary biological studies
S. Scintilla, L. Brustolin, A. Gambalunga, F. Chiara, A. Trevisan, C. Nardon and D. Fregona
Journal of Inorganic Biochemistry, 2017, 166, 76
DOI: 10.1016/j.jinorgbio.2016.09.009

Substituent Effect on Cytotoxicity and Interaction Profile of DNA/BSA With Selected Terpyridine Derivatives of Ester/Ferrocene and Their Fe(III) and Ru(III) Complexes—A Comparative Analysis
Chayan Pandya, Himanshi Sharma, Rakesh R. Panicker, Snehasish Samal, Daphne Morrison Noble, N. Gokulprasanth, Joydip Mondal, Madhvesh Pathak and Akella Sivaramakrishna
Applied Organom Chemis, 2025, 39
DOI: 10.1002/aoc.8001

Ruthenium arene complex induces cell cycle arrest and apoptosis through activation of P53-mediated signaling pathways
Jianfu Zhao, Xiang Zhang, Hongxing Liu, Zushuang Xiong, Meng Li and Tianfeng Chen
Journal of Organometallic Chemistry, 2019, 898, 120869
DOI: 10.1016/j.jorganchem.2019.07.020

Synthesis, Structure and Cytotoxicity of N,N and N,O‐Coordinated RuII Complexes of 3‐Aminobenzoate Schiff Bases against Triple‐negative Breast Cancer
Arpan Mukherjee, Tuhin Subhra Koley, Ayan Chakraborty, Kallol Purkait and Arindam Mukherjee
Chemistry — An Asian Journal, 2021, 16, 3729
DOI: 10.1002/asia.202100917

Anticancer gold complexes: Controlled activation, precision targeting and beyond
Yuan Wang, Sinan Zhong and Taotao Zou
Journal of Inorganic Biochemistry, 2026, 280, 113315
DOI: 10.1016/j.jinorgbio.2026.113315

Importance of Hydrogen Bonding: Structure–Activity Relationships of Ruthenium(III) Complexes with Pyridine-Based Ligands for Alzheimer’s Disease Therapy
Brendan J. Wall, Mark F. Will, Gideon K. Yawson, Paige J. Bothwell, David C. Platt, C. Fiore Apuzzo, Marjorie A. Jones, Gregory M. Ferrence and Michael I. Webb
J. Med. Chem., 2021, 64, 10124
DOI: 10.1021/acs.jmedchem.1c00360

Role of metallomic strategies in developing ruthenium anticancer drugs
Andrei R. Timerbaev
TrAC Trends in Analytical Chemistry, 2016, 80, 547
DOI: 10.1016/j.trac.2016.04.015

Targeting translation: a promising strategy for anticancer metallodrugs
Enrique Ortega, Gloria Vigueras, Francisco José Ballester and José Ruiz
Coordination Chemistry Reviews, 2021, 446, 214129
DOI: 10.1016/j.ccr.2021.214129

Chitosan–Biotin-Conjugated pH-Responsive Ru(II) Glucose Nanogel: A Dual Pathway of Targeting Cancer Cells and Self-Drug Delivery
Pragti, Bidyut Kumar Kundu, Satyam Singh, Wilson Alphonse Carlton Ranjith, Sayantan Sarkar, Avinash Sonawane and Suman Mukhopadhyay
ACS Appl. Mater. Interfaces, 2023, 15, 43345
DOI: 10.1021/acsami.3c07157

Heterodinuclear Ru–Pt Complexes Bridged with 2,3-Bis(pyridyl)pyrazinyl Ligands: Studies on Kinetics, Deoxyribonucleic Acid/Bovine Serum Albumin Binding and Cleavage, In Vitro Cytotoxicity, and In Vivo Toxicity on Zebrafish Embryo Activities
Rajesh Bellam, Deogratius Jaganyi and Ross Stuart Robinson
ACS Omega, 2022, 7, 26226
DOI: 10.1021/acsomega.2c01845

Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs
Aviva Levina, Anthony R. M. Chetcuti and Peter A. Lay
Biomolecules, 2022, 12, 1319
DOI: 10.3390/biom12091319

Uphill Anion Transporters with Ultrahigh Efficiency Based on N‐Heterocyclic Carbene Metal Complexes
Yangyang Lin, Qin Fu, Zhuorui Kang, Yuting Zhu, Haoxuan Yuan, Changxing Ji, Boyu Zhang, Xian Kong, Peng Shi and Chao Lang
Angew Chem Int Ed, 2025, 64
DOI: 10.1002/anie.202518136

Photo and Ultrasound Facilitated the Release of Nitric Oxide From [Ru(NO)(QnCN)(Pro)Cl] Isomers: Synthesis, Cytotoxicity, DNA Binding, and Theoretical Simulation
Chenyang Liu, Tao Wu, Yuhua Liu, Shuxiang Jiao, Chenjie Qin, Juanjuan Wang, Leilei Xie, Wenming Wang and Hongfei Wang
Chemistry A European J, 2026, 32
DOI: 10.1002/chem.202503317

Evaluation of DNA-binding and DNA-photocleavage ability of tetra-cationic porphyrins containing peripheral [Ru(bpy)2Cl]+ complexes: Insights for photodynamic therapy agents
Vanessa A. Oliveira, Hernán Terenzi, Lucas B. Menezes, Otávio A. Chaves and Bernardo A. Iglesias
Journal of Photochemistry and Photobiology B: Biology, 2020, 211, 111991
DOI: 10.1016/j.jphotobiol.2020.111991

Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action
Mehvash Zaki, Farukh Arjmand and Sartaj Tabassum
Inorganica Chimica Acta, 2016, 444, 1
DOI: 10.1016/j.ica.2016.01.006

Investigation of antibacterial activity and related mechanism of a ruthenium(II) polypyridyl complex
Dongdong Sun, Weiwei Zhang, Endong Yang, Nuan Li, Haiping Liu and Weiyun Wang
Inorganic Chemistry Communications, 2015, 56, 17
DOI: 10.1016/j.inoche.2015.03.044

Tuning photochemical and biological properties of nitro-nitrosyl ruthenium complexes via nitrogen heterocycle geometry: Benzimidazole vs. Indazole
Ivan A. Yakovlev, Julia A. Golubeva, Lyubov S. Klyushova, Dmitry G. Sheven, Gennadiy A. Kostin and Artem A. Mikhailov
Journal of Photochemistry and Photobiology A: Chemistry, 2026, 473, 116897
DOI: 10.1016/j.jphotochem.2025.116897

Synthesis, Structural Elucidation, Cytotoxic, Antimicrobial, Antioxidant, Density Functional Theory and Molecular Docking Studies of Mononuclear Ru(II) Complexes of N4O4-Bearing Macrocyclic Ligands
Subhash, Jyoti, Anita Phor and Ashu Chaudhary
J Inorg Organomet Polym, 2024, 34, 827
DOI: 10.1007/s10904-023-02862-y

Ru(II) carbazole thiosemicarbazone complexes with four membered chelate ring: Synthesis, molecular structures and evaluation of biological activities
Ramasamy Raj Kumar, Rengan Ramesh and Jan Grzegorz Małecki
Journal of Photochemistry and Photobiology B: Biology, 2016, 165, 310
DOI: 10.1016/j.jphotobiol.2016.10.039

Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action
Sabiha Parveen, Farukh Arjmand and Sartaj Tabassum
European Journal of Medicinal Chemistry, 2019, 175, 269
DOI: 10.1016/j.ejmech.2019.04.062

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota, Daniel A. Rodrigues, Debbie C. Crans and Eliezer J. Barreiro
J. Med. Chem., 2018, 61, 5805
DOI: 10.1021/acs.jmedchem.7b01689

Mitochondrial Localization of Highly Fluorescent and Photostable BODIPY-Based Ruthenium(II), Rhodium(III), and Iridium(III) Metal Complexes
Gajendra Gupta, Pratibha Kumari, Ji Yeon Ryu, Junseong Lee, Shaikh M. Mobin and Chang Yeon Lee
Inorg. Chem., 2019, 58, 8587
DOI: 10.1021/acs.inorgchem.9b00898

Metallodrugs: Synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy
Jessica A.O. Rodrigues, Neelakanta S. Kiran, Ankita Chatterjee, Bhupendra G. Prajapati, Namdev Dhas, Adenilson O. dos Santos, Francisco F. de Sousa and Eliana B. Souto
Biochemical Pharmacology, 2025, 231, 116644
DOI: 10.1016/j.bcp.2024.116644

Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity
Petar Čanović, Ana Rilak Simović, Snežana Radisavljević, Ioannis Bratsos, Nicola Demitri, Marina Mitrović, Ivanka Zelen and Živadin D. Bugarčić
J Biol Inorg Chem, 2017, 22, 1007
DOI: 10.1007/s00775-017-1479-7

Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells
Denise Lovison, Dario Alessi, Lorenzo Allegri, Federica Baldan, Maurizio Ballico, Giuseppe Damante, Marilisa Galasso, Daniele Guardavaccaro, Silvia Ruggieri, Andrea Melchior, Daniele Veclani, Chiara Nardon and Walter Baratta
Chemistry A European J, 2022, 28
DOI: 10.1002/chem.202200200

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio and Luigi Messori
Molecules, 2019, 24, 1995
DOI: 10.3390/molecules24101995

Exploring the Molecular Mechanisms Underlying the in vitro Anticancer Effects of Multitarget‐Directed Hydrazone Ruthenium(II)–Arene Complexes
Massimiliano Cuccioloni, Laura Bonfili, Valentina Cecarini, Massimo Nabissi, Riccardo Pettinari, Fabio Marchetti, Riccardo Petrelli, Loredana Cappellacci, Mauro Angeletti and Anna Maria Eleuteri
ChemMedChem, 2020, 15, 105
DOI: 10.1002/cmdc.201900551

Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies
S. Scintilla, L. Brustolin, A. Gambalunga, F. Chiara, A. Trevisan, C. Nardon and D. Fregona
Journal of Inorganic Biochemistry, 2016, 165, 159
DOI: 10.1016/j.jinorgbio.2016.11.018

Ternary Co(II), Ni(II) and Cu(II) complexes containing dipyridophenazine and saccharin: Structures, reactivity, binding interactions with biomolecules and DNA damage activity
Priyaranjan Kumar, Ray J. Butcher and Ashis K. Patra
Inorganica Chimica Acta, 2020, 506, 119532
DOI: 10.1016/j.ica.2020.119532

Bioactive half-sandwich Rh and Ir bipyridyl complexes containing artemisinin
Prinessa Chellan, Vicky M. Avery, Sandra Duffy, Kirkwood M. Land, Christina C. Tam, Jong H. Kim, Luisa W. Cheng, Isolda Romero-Canelón and Peter J. Sadler
Journal of Inorganic Biochemistry, 2021, 219, 111408
DOI: 10.1016/j.jinorgbio.2021.111408

Development of the application of speciation in chemistry
Tamás Kiss, Éva A. Enyedy and Tamás Jakusch
Coordination Chemistry Reviews, 2017, 352, 401
DOI: 10.1016/j.ccr.2016.12.016

Regioselectivity of the C-Metalation of 6-Furylpurine: Importance of Directing Effects
Indranil Sinha, Alexander Hepp, Birgitta Schirmer, Jutta Kösters, Johannes Neugebauer and Jens Müller
Inorg. Chem., 2015, 54, 4183
DOI: 10.1021/acs.inorgchem.5b00450

Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]2+ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells
Baskaran Purushothaman, Parthasarathy Arumugam, Hee Ju, Goutam Kulsi, Annie Agnes Suganya Samson and Joon Myong Song
European Journal of Medicinal Chemistry, 2018, 156, 747
DOI: 10.1016/j.ejmech.2018.07.048

Ligand Characterization and DNA Intercalation of Ru(II) Polypyridyl Complexes: A Local Vibrational Mode Study
Hunter La Force, Marek Freindorf and Elfi Kraka
J. Phys. Chem. A, 2024, 128, 5925
DOI: 10.1021/acs.jpca.4c02954

Poly(alkylidenimine) Dendrimers Functionalized with the Organometallic Moiety [Ru(η5-C5H5)(PPh3)2]+ as Promising Drugs Against Cisplatin-Resistant Cancer Cells and Human Mesenchymal Stem Cells
Marisol Gouveia, João Figueira, Manuel G. Jardim, Rita Castro, Helena Tomás, Kari Rissanen and João Rodrigues
Molecules, 2018, 23, 1471
DOI: 10.3390/molecules23061471

Photochemical and Photobiological Properties of Pyridyl-pyrazol(in)e-Based Ruthenium(II) Complexes with Sub-micromolar Cytotoxicity for Phototherapy
Dmytro Havrylyuk, David K. Heidary, Yang Sun, Sean Parkin and Edith C. Glazer
ACS Omega, 2020, 5, 18894
DOI: 10.1021/acsomega.0c02079

Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy
Cheng Zhang, Tong Kang, Xinyi Wang, Jiaqi Song, Jia Zhang and Guanying Li
Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.1035217

RuII(η6‐p‐cymene) Complexes of Bioactive 1,2‐Benzothiazines: Protein Binding vs. Antitumor Activity
Adnan Ashraf, Mario Kubanik, Farhana Aman, Hannah Holtkamp, Tilo Söhnel, Stephen M. F. Jamieson, Muhammad Hanif, Waseeq Ahmad Siddiqui and Christian G. Hartinger
Eur J Inorg Chem, 2016, 2016, 1376
DOI: 10.1002/ejic.201501361

Comparative solution and structural studies of half-sandwich rhodium and ruthenium complexes bearing curcumin and acetylacetone
János P. Mészáros, Jelena M. Poljarevic, G. Tamás Gál, Nóra V. May, Gabriella Spengler and Éva A. Enyedy
Journal of Inorganic Biochemistry, 2019, 195, 91
DOI: 10.1016/j.jinorgbio.2019.02.015

Biological Properties of Transition Metal Complexes with Metformin and Its Analogues
Daniil A. Rusanov, Jiaying Zou and Maria V. Babak
Pharmaceuticals, 2022, 15, 453
DOI: 10.3390/ph15040453

Ruthenium complexes with abiraterone acetate as antiproliferative agents
Anastasia A. Antonets, Ekaterina V. Spitsyna, Vladimir Yu. Tyurin, Dmitrii M. Mazur, Dmitry S. Yakovlev, Denis A. Babkov, Mariya S. Pshenichnikova, Alexander A. Spasov, Elena R. Milaeva and Alexey A. Nazarov
Journal of Inorganic Biochemistry, 2025, 262, 112754
DOI: 10.1016/j.jinorgbio.2024.112754

Anticancer activity of ruthenium(II) polypyridine complexes bearing pyrrolidine substituents
Olga Mazuryk, Michał Łomzik, David Martineau, Marc Beley, Małgorzata Brindell, Grażyna Stochel and Philippe C. Gros
Inorganica Chimica Acta, 2016, 443, 86
DOI: 10.1016/j.ica.2015.12.021

High-resolution crystal structures of a “half sandwich”-type Ru(II) coordination compound bound to hen egg-white lysozyme and proteinase K
Lykourgos Chiniadis, Ioannis Bratsos, Kostas Bethanis, Michael Karpusas, Petros Giastas and Athanasios Papakyriakou
J Biol Inorg Chem, 2020, 25, 635
DOI: 10.1007/s00775-020-01786-z

Anticancer Activity and Autophagy Involvement of Self-Assembled Arene–Ruthenium Metallacycles
Abhishek Dubey, Yong Joon Jeong, Jae Ho Jo, Sangkook Woo, Dong Hwan Kim, Hyunuk Kim, Se Chan Kang, Peter J. Stang and Ki-Whan Chi
Organometallics, 2015, 34, 4507
DOI: 10.1021/acs.organomet.5b00512

Recent advances in cytotoxicity, cellular uptake and mechanism of action of ruthenium metallodrugs: A review
P Sudhindra, S Ajay Sharma, Nilmadhab Roy, Prithvi Moharana and Priyankar Paira
Polyhedron, 2020, 192, 114827
DOI: 10.1016/j.poly.2020.114827

Half sandwiched RutheniumII complexes: En Route towards the targeted delivery by Human Serum Albumin (HSA)
Suboot Hairat and Mehvash Zaki
Journal of Organometallic Chemistry, 2021, 937, 121732
DOI: 10.1016/j.jorganchem.2021.121732

Synthesis and Cytotoxicity Studies on Ru and Rh Nanoparticles as Potential X-Ray Fluorescence Computed Tomography (XFCT) Contrast Agents
Yuyang Li, Kian Shaker, Martin Svenda, Carmen Vogt, Hans M. Hertz and Muhammet S. Toprak
Nanomaterials, 2020, 10, 310
DOI: 10.3390/nano10020310

Modulation of ruthenium anticancer drugs analogs with tolfenamic acid: Reactivity, biological interactions and growth inhibition of yeast cell
Priyaranjan Kumar, Swati Swagatika, Srikanth Dasari, Raghuvir Singh Tomar and Ashis K. Patra
Journal of Inorganic Biochemistry, 2019, 199, 110769
DOI: 10.1016/j.jinorgbio.2019.110769

A mini-review on Ru(II)-curcumin metal complexes based anticancer agents
Rajdeep Mondal, Mannanthara Kunhumon Noushija, Sajeetha Parveen Banu, Nanjan Pandurangan and Sankarasekaran Shanmugaraju
Inorganica Chimica Acta, 2024, 569, 122156
DOI: 10.1016/j.ica.2024.122156

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates
Sara Seršen, Jakob Kljun, Kushtrim Kryeziu, Rostyslav Panchuk, Beatrix Alte, Wilfried Körner, Petra Heffeter, Walter Berger and Iztok Turel
J. Med. Chem., 2015, 58, 3984
DOI: 10.1021/acs.jmedchem.5b00288

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine–Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties
Afroditi Kokkosi, Elpida Garofallidou, Nikolaos Zacharopoulos, Nikolaos Tsoureas, Konstantina Diamanti, Nikolaos S. Thomaidis, Antigoni Cheilari, Christina Machalia, Evangelia Emmanouilidou and Athanassios I. Philippopoulos
Molecules, 2024, 29, 3215
DOI: 10.3390/molecules29133215

NO Releasing and Anticancer Properties of Octahedral Ruthenium–Nitrosyl Complexes with Equatorial 1H-Indazole Ligands
Ewelina Orlowska, Maria V. Babak, Orsolya Dömötör, Eva A. Enyedy, Peter Rapta, Michal Zalibera, Lukáš Bučinský, Michal Malček, Chinju Govind, Venugopal Karunakaran, Yusuf Chouthury Shaik Farid, Tara E. McDonnell, Dominique Luneau, Dominik Schaniel, Wee Han Ang and Vladimir B. Arion
Inorg. Chem., 2018, 57, 10702
DOI: 10.1021/acs.inorgchem.8b01341

Reactivity of hexanuclear ruthenium metallaprisms towards nucleotides and a DNA decamer
Lydia E. H. Paul, Bruno Therrien and Julien Furrer
J Biol Inorg Chem, 2015, 20, 49
DOI: 10.1007/s00775-014-1208-4

Revisiting metallodrugs for the treatment of skin cancers
Carlos M. Manzano, Douglas H. Nakahata and Raphael E.F. de Paiva
Coordination Chemistry Reviews, 2022, 462, 214506
DOI: 10.1016/j.ccr.2022.214506

Ruthenium(II) Complex with 3,4-Methylenedioxy Cinnamic Acid Induces Cell Cycle Arrest at G0/G1 and Apoptosis via ROS Generation and Bioenergetics Disruption in Non-Small Cell Lung Cancer Cells
Guilherme Álvaro Ferreira-Silva, Caio Cesar Candido, Graciana Yokota Garavelli, Carolina Girotto Pressete, Ester Siqueira Caixeta, Angelica Ellen Graminha, Marília Imaculada Frazão Barbosa, Antônio Carlos Doriguetto, Marisa Ionta and Alexandre Ferro Aissa
ACS Omega, 2025, 10, 28956
DOI: 10.1021/acsomega.5c00526

Synthesis, structures, DNA-binding and anticancer activities of some copper(I)-phosphine complexes
Khlood H. Mashat, Bandar A. Babgi, Mostafa A. Hussien, Muhammad Nadeem Arshad and Magda H. Abdellattif
Polyhedron, 2019, 158, 164
DOI: 10.1016/j.poly.2018.10.062

Half‐Sandwich Metal Complexes with β‐Diketone‐Like Ligands and Their Anticancer Activity
Riccardo Pettinari, Fabio Marchetti, Corrado Di Nicola and Claudio Pettinari
Eur J Inorg Chem, 2018, 2018, 3521
DOI: 10.1002/ejic.201800400

Ruthenium(II)–Arene Thiocarboxylates: Identification of a Stable Dimer Selectively Cytotoxic to Invasive Breast Cancer Cells
Liam J. Stephens, Aviva Levina, Iman Trinh, Victoria L. Blair, Melissa V. Werrett, Peter A. Lay and Philip C. Andrews
ChemBioChem, 2020, 21, 1188
DOI: 10.1002/cbic.201900676

Safety and Efficacy Evaluation In Vivo of a Cationic Nucleolipid Nanosystem for the Nanodelivery of a Ruthenium(III) Complex with Superior Anticancer Bioactivity
Marialuisa Piccolo, Maria Grazia Ferraro, Federica Raucci, Claudia Riccardi, Anella Saviano, Irene Russo Krauss, Marco Trifuoggi, Michele Caraglia, Luigi Paduano, Daniela Montesarchio, Francesco Maione, Gabriella Misso, Rita Santamaria and Carlo Irace
Cancers, 2021, 13, 5164
DOI: 10.3390/cancers13205164

Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands
Sujoy Das, Marcelina Strachanowska, Piotr Wadowski, Michał Juszczak, Paulina Tokarz, Aneta Kosińska, Marcin Palusiak, Agnieszka J. Rybarczyk-Pirek, Kinga Wzgarda-Raj, Saranya Vasudevan, Arkadiusz Chworos, Katarzyna Woźniak and Bogna Rudolf
Sci Rep, 2024, 14
DOI: 10.1038/s41598-024-56339-0

Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug
Katia M. Oliveira, João Honorato, Felipe C. Demidoff, Mario S. Schultz, Chaquip D. Netto, Marcia R. Cominetti, Rodrigo S. Correa and Alzir A. Batista
Journal of Inorganic Biochemistry, 2021, 214, 111289
DOI: 10.1016/j.jinorgbio.2020.111289

Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands
Isabel de la Cueva-Alique, Sara Sierra, Laura Muñoz-Moreno, Adrián Pérez-Redondo, Ana M. Bajo, Isabel Marzo, Lourdes Gude, Tomás Cuenca and Eva Royo
Journal of Inorganic Biochemistry, 2018, 183, 32
DOI: 10.1016/j.jinorgbio.2018.02.018

Aminocarbyne-Alkyne Coupling in Diruthenium Complexes: Exploring the Anticancer Potential of the Resulting Vinyliminium Complexes and Comparison with Diiron Homologues
Benedetta Bertoncini, Zhimei Xiao, Stefano Zacchini, Lorenzo Biancalana, Gilles Gasser and Fabio Marchetti
Inorg. Chem., 2024, 63, 12485
DOI: 10.1021/acs.inorgchem.4c01119

Expression proteomics study to determine metallodrug targets and optimal drug combinations
Ronald F. S. Lee, Alexey Chernobrovkin, Dorothea Rutishauser, Claire S. Allardyce, David Hacker, Kai Johnsson, Roman A. Zubarev and Paul J. Dyson
Sci Rep, 2017, 7
DOI: 10.1038/s41598-017-01643-1

Towards Selective Light‐Activated RuII‐Based Prodrug Candidates
Cristina Mari, Vanessa Pierroz, Anna Leonidova, Stefano Ferrari and Gilles Gasser
Eur J Inorg Chem, 2015, 2015, 3879
DOI: 10.1002/ejic.201500602

Equilibrium, Kinetic, and Computational Studies on the Formation of Cu2+ and Zn2+ Complexes with an Indazole-Containing Azamacrocyclic Scorpiand: Evidence for Metal-Induced Tautomerism
Begoña Verdejo, Laura Acosta-Rueda, M. Paz Clares, Almudena Aguinaco, Manuel G. Basallote, Concepción Soriano, Roberto Tejero and Enrique García-España
Inorg. Chem., 2015, 54, 1983
DOI: 10.1021/ic5029004

Acute toxicity evaluation of a thiazolo arene ruthenium (II) complex in rats
Adriana Grozav, Viorel Miclaus, Oliviu Vostinaru, Steliana Ghibu, Cristian Berce, Ioana Rotar, Cristina Mogosan, Bruno Therrien, Felicia Loghin and Daniela-Saveta Popa
Regulatory Toxicology and Pharmacology, 2016, 80, 233
DOI: 10.1016/j.yrtph.2016.06.018

Synthesis, structure and antiproliferative activity of dinuclear ruthenium arene complexes with differently coordinated thiosemicarbazones
Wei Su, Yuchun Li, Jun‐an Xiao, Yuexing Zhang and Peiyuan Li
Applied Organom Chemis, 2018, 32
DOI: 10.1002/aoc.4420

Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
Hanif-Ur-Rehman, Tatiana E. Freitas, Renata N. Gomes, Alison Colquhoun and Denise de Oliveira Silva
Journal of Inorganic Biochemistry, 2016, 165, 181
DOI: 10.1016/j.jinorgbio.2016.10.003

Die Wechselwirkung mit ribosomalen Proteinen begleitet die Stressinduktion des Wirkstoffkandidaten BOLD‐100/KP1339 im endoplasmatischen Retikulum
Benjamin Neuditschko, Anton A. Legin, Dina Baier, Arno Schintlmeister, Siegfried Reipert, Michael Wagner, Bernhard K. Keppler, Walter Berger, Samuel M. Meier‐Menches and Christopher Gerner
Angewandte Chemie, 2021, 133, 5121
DOI: 10.1002/ange.202015962

Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths
Dipanjan Karati, Shreyasi Meur, Swarupananda Mukherjee and Souvik Roy
Coordination Chemistry Reviews, 2024, 519, 216118
DOI: 10.1016/j.ccr.2024.216118

Synthesis, characterization, and antitumor properties of ruthenium(II) anthraquinone complexes
Jin-Quan Wang, Zi-Zhuo Zhao, Hua-Ben Bo and Qi-Zhu Chen
Journal of Coordination Chemistry, 2016, 69, 177
DOI: 10.1080/00958972.2015.1120291

Electrophoretic separation techniques and their hyphenation to mass spectrometry in biological inorganic chemistry
Hannah Holtkamp, Gerlinde Grabmann and Christian G. Hartinger
ELECTROPHORESIS, 2016, 37, 959
DOI: 10.1002/elps.201500502

Tuning excited state of bipyridyl platinum(II) complexes with bio-active flavonolate ligand: Structures, photoreactivity, and DFT calculations
Xiaozhen Han, Mehdi Sahihi, Sarah Whitfield and Ivan Jimenez
Inorganica Chimica Acta, 2020, 513, 119952
DOI: 10.1016/j.ica.2020.119952

α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes
Lorenzo Biancalana, Lucinda K. Batchelor, Tiziana Funaioli, Stefano Zacchini, Marco Bortoluzzi, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Inorg. Chem., 2018, 57, 6669
DOI: 10.1021/acs.inorgchem.8b00882

The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes
Erika Stefàno, Federica De Castro, Asjad Ali, Michele Benedetti and Francesco Paolo Fanizzi
Molecules, 2025, 30, 3828
DOI: 10.3390/molecules30183828

In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex
Chilaluck C. Konkankit, A. Paden King, Kevin M. Knopf, Teresa L. Southard and Justin J. Wilson
ACS Med. Chem. Lett., 2019, 10, 822
DOI: 10.1021/acsmedchemlett.9b00128

Metallo-Drugs in Cancer Therapy: Past, Present and Future
Roxana Liana Lucaciu, Adriana Corina Hangan, Bogdan Sevastre and Luminița Simona Oprean
Molecules, 2022, 27, 6485
DOI: 10.3390/molecules27196485

Concomitant polymorphism in an organometallic ruthenium(II) complex with an N,N′-donor ligand
Katja Traven, Iztok Turel, Julia Koziskova, Lukáč Bučinský and Jozef Kožíšek
Acta Crystallogr C Struct Chem, 2018, 74, 683
DOI: 10.1107/S2053229618006654

Reactions of Ru(III)-drugs KP1019 and KP418 with guanine, 2′-deoxyguanosine and guanosine: a DFT study
Pramod Kumar Shah, Nihar R. Jena and Pradeep Kumar Shukla
J Mol Model, 2022, 28
DOI: 10.1007/s00894-022-05304-7

Electron Paramagnetic Resonance as a Tool for Studying the Mechanisms of Paramagnetic Anticancer Metallodrugs
Kathleen E. Prosser and Charles J. Walsby
Eur J Inorg Chem, 2017, 2017, 1573
DOI: 10.1002/ejic.201601142

Cytotoxic Ruthenium(II) Complexes of Pyrazolylbenzimidazole Ligands That Inhibit VEGFR2 Phosphorylation
Ayan Chakraborty, Souryadip Roy, Manas Pratim Chakraborty, Shantanu Saha Roy, Kallol Purkait, Tuhin Subhra Koley, Rahul Das, Moulinath Acharya and Arindam Mukherjee
Inorg. Chem., 2021, 60, 18379
DOI: 10.1021/acs.inorgchem.1c02979

Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis
Jakub Cervinka, Alberto Gobbo, Lorenzo Biancalana, Lenka Markova, Vojtech Novohradsky, Massimo Guelfi, Stefano Zacchini, Jana Kasparkova, Viktor Brabec and Fabio Marchetti
J. Med. Chem., 2022, 65, 10567
DOI: 10.1021/acs.jmedchem.2c00722

Use of 1,2,4-triazolo[1,5-a]pyrimidines to design new “piano-stool” ruthenium(II) compounds
Iwona Łakomska, Krystian Stefańczak, Marzena Fandzloch, Jerzy Sitkowski, Beata Filip-Psurska and Andrzej Wojtczak
Polyhedron, 2016, 109, 33
DOI: 10.1016/j.poly.2016.01.038

Ruthenium(III) complexes with imidazole ligands that modulate the aggregation of the amyloid-β peptide via hydrophobic interactions
Gideon K. Yawson, Samantha E. Huffman, Samuel S. Fisher, Paige J. Bothwell, David C. Platt, Marjorie A. Jones, Gregory M. Ferrence, Christopher G. Hamaker and Michael I. Webb
Journal of Inorganic Biochemistry, 2021, 214, 111303
DOI: 10.1016/j.jinorgbio.2020.111303

Recent Considerations in the Application of RAPTA‐C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies
Magdalena Rausch, Paul J. Dyson and Patrycja Nowak‐Sliwinska
Advanced Therapeutics, 2019, 2
DOI: 10.1002/adtp.201900042

Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications
Federica Brescia, Ioannis Titilas, Simona Cacciapuoti and Luca Ronconi
Molecules, 2025, 30, 3537
DOI: 10.3390/molecules30173537

Synthesis, structural characterization and in vitro cytotoxicity assessment of new mononuclear Cu(II) and Co(II) complexes against MDA–MB–231, HCC–1806 and HT–29 cancer cell lines
Masrat Bashir, Imtiyaz Yousuf, Mushtaq Ahmad, Farukh Arjmand and Sartaj Tabassum
Polyhedron, 2023, 229, 116189
DOI: 10.1016/j.poly.2022.116189

Thiourea compounds as multifaceted bioactive agents in medicinal chemistry
Adeeba Khan, Palak Dawar and Suranjan De
Bioorganic Chemistry, 2025, 158, 108319
DOI: 10.1016/j.bioorg.2025.108319

Ruthenium–Cyclopentadienyl Bipyridine–Biotin Based Compounds: Synthesis and Biological Effect
Leonor Côrte-Real, Brittany Karas, Ana Rita Brás, Adhan Pilon, Fernando Avecilla, Fernanda Marques, Ana Preto, Brian T. Buckley, Keith R. Cooper, Cathleen Doherty, M. Helena Garcia and Andreia Valente
Inorg. Chem., 2019, 58, 9135
DOI: 10.1021/acs.inorgchem.9b00735

CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity
Stephanie. W. Chang, Andrew R. Lewis, Kathleen E. Prosser, John R. Thompson, Margarita Gladkikh, Marcel B. Bally, Jeffrey J. Warren and Charles J. Walsby
Inorg. Chem., 2016, 55, 4850
DOI: 10.1021/acs.inorgchem.6b00359

X-ray Structure Analysis of Indazoliumtrans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism
Aleksandar Bijelic, Sarah Theiner, Bernhard K. Keppler and Annette Rompel
J. Med. Chem., 2016, 59, 5894
DOI: 10.1021/acs.jmedchem.6b00600

Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
James P. C. Coverdale, Thaisa Laroiya-McCarron and Isolda Romero-Canelón
Inorganics, 2019, 7, 31
DOI: 10.3390/inorganics7030031

Effect ofN,NCoordination and RuIIHalide Bond in Enhancing Selective Toxicity of a Tyramine-Based RuII(p-Cymene) Complex
Arpan Mukherjee, Sourav Acharya, Kallol Purkait, Kaustav Chakraborty, Ashima Bhattacharjee and Arindam Mukherjee
Inorg. Chem., 2020, 59, 6581
DOI: 10.1021/acs.inorgchem.0c00694

Ruthenium(II) dimethylsulfoxide complex with pyrazole/dithiocarbazate ligand
Analu Rocha Costa, Thacilla Ingrid de Menezes, Ruan Reis Nascimento, Paulo Neilson Marques dos Anjos, Rommel Bezerra Viana, André Gustavo de Araujo Fernandes and Rodrigo Luis Silva Ribeiro Santos
J Therm Anal Calorim, 2019, 138, 1683
DOI: 10.1007/s10973-019-08185-w

Zwitterionic Ru(III) Complexes: Stability of Metal–Ligand Bond and Host–Guest Binding with Cucurbit[7]uril
Sanaz Malali, Jan Chyba, Michal Knor, Michal Horní, Marek Nečas, Jan Novotný and Radek Marek
Inorg. Chem., 2020, 59, 10185
DOI: 10.1021/acs.inorgchem.0c01328

Synthesis, electrochemical, biological and catalytical studies of half-sandwich Ru(II)-NSHC complexes bearing benzothiazol-2-ylidene
Hayriye Tuncer, Rafet Kılınçarslan, Hüseyin Karci, Muhammed Dündar, İlknur Özdemir, Ahmet Koç, Namık Özdemir, Merve Güzel, Metin Ak, İsmail Özdemir and Bekir Çetinkaya
Journal of Molecular Structure, 2024, 1318, 139424
DOI: 10.1016/j.molstruc.2024.139424

Synthesis, spectroscopic characterization and computational study of Ru(II)/DMSO complexes with monocoordinated carbazate ligands
Luana M. Sousa, Diesley M. S. Araújo, Katia M. Oliveira, Letícia P. De Oliveira, Pedro I. S. Maia, Victor M. Deflon, Alzir A. Batista, Antônio E. H. Machado, Wendell Guerra and Gustavo Von Poelhsitz
Journal of Coordination Chemistry, 2020, 73, 1605
DOI: 10.1080/00958972.2020.1777286

An Alkynyl‐Dangling Ru(II) Polypyridine Complex for Targeted Antimicrobial Photodynamic Therapy
Yao Jian, Zhihui Jin, Shuang Qi, Xuwen Da, Zhanhua Wang, Xuesong Wang and Qianxiong Zhou
Chemistry A European J, 2022, 28
DOI: 10.1002/chem.202103359

Recent advances and application of ruthenium complexes in tumor malignancy
Rahul Kanaoujiya, Meenakshi, Shekhar Srivastava, Rasmeet Singh and Ghulam Mustafa
Materials Today: Proceedings, 2023, 72, 2822
DOI: 10.1016/j.matpr.2022.07.098

The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray, Maria V. Babak, Christian G. Hartinger and Paul J. Dyson
Coordination Chemistry Reviews, 2016, 306, 86
DOI: 10.1016/j.ccr.2015.06.014

pH-Responsive luminescence sensing, photoredox catalysis and photodynamic applications of ruthenium(II) photosensitizers bearing imidazo[4,5-f][1,10]phenanthroline scaffolds
Sushil Kumar, Siddhant Singh, Arun Kumar, K.S.R. Murthy and Alok Kumar Singh
Coordination Chemistry Reviews, 2022, 452, 214272
DOI: 10.1016/j.ccr.2021.214272

Metalofármacos en la terapia contra el cáncer
Elizabeth Márquez López, Esmeralda Sánchez Pavón, Rodolfo Peña Rodríguez, Delia Hernández Romero, José M. Rivera Villanueva, Raúl Colorado Peralta and David Morales Morales
rev. TECNOCIENCIA Chih., 2022, 16, e1010
DOI: 10.54167/tch.v16i3.1010

Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes
Adriana Grozav, Ovidiu Balacescu, Loredana Balacescu, Thomas Cheminel, Ioana Berindan-Neagoe and Bruno Therrien
J. Med. Chem., 2015, 58, 8475
DOI: 10.1021/acs.jmedchem.5b00855

First iron(II) organometallic compound acting as ABCB1 inhibitor
Adhan Pilon, Fernando Avecilla, Miklós Mohai, Éva A. Enyedy, Bálint Rácz, Gabriella Spengler, M. Helena Garcia and Andreia Valente
European Journal of Medicinal Chemistry, 2023, 256, 115466
DOI: 10.1016/j.ejmech.2023.115466

Ruthenium-Based Small-Molecule Complexes: A Promising Approach for Drug Discovery
Priyank Purohit, Akanksha Bhatt and Ravi Kumar Mittal
Synlett, 2025, 36, 2791
DOI: 10.1055/s-0043-1773514

Selective Ru(II)/lawsone complexes inhibiting tumor cell growth by apoptosis
Katia M. Oliveira, Luna-Dulcey Liany, Rodrigo S. Corrêa, Victor M. Deflon, Marcia R. Cominetti and Alzir A. Batista
Journal of Inorganic Biochemistry, 2017, 176, 66
DOI: 10.1016/j.jinorgbio.2017.08.019

Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium(III) complexes
Manzoor Ahmad Malik, Md Kausar Raza, Ovas Ahmad Dar, Amadudin, Mohammad Abid, Mohmmad Younus Wani, Abdullah Saad Al-Bogami and Athar Adil Hashmi
Bioorganic Chemistry, 2019, 87, 773
DOI: 10.1016/j.bioorg.2019.03.080

RuII(p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo
Oscar A. Lenis-Rojas, M. Paula Robalo, Ana Isabel Tomaz, Andreia Carvalho, Alexandra R. Fernandes, Fernanda Marques, Mónica Folgueira, Julián Yáñez, Digna Vázquez-García, Margarita López Torres, Alberto Fernández and Jesús J. Fernández
Inorg. Chem., 2018, 57, 13150
DOI: 10.1021/acs.inorgchem.8b01270

Prolongation excitation wavelength of two-photon active photosensitizer for near-infrared light-induced in vitro photodynamic therapy
Zhongwei Xu, Xin Lu, Yuhan Zhu, Chaoya Xiong, Bo Li, Shengli Li, Qiong Zhang, Xiaohe Tian, Dandan Li and Yupeng Tian
Journal of Molecular Structure, 2022, 1254, 132030
DOI: 10.1016/j.molstruc.2021.132030

Exploring the Impact of Phenanthroline‐Based Glycoconjugated Ru(II) Polypyridyl Photosensitizers on Metastasis‐Related Processes
Elena de la Torre‐Rubio, María‐Selma Arias‐Pérez, Lourdes Gude, Tomás Cuenca, Cristina García‐Iriepa and Eva Royo
Chemistry A European J, 2025, 31
DOI: 10.1002/chem.202501105

New highly cytotoxic organic and organometallic bexarotene derivatives
Yulia N. Nosova, Dmitry S. Karlov, Sergey A. Pisarev, Ilya A. Shutkov, Vladimir A. Palyulin, Mathurin Baquié, Elena R. Milaeva, Paul J. Dyson and Alexey A. Nazarov
Journal of Organometallic Chemistry, 2017, 839, 91
DOI: 10.1016/j.jorganchem.2017.03.031

Design Strategies and Medicinal Applications of Metal-Peptidic Bioconjugates
Samuel M. Meier-Menches and Angela Casini
Bioconjugate Chem., 2020, 31, 1279
DOI: 10.1021/acs.bioconjchem.0c00152

Water-soluble Ru(II)-anethole compounds with promising cytotoxicity toward the human gastric cancer cell line AGS
Eduardo Carrillo, Sebastián Ramírez-Rivera, Giuliano Bernal, Gisela Aquea, Catherine Tessini and Franz A. Thomet
Life Sciences, 2019, 217, 193
DOI: 10.1016/j.lfs.2018.12.010

Synthesis, spectral studies, DNA binding, photocleavage, antimicrobial and anticancer activities of isoindol Ru(II) polypyridyl complexes
Ch. Ravi, Ravi Kumar Vuradi, Srishailam Avudoddi, Praveen Kumar Yata, Venkat Reddy Putta, G. Srinivas, Ramchander Merugu and S. Satyanarayana
Nucleosides, Nucleotides & Nucleic Acids, 2019, 38, 788
DOI: 10.1080/15257770.2019.1610890

Exploring the Future of Metal‐Based Anticancer Agents: A Comprehensive Review of Ruthenium‐Based Complexes
Sanyukta Bhattacharya, Tenzin Adon, Karen Dsouza and Honnavalli Yogish Kumar
ChemistrySelect, 2025, 10
DOI: 10.1002/slct.202404147

Enriching BODIPY Triplet States via Ruthenium(II) Conjugation for Improved Photodynamic Therapy
Subhadeep Paul and Arpan Bera
J. Med. Chem., 2026, 69, 721
DOI: 10.1021/acs.jmedchem.5c02024

Highly water-soluble ruthenium(II) terpyridine coordination compounds form stable adducts with blood-borne metal transporting proteins
Marija Nišavić, Milovan Stoiljković, Ivo Crnolatac, Maja Milošević, Ana Rilak and Romana Masnikosa
Arabian Journal of Chemistry, 2018, 11, 291
DOI: 10.1016/j.arabjc.2016.07.021

A Dimetallic Osmium(II) Complex as a Potential Phototherapeutic Agent: Binding and Photocleavage Studies with Plasmid DNA
Shawn Swavey and Kaiyu Li
Eur J Inorg Chem, 2015, 2015, 5551
DOI: 10.1002/ejic.201500995

Increasing the Cytotoxicity of Ru(II) Polypyridyl Complexes by Tuning the Electronic Structure of Dioxo Ligands
Anna Notaro, Marta Jakubaszek, Nils Rotthowe, Federica Maschietto, Robin Vinck, Patrick S. Felder, Bruno Goud, Mickaël Tharaud, Ilaria Ciofini, Fethi Bedioui, Rainer F. Winter and Gilles Gasser
J. Am. Chem. Soc., 2020, 142, 6066
DOI: 10.1021/jacs.9b12464

Upregulation of Glucose-Regulated Protein 78 in Metastatic Cancer Cells Is Necessary for Lung Metastasis Progression
Michael M. Lizardo, James J. Morrow, Tyler E. Miller, Ellen S. Hong, Ling Ren, Arnulfo Mendoza, Charles H. Halsey, Peter C. Scacheri, Lee J. Helman and Chand Khanna
Neoplasia, 2016, 18, 699
DOI: 10.1016/j.neo.2016.09.001

A Maltol‐Containing Ruthenium Polypyridyl Complex as a Potential Anticancer Agent
Anna Notaro, Marta Jakubaszek, Severin Koch, Riccardo Rubbiani, Orsolya Dömötör, Éva A. Enyedy, Mazzarine Dotou, Fethi Bedioui, Mickaël Tharaud, Bruno Goud, Stefano Ferrari, Enzo Alessio and Gilles Gasser
Chemistry A European J, 2020, 26, 4997
DOI: 10.1002/chem.201904877

Structural, spectral characterization and molecular docking analyses of mer-ruthenium (II) complexes containing the bidentate chelating ligands
Sultan Erkan, Serpil Kaya, Koray Sayin and Duran Karakaş
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2020, 224, 117399
DOI: 10.1016/j.saa.2019.117399

Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide
Jahanzaib Arshad, Kelvin K. H. Tong, Sanam Movassaghi, Tilo Söhnel, Stephen M. F. Jamieson, Muhammad Hanif and Christian G. Hartinger
Molecules, 2021, 26, 833
DOI: 10.3390/molecules26040833

Ruthenium anticancer agent KP1019 binds more tightly than NAMI-A to tRNAPhe
Brendan G. Dwyer, Emily Johnson, Efren Cazares, Karen L. McFarlane Holman and Sarah R. Kirk
Journal of Inorganic Biochemistry, 2018, 182, 177
DOI: 10.1016/j.jinorgbio.2018.02.019

Left versus right: Exploring the effects of chiral threading intercalators using optical tweezers
Adam A. Jabak, Nicholas Bryden, Fredrik Westerlund, Per Lincoln, Micah J. McCauley, Ioulia Rouzina, Mark C. Williams and Thayaparan Paramanathan
Biophysical Journal, 2022, 121, 3745
DOI: 10.1016/j.bpj.2022.04.025

Insight into the Biological Activity of Organometallic Acetylsalicylic Acid (Aspirin) Derivatives
Konrad Kowalski
ChemPlusChem, 2019, 84, 403
DOI: 10.1002/cplu.201900086

Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma
Jenifer B. Gifford, Wei Huang, Ann E. Zeleniak, Antreas Hindoyan, Hong Wu, Timothy R. Donahue and Reginald Hill
Molecular Cancer Therapeutics, 2016, 15, 1043
DOI: 10.1158/1535-7163.MCT-15-0774

Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
Mousumi Pal, Utpal Nandi and Debaraj Mukherjee
European Journal of Medicinal Chemistry, 2018, 150, 419
DOI: 10.1016/j.ejmech.2018.03.015

Polymetallic Complexes for Applications as Photosensitisers in Anticancer Photodynamic Therapy
Patrick S. Felder, Sarah Keller and Gilles Gasser
Advanced Therapeutics, 2020, 3
DOI: 10.1002/adtp.201900139

Exploring Metal Complexes for Cancer Treatment: Mechanistic Insights and Therapeutic Potential
Pandey Priya Arun, Ritu Raj Patel, Sudhir Kumar Singh, Kailash Parmar and Meenakshi Singh
Journal of Organometallic Chemistry, 2025, 1035, 123682
DOI: 10.1016/j.jorganchem.2025.123682

Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η6-toluene) complexes of picolinate derivatives
Jelena M. Poljarević, G. Tamás Gál, Nóra V. May, Gabriella Spengler, Orsolya Dömötör, Aleksandar R. Savić, Sanja Grgurić-Šipka and Éva A. Enyedy
Journal of Inorganic Biochemistry, 2018, 181, 74
DOI: 10.1016/j.jinorgbio.2017.12.017

Water-soluble trithiolato-bridged dinuclear ruthenium(II) and osmium(II) arene complexes with bisphosphonate functionalized ligands as anticancer organometallics
Christoph A. Riedl, Alexander Rosner, Sophia Harringer, Philipp Salomon, Michaela Hejl, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Journal of Inorganic Biochemistry, 2021, 225, 111618
DOI: 10.1016/j.jinorgbio.2021.111618

GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells
Min Lin, Yan Mo, Cheng-min Li, Ying-zhe Liu and Xue-ping Feng
Med Oncol, 2025, 42
DOI: 10.1007/s12032-024-02586-0

Challenges and opportunities in the development of metal-based anticancer theranostic agents
Shreyas P. Vaidya, Shubhankar Gadre, Ravi Teja Kamisetti and Malay Patra
Bioscience Reports, 2022, 42
DOI: 10.1042/BSR20212160

Fast repetition rate fs pulsed lasers for advanced PLIM microscopy
Sviatlana Kalinina, Alexander Jelzow, Tobias Plötzing and Angelika Rück
J. Innov. Opt. Health Sci., 2019, 12
DOI: 10.1142/S1793545819400042

Thiocarbonyl-bound metallonitrosyl complexes with visible-light induced DNA cleavage and promising vasodilation activity
Carlos D.S. Silva, Iury A. Paz, Felipe D. Abreu, Aurideia P. de Sousa, Carla P. Veríssimo, Nilberto R.F. Nascimento, Tércio F. Paulo, Davila Zampieri, Marcos N. Eberlin, Ana C.S. Gondim, Loraine C. Andrade, Idalina M.M. Carvalho, Eduardo H.S. Sousa and Luiz G.F. Lopes
Journal of Inorganic Biochemistry, 2018, 182, 83
DOI: 10.1016/j.jinorgbio.2018.02.005

Design, syntheses, characterization, and cytotoxicity studies of novel heterobinuclear oxindolimine copper(II)-platinum(II) complexes
Esther Escribano Aranda, Tiago Araújo Matias, Koiti Araki, Adriana Pires Vieira, Elaine Andrade de Mattos, Pio Colepicolo, Carolina Portela Luz, Fábio Luiz Navarro Marques and Ana Maria da Costa Ferreira
Journal of Inorganic Biochemistry, 2016, 165, 108
DOI: 10.1016/j.jinorgbio.2016.08.001

Synthesis, structure and anticancer properties of new biotin- and morpholine-functionalized ruthenium and osmium half-sandwich complexes
Mickaël Marloye, Haider Inam, Connor J. Moore, Vinciane Debaille, Justin R. Pritchard, Michel Gelbcke, Franck Meyer, François Dufrasne and Gilles Berger
J Biol Inorg Chem, 2021, 26, 535
DOI: 10.1007/s00775-021-01873-9

Uphill Anion Transporters with Ultrahigh Efficiency Based on N‐Heterocyclic Carbene Metal Complexes
Yangyang Lin, Qin Fu, Zhuorui Kang, Yuting Zhu, Haoxuan Yuan, Changxing Ji, Boyu Zhang, Xian Kong, Peng Shi and Chao Lang
Angewandte Chemie, 2025, 137
DOI: 10.1002/ange.202518136

Combination of ICP-MS, capillary electrophoresis, and their hyphenation for probing Ru(III) metallodrug–DNA interactions
Lidia S. Foteeva, Magdalena Matczuk, Katarzyna Pawlak, Svetlana S. Aleksenko, Sergey V. Nosenko, Vasily K. Karandashev, Maciej Jarosz and Andrei R. Timerbaev
Anal Bioanal Chem, 2017, 409, 2421
DOI: 10.1007/s00216-017-0186-0

Ruthenium complexes for breast cancer therapy
Shaheen Sadique, Abeer Ameen Baqer, Abbas Washeel Salman, Muhammad Adnan Iqbal, Mustafa M. Kadim, Faisal Jamil, Adnan Majeed, Shaista Manahil and Areeba Altaf
Reviews in Inorganic Chemistry, 2024, 44, 191
DOI: 10.1515/revic-2023-0010

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections
Assunta D’Amato, Annaluisa Mariconda, Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, Maria Stefania Sinicropi and Pasquale Longo
Pharmaceuticals, 2023, 16, 1729
DOI: 10.3390/ph16121729

Indazole as a Privileged Scaffold: The Derivatives and their Therapeutic Applications
Jinling Qin, Weyland Cheng, Yong-Tao Duan, Hua Yang and Yongfang Yao
ACAMC, 2021, 21, 839
DOI: 10.2174/1871520620999200818160350

Anticancer Activity and In Vitro to In Vivo Mechanistic Recapitulation of Novel Ruthenium-Based Metallodrugs in the Zebrafish Model
Brittany F Karas, Jordan M Hotz, Brian M Gural, Kristin R Terez, Victoria L DiBona, Leonor Côrte-Real, Andreia Valente, Brian T Buckley and Keith R Cooper
Toxicological Sciences, 2021, 182, 29
DOI: 10.1093/toxsci/kfab041

Dinuclear arene ruthenium thiolato complexes with fluorous side-chains
David Stíbal, Tina Riedel, Paul J. Dyson, Georg Süss-Fink and Bruno Therrien
Inorganica Chimica Acta, 2016, 444, 51
DOI: 10.1016/j.ica.2016.01.031

Novel Approach to Generate a Self-Deliverable Ru(II)-Based Anticancer Agent in the Self-Reacting Confined Gel Space
Novina Malviya, Chanchal Sonkar, Rakesh Ganguly, Debojit Bhattacherjee, Krishna Pada Bhabak and Suman Mukhopadhyay
ACS Appl. Mater. Interfaces, 2019, 11, 47606
DOI: 10.1021/acsami.9b17075

Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles
Stephan Mokesch, Klaudia Cseh, Heiko Geisler, Michaela Hejl, Matthias H. M. Klose, Alexander Roller, Samuel M. Meier-Menches, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Front. Chem., 2020, 8
DOI: 10.3389/fchem.2020.00209

Exploring Biginelli hybrids in the AI-driven development of ruthenium complexes: Anticancer activity, DNA/HSA binding study, impacts on apoptosis and BCL-2/BCL-XL suppression
Ana Rilak Simović, Dejan Milenković, Dragana Šeklić, Milena Jovanović, Emilija Milović, Milica Međedović, Milan Vraneš and Nenad Janković
Journal of Inorganic Biochemistry, 2025, 272, 112988
DOI: 10.1016/j.jinorgbio.2025.112988

Cocrystallization and sorption routes of binding ruthenium ions with hydroxyapatite
V. Yu. Yaryshev, A. V. Severin and M. A. Orlova
Russ Chem Bull, 2025, 74, 2805
DOI: 10.1007/s11172-025-4761-9

Perspectives and state-of-the-art use of metal-derived, porous nanomaterials and metallo-drugs for biomedical applications
Paulo Sérgio Taube, Donald Fernandes, Arthur Abinader Vasconcelos, José Arnaldo Santana Costa, Márcio Peres de Araujo, Alan Kelbis Oliveira Lima, Nida Wahab, Elisa Kawana Leal dos Santos, Marcielli Indiara de Oliveira, Juliana Paula da Silva, Karla Furtado Andriani, Tainá Pereira da Silva Oliveira, Marina Carvalho Sampaio, Hugo de Campos Braga, Amanda Cruz Serra de Araújo and Kashif Gul
3 Biotech, 2025, 15
DOI: 10.1007/s13205-025-04540-x

Theoretical determination of the aquation reaction mechanism of cyclometalated benzimidazole Ru(II) and Ir(III) anticancer complexes
Fortuna Ponte, Ida Ritacco, Gloria Mazzone, Nino Russo and Emilia Sicilia
Inorganica Chimica Acta, 2018, 470, 325
DOI: 10.1016/j.ica.2017.06.001

Synthesis, characterization and antitumor mechanism investigation of ruthenium(II) polypyridyl complexes with artesunate moiety
Bi-Chun Chen, Jun-Jian Lu, Ning Jiang, Xiu-Rong Ma, Rong-Tao Li and Rui-Rong Ye
J Biol Inorg Chem, 2021, 26, 909
DOI: 10.1007/s00775-021-01901-8

A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway
Yu Lu, Di Zhu, Lin Gui, Yuanming Li, Wenjing Wang, Jiawang Liu and Yuji Wang
J Nanobiotechnol, 2021, 19
DOI: 10.1186/s12951-021-00799-3

A Dinuclear Osmium(II) Complex Near-Infrared Nanoscopy Probe for Nuclear DNA
Fabian Dröge, Felicity F. Noakes, Stuart A. Archer, Sreejesh Sreedharan, Ahtasham Raza, Craig C. Robertson, Sheila MacNeil, John W. Haycock, Heather Carson, Anthony J. H. M. Meijer, Carl G. W. Smythe, Jorge Bernardino de la Serna, Benjamin Dietzek-Ivanšić and Jim A. Thomas
J. Am. Chem. Soc., 2021, 143, 20442
DOI: 10.1021/jacs.1c10325

Small differences in structure, a large difference in activity – Comparing a new Ru(II)-3-hydroxyiminoflavanone complex with analogous Ru(II) compounds
M. Kasprzak, M. Fabijańska, L. Chęcińska, K. Studzian, M. Markowicz-Piasecka, J. Sikora, E. Mikiciuk-Olasik and J. Ochocki
Inorganica Chimica Acta, 2017, 457, 69
DOI: 10.1016/j.ica.2016.11.021

Redox and apoptotic potential of novel ruthenium complexes in rat blood and heart
Katarina Mihajlovic, Isidora Milosavljevic, Jovana Jeremic, Maja Savic, Jasmina Sretenovic, Ivan Srejovic, Vladimir Zivkovic, Nemanja Jovicic, Milica Paunovic, Sergey Bolevich, Vladimir Jakovljevic and Slobodan Novokmet
Can. J. Physiol. Pharmacol., 2021, 99, 207
DOI: 10.1139/cjpp-2020-0349

Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic N,O-Coordinated Pt(II) and Ru(II) Complexes of Trimethoxy Aniline-Based Schiff Bases
Sourav Acharya, Moumita Maji, Manas Pratim Chakraborty, Indira Bhattacharya, Rahul Das, Arnab Gupta and Arindam Mukherjee
Inorg. Chem., 2021, 60, 3418
DOI: 10.1021/acs.inorgchem.0c03820

Insights into the Protein Ruthenation Mechanism by Antimetastatic Metallodrugs: High-Resolution X-ray Structures of the Adduct Formed between Hen Egg-White Lysozyme and NAMI-A at Various Time Points
Lykourgos Chiniadis, Petros Giastas, Ioannis Bratsos and Athanasios Papakyriakou
Inorg. Chem., 2021, 60, 10729
DOI: 10.1021/acs.inorgchem.1c01441

Non-platinum complexes containing releasable biologically active ligands
Pavel Štarha and Zdeněk Trávníček
Coordination Chemistry Reviews, 2019, 395, 130
DOI: 10.1016/j.ccr.2019.06.001

Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer
Marina Martínez-Carmona, Quy P. Ho, Jérémy Morand, Ana García, Enrique Ortega, Luiza C. S. Erthal, Eduardo Ruiz-Hernandez, M. Dolores Santana, José Ruiz, Maria Vallet-Regí and Yurii K. Gun’ko
Inorg. Chem., 2020, 59, 10275
DOI: 10.1021/acs.inorgchem.0c01436

Anticancer activity of ruthenium(II) plumbagin complexes with polypyridyl as ancillary ligands via inhibiting energy metabolism and GADD45A-mediated cell cycle arrest
Yu-Lan Li, Xiao-Min Zhu, Nan-Feng Chen, Shao-Ting Chen, Yang Yang, Hong Liang and Zhen-Feng Chen
European Journal of Medicinal Chemistry, 2022, 236, 114312
DOI: 10.1016/j.ejmech.2022.114312

A review on the anti-parasitic activity of ruthenium compounds
Shibam Chakraborty, Sumit Ghosh, Shauryabrota Dalui and Avijit Dey
JoBAZ, 2024, 85
DOI: 10.1186/s41936-024-00371-z

Ruthenium-p-Cymene Complexes Incorporating Substituted Pyridine–Quinoline Ligands with –Br (Br-Qpy) and –Phenoxy (OH-Ph-Qpy) Groups for Cytotoxicity and Catalytic Transfer Hydrogenation Studies: Synthesis and Characterization
Alexandros Dritsopoulos, Nikolaos Zacharopoulos, Aigli-Eleonora Peyret, Eftychia Karampella, Nikolaos Tsoureas, Antigoni Cheilari, Christina Machalia, Evangelia Emmanouilidou, Aikaterini K. Andreopoulou, Joannis K. Kallitsis and Athanassios I. Philippopoulos
Chemistry, 2024, 6, 773
DOI: 10.3390/chemistry6040046

Relevance of Fluorinated Ligands to the Design of Metallodrugs for Their Potential Use in Cancer Treatment
José C. Páez-Franco, Miriam R. Zermeño-Ortega, Carmen Myriam de la O-Contreras, Daniel Canseco-González, Jesus R. Parra-Unda, Alcives Avila-Sorrosa, Raúl G. Enríquez, Juan M. Germán-Acacio and David Morales-Morales
Pharmaceutics, 2022, 14, 402
DOI: 10.3390/pharmaceutics14020402

Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance
Andreia Valente, Ana Podolski-Renić, Isabella Poetsch, Nenad Filipović, Óscar López, Iztok Turel and Petra Heffeter
Drug Resistance Updates, 2021, 58, 100778
DOI: 10.1016/j.drup.2021.100778

Anticancer activity studies of ruthenium(II) polypyridyl complexes against human gastric carcinoma SGC-7901 cell
Chuan-Chuan Zeng, Cheng Zhang, Shang-Hai Lai, Hui Yin, Bing Tang, Dan Wan and Yun-Jun Liu
Inorganic Chemistry Communications, 2016, 70, 210
DOI: 10.1016/j.inoche.2016.06.020

Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity
Galdina V. Suárez-Moreno, Delia Hernández-Romero, Óscar García-Barradas, Óscar Vázquez-Vera, Sharon Rosete-Luna, Carlos A. Cruz-Cruz, Aracely López-Monteon, Jesús Carrillo-Ahumada, David Morales-Morales and Raúl Colorado-Peralta
Coordination Chemistry Reviews, 2022, 472, 214790
DOI: 10.1016/j.ccr.2022.214790

Spectroscopic studies on interactions of the tetrakis(acetato)chloridodiruthenium(II,III) complex and the Ru2(II,III)-NSAID-derived metallodrugs of ibuprofen and ketoprofen with human serum albumin
Rodrigo Luis Silva Ribeiro Santos, Rute Nazaré Fernandes Sanches and Denise de Oliveira Silva
Journal of Coordination Chemistry, 2015, 68, 3209
DOI: 10.1080/00958972.2015.1074684

Metals in Cancer Research: Beyond Platinum Metallodrugs
Angela Casini and Alexander Pöthig
ACS Cent. Sci., 2024, 10, 242
DOI: 10.1021/acscentsci.3c01340

A critical analysis of the potential of iron heterobimetallic complexes in anticancer research
Boglárka Tűz, Isabel Correia and Paulo N. Martinho
Journal of Inorganic Biochemistry, 2025, 264, 112813
DOI: 10.1016/j.jinorgbio.2024.112813

α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents
Kaiming Cao, Yang Zhu, Zhuanghao Hou, Manman Liu, Yanyan Yang, Hongze Hu, Yi Dai, Yu Wang, Siming Yuan, Guangming Huang, Jiaming Mei, Peter J. Sadler and Yangzhong Liu
Angew Chem Int Ed, 2023, 62
DOI: 10.1002/anie.202215360

Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy
Sourav De, Sabnaz Kazi, Sabyasachi Banerjee, Subhasis Banerjee, Nandan Sarkar, Suraj Kumar Shah, Yung-Chih Kuo and S.K. Ashok Kumar
Coordination Chemistry Reviews, 2024, 498, 215462
DOI: 10.1016/j.ccr.2023.215462

From Sunscreen to Anticancer Agent: Ruthenium(II) Arene Avobenzone Complexes Display Potent Anticancer Activity
Riccardo Pettinari, Fabio Marchetti, Agnese Petrini, Claudio Pettinari, Giulio Lupidi, Piotr Smoleński, Rosario Scopelliti, Tina Riedel and Paul J. Dyson
Organometallics, 2016, 35, 3734
DOI: 10.1021/acs.organomet.6b00694

Synthesis and Photobiological Activity of Ru(II) Dyads Derived from Pyrrole-2-carboxylate Thionoesters
Deborah A. Smithen, Huimin Yin, Michael H. R. Beh, Marc Hetu, T. Stanley Cameron, Sherri A. McFarland and Alison Thompson
Inorg. Chem., 2017, 56, 4121
DOI: 10.1021/acs.inorgchem.7b00072

A Bioactivel-Phenylalanine-Derived Arene in Multitargeted Organoruthenium Compounds: Impact on the Antiproliferative Activity and Mode of Action
Sanam Movassaghi, Euphemia Leung, Muhammad Hanif, Betty Y. T. Lee, Hannah U. Holtkamp, Jason K. Y. Tu, Tilo Söhnel, Stephen M. F. Jamieson and Christian G. Hartinger
Inorg. Chem., 2018, 57, 8521
DOI: 10.1021/acs.inorgchem.8b01187

Ruthenium(II) Diphosphine Complexes with Mercapto Ligands That Inhibit Topoisomerase IB and Suppress Tumor Growth In Vivo
Monize M. da Silva, Gabriel H. Ribeiro, Mariana S. de Camargo, Antônio G. Ferreira, Leandro Ribeiro, Marília I. F. Barbosa, Victor M. Deflon, Silvia Castelli, Alessandro Desideri, Rodrigo S. Corrêa, Arthur B. Ribeiro, Heloiza D. Nicolella, Saulo D. Ozelin, Denise C. Tavares and Alzir A. Batista
Inorg. Chem., 2021, 60, 14174
DOI: 10.1021/acs.inorgchem.1c01539

Improving the anticancer activity of fluorinated glucosamine and galactosamine analogs by attachment of a ferrocene or ruthenium tetrazene motif
Vojtěch Hamala, Kateřina Ondrášková, Lucie Červenková Šťastná, Aleš Krčil, Monika Müllerová, Martin Kurfiřt, Kateřina Hiršová, Jitka Holčáková, Róbert Gyepes, Ivana Císařová, Jana Bernášková, Roman Hrstka and Jindřich Karban
Applied Organom Chemis, 2024, 38
DOI: 10.1002/aoc.7399

Interactions of (η5-CpRu)-[12]cycloparaphenylene full-sandwich complexes with 9-methylguanine
Konstantinos Ypsilantis, Theodoros Tsolis and Achilleas Garoufis
Inorganic Chemistry Communications, 2021, 134, 108992
DOI: 10.1016/j.inoche.2021.108992

Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes
Bingqing Liu, Susan Monro, Levi Lystrom, Colin G. Cameron, Katsuya Colón, Huimin Yin, Svetlana Kilina, Sherri A. McFarland and Wenfang Sun
Inorg. Chem., 2018, 57, 9859
DOI: 10.1021/acs.inorgchem.8b00789

Use of anethole-type ligands to design cytotoxic organometallic ruthenium compounds: An experimental and computational study
Ricardo A. Delgado, Antonio Galdámez, Catherine Tessini, Sebastián Ramírez-Rivera, Gisela Aquea, Giuliano Bernal, Balazs Pinter and Franz A. Thomet
Journal of Organometallic Chemistry, 2020, 908, 121094
DOI: 10.1016/j.jorganchem.2019.121094

Synthesis, biological activities studies of ruthenium(II) polypyridyl complexes
Bing Tang, Bing-Jie Han, Dan Wan, Shang-Hai Lai, Xiu-Zhen Wang, Cheng Zhang, Chuan-Chuan Zeng and Yun-Jun Liu
Transit Met Chem, 2017, 42, 373
DOI: 10.1007/s11243-016-0106-8

Nucleobase Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity
Diogo E. L. Carvalho, Katia M. Oliveira, Larissa M. Bomfim, Milena B. P. Soares, Daniel P. Bezerra, Alzir A. Batista and Rodrigo S. Correa
ACS Omega, 2020, 5, 122
DOI: 10.1021/acsomega.9b01921

Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line
Pavel Štarha, Lucie Hanousková, Zdeněk Trávníček and Jason B. Love
PLoS ONE, 2015, 10, e0143871
DOI: 10.1371/journal.pone.0143871

Response Profiling Using Shotgun Proteomics Enables Global Metallodrug Mechanisms of Action To Be Established
Dominique Kreutz, Andrea Bileck, Kerstin Plessl, Denise Wolrab, Michael Groessl, Bernhard K. Keppler, Samuel M. Meier and Christopher Gerner
Chemistry A European J, 2017, 23, 1881
DOI: 10.1002/chem.201604516

Cytotoxic organometallic [Ru(η6-anethole)(en)(X)]PF6 (X = Br or I) complexes: Synthesis, characterization and in vitro biological evaluation
David Astudillo, Antonio Galdámez, Maritza E. Sanguinetti, Joan Villena and Franz A. Thomet
Inorganic Chemistry Communications, 2017, 84, 221
DOI: 10.1016/j.inoche.2017.08.024

Synthesis, cytotoxic and antitubercular activities of copper(II) complexes with heterocyclic bases and 3-hydroxypicolinic acid
Janaina do Couto Almeida, Ivana M. Marzano, Marcos Pivatto, Norberto P. Lopes, Ana M. Da Costa Ferreira, F.R. Pavan, I.C. Silva, Elene C. Pereira-Maia, G. Von Poelhsitz and Wendell Guerra
Inorganica Chimica Acta, 2016, 446, 87
DOI: 10.1016/j.ica.2016.03.005

Comparative equilibrium and structural studies of new pentamethylcyclopentadienyl rhodium complexes bearing (O,N) donor bidentate ligands
Orsolya Dömötör, Carmen M. Hackl, Krisztina Bali, Alexander Roller, Michaela Hejl, Michael A. Jakupec, Bernhard K. Keppler, Wolfgang Kandioller and Éva A. Enyedy
Journal of Organometallic Chemistry, 2017, 846, 287
DOI: 10.1016/j.jorganchem.2017.06.027

Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
Wen Sun, Raweewan Thiramanas, Leonardo D. Slep, Xiaolong Zeng, Volker Mailänder and Si Wu
Chemistry A European J, 2017, 23, 10832
DOI: 10.1002/chem.201701224

Synthesis, structural, DFT studies and antibacterial evaluation of Cp∗ rhodium and Cp∗ iridium complexes using hydrazide based dipyridyl ketone ligand
A. Basava Punna Rao, Narasinga Rao Palepu, Debojit Kumar Deb, A. Uma, T. Chiranjeevi, Biplab Sarkar, Werner Kaminsky and Kollipara Mohan Rao
Inorganica Chimica Acta, 2016, 443, 126
DOI: 10.1016/j.ica.2015.12.035

Recent Progress in Polynuclear Ruthenium Complex-Based DNA Binders/Structural Probes and Anticancer Agents
Si-Qi Zhang, Li-Hua Gao, Hua Zhao and Ke-Zhi Wang
CMC, 2020, 27, 3735
DOI: 10.2174/0929867326666181203143422

Synthesis, Structure, and Hydrolytic Activation of Ruthenium (III)-Pyrazole Complex
Mylene Planques, Arushi Shyam, Richard S. Perkins, Frank R. Fronczek, Radhey S. Srivastava and Liviu Mitu
Journal of Chemistry, 2022, 2022, 1
DOI: 10.1155/2022/4056110

Is Matching Ruthenium with Dithiocarbamato Ligands a Potent Chemotherapeutic Weapon in Oncology?
Chiara Nardon, Leonardo Brustolin and Dolores Fregona
Future Med. Chem., 2016, 8, 211
DOI: 10.4155/fmc.15.175

A Dual-Pronged Approach: A Ruthenium(III) Complex That Modulates Amyloid-β Aggregation and Disrupts Its Formed Aggregates
Gideon K. Yawson, Mark F. Will, Samantha E. Huffman, Evan T. Strandquist, Paige J. Bothwell, Ethan B. Oliver, C. Fiore Apuzzo, David C. Platt, Christopher S. Weitzel, Marjorie A. Jones, Gregory M. Ferrence, Christopher G. Hamaker and Michael I. Webb
Inorg. Chem., 2022, 61, 2733
DOI: 10.1021/acs.inorgchem.1c01651

Bilosomal Encapsulation of Binuclear Phosphino Ru(II)–Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers
Sandra Kozieł, Daria Wojtala, Agata Barzowska-Gogola, Barbara Pucelik, Ewelina Waglewska, Miłosz Siczek, Maciej Witwicki, Alessandro Niorettini, Agnieszka Kyzioł, Magdalena Malik, Urszula Bazylińska, Ewa Błaszczak and Urszula K. Komarnicka
J. Med. Chem., 2025, 68, 14442
DOI: 10.1021/acs.jmedchem.5c00486

Ruthenium(II) complexes of 1,3-thiazolidine-2-thione: Cytotoxicity against tumor cells and anti-Trypanosoma cruzi activity enhanced upon combination with benznidazole
Rodrigo S. Corrêa, Monize M. da Silva, Angelica E. Graminha, Cássio S. Meira, Jamyle A.F. dos Santos, Diogo R.M. Moreira, Milena B.P. Soares, Gustavo Von Poelhsitz, Eduardo E. Castellano, Carlos Bloch, Marcia R. Cominetti and Alzir A. Batista
Journal of Inorganic Biochemistry, 2016, 156, 153
DOI: 10.1016/j.jinorgbio.2015.12.024

Enhancing the Activity of Drugs by Conjugation to Organometallic Fragments
Prinessa Chellan and Peter J. Sadler
Chemistry A European J, 2020, 26, 8676
DOI: 10.1002/chem.201904699

Synthesis, Structure, Stability, and Inhibition of Tubulin Polymerization by RuII–p-Cymene Complexes of Trimethoxyaniline-Based Schiff Bases
Sourav Acharya, Moumita Maji, Ruturaj, Kallol Purkait, Arnab Gupta and Arindam Mukherjee
Inorg. Chem., 2019, 58, 9213
DOI: 10.1021/acs.inorgchem.9b00853

Ruthenium(II) Phosphine/Mercapto Complexes: Their in Vitro Cytotoxicity Evaluation and Actions as Inhibitors of Topoisomerase and Proteasome Acting as Possible Triggers of Cell Death Induction
Gabriel H. Ribeiro, Adriana P. M. Guedes, Tamires D. de Oliveira, Camila R. S. T. b. de Correia, Legna Colina-Vegas, Mauro A. Lima, Joaquim A. Nóbrega, Márcia R. Cominetti, Fillipe V. Rocha, Antônio G. Ferreira, Eduardo E. Castellano, Felipe R. Teixeira and Alzir A. Batista
Inorg. Chem., 2020, 59, 15004
DOI: 10.1021/acs.inorgchem.0c01835

Applying a Trojan Horse Strategy to Ruthenium Complexes in the Pursuit of Novel Antibacterial Agents
Quentin Laurent, Lucinda K. Batchelor and Paul J. Dyson
Organometallics, 2018, 37, 915
DOI: 10.1021/acs.organomet.7b00885

Nano-Based Systems and Biomacromolecules as Carriers for Metallodrugs in Anticancer Therapy
Mina Poursharifi, Marek T. Wlodarczyk and Aneta J. Mieszawska
Inorganics, 2018, 7, 2
DOI: 10.3390/inorganics7010002

Mn(II) Polypyridyl Complexes: Precursors to High Valent Mn(V)=O Species and Inhibitors of Cancer Cell Proliferation
Pragya Arora, Sikha Gupta, Sai Kumari Vechalapu, Rakesh Kumar, Ayushi Awasthi, Sathyapriya Senthil, Shweta Khanna, Dharmaraja Allimuthu and Apparao Draksharapu
Chemistry A European J, 2023, 29
DOI: 10.1002/chem.202301506

How to Use Quantum Computers for Biomolecular Free Energies
Jakob Günther, Thomas Weymuth, Moritz Bensberg, Freek Witteveen, Matthew S. Teynor, F. Emil Thomasen, Valentina Sora, William Bro-Jørgensen, Raphael T. Husistein, Mihael Erakovic, Marek Miller, Leah Weisburn, Minsik Cho, Marco Eckhoff, Aram W. Harrow, Anders Krogh, Troy Van Voorhis, Kresten Lindorff-Larsen, Gemma Solomon, Markus Reiher and Matthias Christandl
J. Chem. Theory Comput., 2026
DOI: 10.1021/acs.jctc.5c02088

An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era
Angelo Spinello and Alessandra Magistrato
Expert Opinion on Drug Discovery, 2017, 1
DOI: 10.1080/17460441.2017.1340272

Synthesis and structure elucidation of tailored metal-based intercalative agents derived from anthraldehyde & L-valine that show selective inhibition against triple-negative resistant breast cancer cells
Salman Khan, Mohd. Tauqeer, Farukh Arjmand and Sartaj Tabassum
Polyhedron, 2025, 269, 117398
DOI: 10.1016/j.poly.2025.117398

Highly effective Ru(II) and Os(II) half-sandwich complexes induce cytotoxicity in cancer cells through combined mitochondrial and endoplasmic reticulum stress
Jan Hošek, Kamila Petrželová, Renata Héžová, Nicol Straková, Simona Kajabová, Ivan Nemec, Pavlína Šimečková, Kateřina Pěnčíková, Josef Mašek, Ján Moncoľ and Pavel Štarha
European Journal of Medicinal Chemistry, 2025, 297, 117970
DOI: 10.1016/j.ejmech.2025.117970

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms
Jana Hildebrandt, Norman Häfner, Daniel Kritsch, Helmar Görls, Matthias Dürst, Ingo B. Runnebaum and Wolfgang Weigand
IJMS, 2022, 23, 4976
DOI: 10.3390/ijms23094976

Covalent and noncovalent interactions of coordination compounds with DNA: An overview
Lucia Andrezálová and Zuzana Országhová
Journal of Inorganic Biochemistry, 2021, 225, 111624
DOI: 10.1016/j.jinorgbio.2021.111624

Synthesis and Antiproliferative Activity of New Ruthenium Complexes with Ethacrynic-Acid-Modified Pyridine and Triphenylphosphine Ligands
Gabriele Agonigi, Tina Riedel, Stefano Zacchini, Emilia Păunescu, Guido Pampaloni, Niccolò Bartalucci, Paul J. Dyson and Fabio Marchetti
Inorg. Chem., 2015, 54, 6504
DOI: 10.1021/acs.inorgchem.5b00802

Ligand Design forN,O- orN,N-Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity
Riccardo Pettinari, Fabio Marchetti, Corrado Di Nicola, Claudio Pettinari, Agustín Galindo, Riccardo Petrelli, Loredana Cappellacci, Massimiliano Cuccioloni, Laura Bonfili, Anna Maria Eleuteri, M. Fátima C. Guedes da Silva and Armando J. L. Pombeiro
Inorg. Chem., 2018, 57, 14123
DOI: 10.1021/acs.inorgchem.8b01935

Metal–ligand interactions in drug design
Laura Riccardi, Vito Genna and Marco De Vivo
Nat Rev Chem, 2018, 2, 100
DOI: 10.1038/s41570-018-0018-6

Synthesis of Novel N-Heterocyclic Carbene-Ruthenium (II) Complexes, “Precious” Tools with Antibacterial, Anticancer and Antioxidant Properties
Jessica Ceramella, Rubina Troiano, Domenico Iacopetta, Annaluisa Mariconda, Michele Pellegrino, Alessia Catalano, Carmela Saturnino, Stefano Aquaro, Maria Stefania Sinicropi and Pasquale Longo
Antibiotics, 2023, 12, 693
DOI: 10.3390/antibiotics12040693

Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds
Elizabeth T. Papish and Olaitan E. Oladipupo
Current Opinion in Chemical Biology, 2022, 68, 102143
DOI: 10.1016/j.cbpa.2022.102143

Nano-Ru-HKUST-1 enhanced PVA hydrogels: Laying the foundation for MOF-based cartilage tissue scaffolds
Leonarda Vukonic, Nádia E. Santos, Christoph Bauer, Felix Groß, P.J. Thurner, Manel Rodriguez Ripoll, Carsten Gachot, Stefan Nehrer, Susana S. Braga, Filipe A. Almeida Paz and Rosa Maria Nothnagel
Materials Today Chemistry, 2026, 53, 103446
DOI: 10.1016/j.mtchem.2026.103446

Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
Angelica E. Graminha, João Honorato, Liany Luna Dulcey, Luani Rezende Godoy, Marília F. Barbosa, Marcia R. Cominetti, Antonio C. Menezes and Alzir A. Batista
Journal of Inorganic Biochemistry, 2020, 206, 111021
DOI: 10.1016/j.jinorgbio.2020.111021

Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
Shadia A. Elsayed, Shane Harrypersad, Heba A. Sahyon, Mohammed Abu El-Magd and Charles J. Walsby
Molecules, 2020, 25, 4284
DOI: 10.3390/molecules25184284

Potent Ruthenium–Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to In Vivo Evaluation in Zebrafish
Manikandan M, Shubhankar Gadre, Sushanta Chhatar, Gourav Chakraborty, Naushad Ahmed, Chinmoy Patra and Malay Patra
J. Med. Chem., 2022, 65, 16353
DOI: 10.1021/acs.jmedchem.2c01174

Luminescent ruthenium(II)-para-cymene complexes of aryl substituted imidazo-1,10-phenanthroline as anticancer agents and the effect of remote substituents on cytotoxic activities
Sourav De, R. Selva Kumar, Ashna Gauthaman, S.K. Ashok Kumar, Priyankar Paira, Anbalagan Moorthy and Subhasis Banerjee
Inorganica Chimica Acta, 2021, 515, 120066
DOI: 10.1016/j.ica.2020.120066

α‐Synuclein as a Target for Metallo‐Anti‐Neurodegenerative Agents
Kaiming Cao, Yang Zhu, Zhuanghao Hou, Manman Liu, Yanyan Yang, Hongze Hu, Yi Dai, Yu Wang, Siming Yuan, Guangming Huang, Jiaming Mei, Peter J. Sadler and Yangzhong Liu
Angewandte Chemie, 2023, 135
DOI: 10.1002/ange.202215360

Synthesis, Biological Activity and Medicinal Applications of Ruthenium Complexes Containing Carbohydrate Ligands
Ana Cristina Fernandes
CMC, 2019, 26, 6412
DOI: 10.2174/0929867326666190124124350

The Combination of Active‐Targeted Photodynamic Therapy and Photoactivated Chemotherapy for Enhanced Cancer Treatment
Nkune Williams Nkune and Heidi Abrahamse
Journal of Biophotonics, 2025, 18
DOI: 10.1002/jbio.70005

Synthesis, Characterization, Cytotoxic Activity, and Metabolic Studies of Ruthenium(II) Polypyridyl Complexes Containing Flavonoid Ligands
Alexandra-Cristina Munteanu, Anna Notaro, Marta Jakubaszek, Joseph Cowell, Mickaël Tharaud, Bruno Goud, Valentina Uivarosi and Gilles Gasser
Inorg. Chem., 2020, 59, 4424
DOI: 10.1021/acs.inorgchem.9b03562

Tuning of cytotoxic activity by bio-mimetic ligands in ruthenium nitrosyl complexes
E.D. Rechitskaya, N.V. Kuratieva, E.V. Lider, J.A. Eremina, L.S. Klyushova, I.V. Eltsov and G.A. Kostin
Journal of Molecular Structure, 2020, 1219, 128565
DOI: 10.1016/j.molstruc.2020.128565

New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity
Dalila Iacopini, Ján Vančo, Sebastiano Di Pietro, Vittorio Bordoni, Stefano Zacchini, Fabio Marchetti, Zdeněk Dvořák, Tomáš Malina, Lorenzo Biancalana, Zdeněk Trávníček and Valeria Di Bussolo
Bioorganic Chemistry, 2022, 126, 105901
DOI: 10.1016/j.bioorg.2022.105901

Coumarin‐modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells
Silvio Jakopec, Lejla F. Hamzic, Luka Bočkor, Iris Car, Berislav Perić, Srećko I. Kirin, Mirela Sedić and Silvana Raić‐Malić
Archiv der Pharmazie, 2024, 357
DOI: 10.1002/ardp.202400271

Towards anticancer fluoroquinolones: A review article
Mohamed A. A. Abdel‐Aal, Salah A. Abdel‐Aziz, Montaser Sh. A. Shaykoon and Gamal El‐Din A. Abuo‐Rahma
Archiv der Pharmazie, 2019, 352
DOI: 10.1002/ardp.201800376

Dicationic Ruthenium(II)–Arene–Curcumin Complexes Containing Methylated 1,3,5‐Triaza‐7‐phosphaadamantane: Synthesis, Structure, and Cytotoxicity
Riccardo Pettinari, Francesca Condello, Fabio Marchetti, Claudio Pettinari, Piotr Smoleński, Tina Riedel, Rosario Scopelliti and Paul J. Dyson
Eur J Inorg Chem, 2017, 2017, 2905
DOI: 10.1002/ejic.201700183

Locked and Loaded: Ruthenium(II)-Capped Cucurbit[n]uril-Based Rotaxanes with Antimetastatic Properties
Martin Sojka, Michaela Fojtu, Jindriska Fialova, Michal Masarik, Marek Necas and Radek Marek
Inorg. Chem., 2019, 58, 10861
DOI: 10.1021/acs.inorgchem.9b01203

Ru(II) containing photosensitizers for photodynamic therapy: A critique on reporting and an attempt to compare efficacy
Manjunatha Ankathatti Munegowda, Angelica Manalac, Madrigal Weersink, Sherri A. McFarland and Lothar Lilge
Coordination Chemistry Reviews, 2022, 470, 214712
DOI: 10.1016/j.ccr.2022.214712

Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
Gabriel H. Ribeiro, Legna Colina-Vegas, Juan C.T. Clavijo, Javier Ellena, Marcia R. Cominetti and Alzir A. Batista
Journal of Inorganic Biochemistry, 2019, 193, 70
DOI: 10.1016/j.jinorgbio.2019.01.006

Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles
Maria S. Novak, Gabriel E. Büchel, Bernhard K. Keppler and Michael A. Jakupec
J Biol Inorg Chem, 2016, 21, 347
DOI: 10.1007/s00775-016-1345-z

Metal-Based Antitumor Compounds: Beyond Cisplatin
Peter V Simpson, Nima Maheshkumar Desai, Ilaria Casari, Massimiliano Massi and Marco Falasca
Future Med. Chem., 2019, 11, 119
DOI: 10.4155/fmc-2018-0248

Ruthenium(II) Complex with 8-Hydroxyquinoline Exhibits Antitumor Activity in Breast Cancer Cell Lines
Amr Khalifa, Salah Sheweita, Asmaa Namatalla, Mohamed Khalifa, Alessio Nencioni and Ahmed Sultan
Cancers, 2025, 17, 195
DOI: 10.3390/cancers17020195

An overview on the anticancer activity of Ru(II)/acylthiourea complexes
Gabriel H. Ribeiro, Analu R. Costa, Aparecido R. de Souza, Fabiana V. da Silva, Felipe T. Martins, Ana M. Plutin and Alzir A. Batista
Coordination Chemistry Reviews, 2023, 488, 215161
DOI: 10.1016/j.ccr.2023.215161

Ru(II)‐η6‐benzene Complexes of Dibenzosuberenyl Appended Aroyl/Acylthiourea Ligands: In vitro Biomolecular Interaction Studies and Catalytic Transfer Hydrogenation
Gandhaveeti Rohini, Jebiti Haribabu, Mani M. Sheeba, Aneesrahman K. N., Nattamai S. P. Bhuvanesh, Chandrasekhar Balachandran, Ramasamy Karvembu and Anandaram Sreekanth
ChemistrySelect, 2018, 3, 18
DOI: 10.1002/slct.201702538

New 4′-(4-chlorophenyl)-2,2′:6′,2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies
Milan M. Milutinović, Ana Rilak, Ioannis Bratsos, Olivera Klisurić, Milan Vraneš, Nevenka Gligorijević, Siniša Radulović and Živadin D. Bugarčić
Journal of Inorganic Biochemistry, 2017, 169, 1
DOI: 10.1016/j.jinorgbio.2016.10.001

Anti-cancer and anti-inflammatory activities of a new family of coordination compounds based on divalent transition metal ions and indazole-3-carboxylic acid
Antonio A. García-Valdivia, Fatin Jannus, Amalia García-García, Duane Choquesillo-Lazarte, Belén Fernández, Marta Medina-O'donnell, José A. Lupiáñez, Javier Cepeda, Fernando J. Reyes-Zurita and Antonio Rodríguez-Diéguez
Journal of Inorganic Biochemistry, 2021, 215, 111308
DOI: 10.1016/j.jinorgbio.2020.111308

Half‐sandwich Ruthenium (II) complexes with triphenylamine modified dipyridine skeleton and application in biology/luminescence imaging
Xingxing Ge, Xicheng Liu, Zhenzhen Tian, Shujiao Chen, Xinyu Liu, Lihua Guo, Peiwei Gong, Baoping Ling, Xiang‐Ai Yuan and Zhe Liu
Applied Organom Chemis, 2019, 33
DOI: 10.1002/aoc.5171

Anticancer Activities of Mononuclear Ruthenium(II) Coordination Complexes
William M. Motswainyana and Peter A. Ajibade
Advances in Chemistry, 2015, 2015, 1
DOI: 10.1155/2015/859730

Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study
Claudia Riccardi, Antonella Campanella, Daniela Montesarchio, Pompea Del Vecchio, Rosario Oliva and Luigi Paduano
Molecules, 2023, 28, 2800
DOI: 10.3390/molecules28062800

Bioreducible and traceable Ru(III) prodrug-loaded mesoporous silica nanoparticles for sequentially targeted nonsmall cell lung cancer chemotherapy
Fangman Chen, Fan Zhang, Dan Shao, Weibin Zhang, Liqin Zheng, Wei Wang, Wendi Yang, Zheng Wang, Jianxin Chen, Wen-fei Dong, Fangnan Xiao and Yunkun Wu
Applied Materials Today, 2020, 19, 100558
DOI: 10.1016/j.apmt.2020.100558

Cell cycle, apoptosis, cellular uptake and whole-transcriptome microarray gene expression analysis of HeLa cells treated with a ruthenium(II)-arene complex with an isoquinoline-3-carboxylic acid ligand
Katarina K. Jovanović, Miljana Tanić, Ivanka Ivanović, Nevenka Gligorijević, Biljana P. Dojčinović and Siniša Radulović
Journal of Inorganic Biochemistry, 2016, 163, 362
DOI: 10.1016/j.jinorgbio.2016.04.011

Synthesis, characterization and biological evaluation of novel Ru(II)–arene complexes containing intercalating ligands
Stefan Nikolić, Loganathan Rangasamy, Nevenka Gligorijević, Sandra Aranđelović, Siniša Radulović, Gilles Gasser and Sanja Grgurić-Šipka
Journal of Inorganic Biochemistry, 2016, 160, 156
DOI: 10.1016/j.jinorgbio.2016.01.005

Speciation of metal drugs, supplements and toxins in media and bodily fluids controls in vitro activities
Aviva Levina, Debbie C. Crans and Peter A. Lay
Coordination Chemistry Reviews, 2017, 352, 473
DOI: 10.1016/j.ccr.2017.01.002

A ruthenium(II) complex inhibits tumor growth in vivo with fewer side-effects compared with cisplatin
Jin-Quan Wang, Ping-Yu Zhang, Liang-Nian Ji and Hui Chao
Journal of Inorganic Biochemistry, 2015, 146, 89
DOI: 10.1016/j.jinorgbio.2015.02.003

In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pr i )2Ru2(μ-S-p-C6H4OH)3]Cl
Darina Muthná, Pavel Tomšík, Radim Havelek, Renata Köhlerová, Vidhya Kasilingam, Eva Čermáková, David Stíbal, Martina Řezáčová and Georg Süss-Fink
Anti-Cancer Drugs, 2016, 27, 643
DOI: 10.1097/CAD.0000000000000374

Nucleophilic substitution reactions of [(η5-Cp*)Ru(η6-C6H5CO2H)]+: Synthesis, characterization and cytotoxicity of organoruthenium ester and amide complexes
Bradley T. Loughrey, Michael L. Williams, Peter G. Parsons and Peter C. Healy
Journal of Organometallic Chemistry, 2016, 819, 1
DOI: 10.1016/j.jorganchem.2016.06.012

A review on homo multinuclear anticancer Metallotherapuetics
Sudhindra Pete, Nilmadhab Roy and Priyankar Paira
Inorganica Chimica Acta, 2021, 517, 120184
DOI: 10.1016/j.ica.2020.120184

Cell‐based studies of the first‐in‐class half‐sandwich Ir(III) complex containing histone deacetylase inhibitor 4‐phenylbutyrate
Pavel Štarha, Zdeněk Trávníček, Bohuslav Drahoš, Radovan Herchel and Zdeněk Dvořák
Applied Organom Chemis, 2018, 32
DOI: 10.1002/aoc.4246

Metal Complexes in Cancer Treatment: Journey So Far
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Prateek Pathak, Maria Grishina, Jagat Pal Yadav, Amita Verma and Pradeep Kumar
Chemistry & Biodiversity, 2023, 20
DOI: 10.1002/cbdv.202300061

The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation
Dina Baier, Beatrix Schoenhacker-Alte, Mate Rusz, Christine Pirker, Thomas Mohr, Theresa Mendrina, Dominik Kirchhofer, Samuel M. Meier-Menches, Katharina Hohenwallner, Martin Schaier, Evelyn Rampler, Gunda Koellensperger, Petra Heffeter, Bernhard Keppler and Walter Berger
Pharmaceutics, 2022, 14, 238
DOI: 10.3390/pharmaceutics14020238

A Survey of the Mechanisms of Action of Anticancer Transition Metal Complexes
Mickaël Marloye, Gilles Berger, Michel Gelbcke and François Dufrasne
Future Med. Chem., 2016, 8, 2263
DOI: 10.4155/fmc-2016-0153

Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, Rita Santamaria and Carlo Irace
Pharmaceutics, 2022, 14, 954
DOI: 10.3390/pharmaceutics14050954

Ruthenium(II) complexes containing PEGylated N-heterocyclic carbene ligands for tunning biocompatibility in the fight against cancer
Oscar Barrios, Claudia Inclán, Pablo Herrera, Alicia Bort, Avelino Martín, Jesús Cano, Inés Díaz-Laviada and Rafael Gómez
Journal of Inorganic Biochemistry, 2025, 262, 112765
DOI: 10.1016/j.jinorgbio.2024.112765

Antitumor activity of ruthenium(III) complexes with [N2O2]-tetradentate Schiff base ligands
Zdravka Petrova, Teodora Mocanu, Rossen Spasov, Anamaria Hanganu, Gabriela Marinescu, Daniela C. Culita and Radostina Alexandrova
Journal of Inorganic Biochemistry, 2025, 266, 112853
DOI: 10.1016/j.jinorgbio.2025.112853

Response to the comment on: “Dissolved oxygen sensing characteristics of plastic optical fiber coated with hydrogel film” – The wider context of fibre optic oxygen sensing
Bian Zhenglan, Zhao Chunpeng and Chu Fenghong
Optical Fiber Technology, 2022, 68, 102811
DOI: 10.1016/j.yofte.2021.102811

Modification of Aβ Peptide Aggregation via Covalent Binding of a Series of Ru(III) Complexes
Luiza M. F. Gomes, Janaina C. Bataglioli, Allison J. Jussila, Jason R. Smith, Charles J. Walsby and Tim Storr
Front. Chem., 2019, 7
DOI: 10.3389/fchem.2019.00838

Synthesis, reactivities and anti-cancer properties of ruthenium(II) complexes with a thiaether macrocyclic ligand
Hannah A. O’Riley, Aviva Levina, Jade B. Aitken and Peter A. Lay
Inorganica Chimica Acta, 2017, 454, 128
DOI: 10.1016/j.ica.2016.07.050

Naphthoquinones of natural origin: Aqueous chemistry and coordination to half-sandwich organometallic cations
János P. Mészáros, Heiko Geisler, Jelena M. Poljarević, Alexander Roller, Maria S. Legina, Michaela Hejl, Michael A. Jakupec, Bernhard K. Keppler, Wolfgang Kandioller and Éva A. Enyedy
Journal of Organometallic Chemistry, 2020, 907, 121070
DOI: 10.1016/j.jorganchem.2019.121070

Tailored Metal-Based Catalysts: A New Platform for Targeted Anticancer Therapies
Maria Inês P. S. Leitão and Tânia S. Morais
J. Med. Chem., 2024, 67, 16967
DOI: 10.1021/acs.jmedchem.4c01680

Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation
Mohamed M. Aboelnga, Heba A. Sahyon and Shadia A. Elsayed
Applied Organom Chemis, 2024, 38
DOI: 10.1002/aoc.7427

Nonsteroidal Anti-inflammatory—Organometallic Anticancer Compounds
Emilia Păunescu, Sarah McArthur, Mylène Soudani, Rosario Scopelliti and Paul J. Dyson
Inorg. Chem., 2016, 55, 1788
DOI: 10.1021/acs.inorgchem.5b02690

Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity
Małgorzata Fabijańska, Maria M. Kasprzak and Justyn Ochocki
IJMS, 2021, 22, 7568
DOI: 10.3390/ijms22147568

Organic Sulfur Derivatives and Their Metal Complexes as Promising Pharmacologically Active Compounds
V. P. Osipova and N. T. Berberova
Russ J Coord Chem, 2023, 49, S196
DOI: 10.1134/S1070328423600894

A novel combinatory treatment against a CDDP-resistant non-small cell lung cancer based on a Ruthenium(II)-cyclopentadienyl compound
Iris C. Salaroglio, Denitsa Stefanova, Ricardo G. Teixeira, Nuno F.B. Oliveira, Amer Ahmed, Fabio Fusi, Virginia Tzankova, Yordan Yordanov, Miguel Machuqueiro, Simona Saponara, Andreia Valente and Chiara Riganti
Pharmacological Research, 2024, 208, 107353
DOI: 10.1016/j.phrs.2024.107353

Ruthenium(II)-Polypyridyl Compounds with π-Extended Nitrogen Donor Ligands Induce Apoptosis in Human Lung Adenocarcinoma (A549) Cells by Triggering Caspase-3/7 Pathway
Bruno Peña, Sayan Saha, Rola Barhoumi, Robert C. Burghardt and Kim R. Dunbar
Inorg. Chem., 2018, 57, 12777
DOI: 10.1021/acs.inorgchem.8b01988

Recent advances in Rh(III)-based anticancer complexes
Souvik Saha, Rajesh Kushwaha, Apurba Mandal, Nidhi Singh and Samya Banerjee
Coordination Chemistry Reviews, 2025, 525, 216306
DOI: 10.1016/j.ccr.2024.216306

Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes
Orsolya Dömötör, Rodrigo F.M. de Almeida, Leonor Côrte-Real, Cristina P. Matos, Fernanda Marques, António Matos, Carla Real, Tamás Kiss, Éva Anna Enyedy, M. Helena Garcia and Ana Isabel Tomaz
Journal of Inorganic Biochemistry, 2017, 168, 27
DOI: 10.1016/j.jinorgbio.2016.12.008

[(p-MeC6H4Pr )2Ru2(SC6H4-p-Bu )3]Cl (diruthenium-1), a dinuclear arene ruthenium compound with very high anticancer activity: An in vitro and in vivo study
Pavel Tomšík, Darina Muthná, Martina Řezáčová, Stanislav Mičuda, Jana Ćmielová, Miloš Hroch, René Endlicher, Zuzana Červinková, Emil Rudolf, Stephan Hann, David Stíbal, Bruno Therrien and Georg Süss-Fink
Journal of Organometallic Chemistry, 2015, 782, 42
DOI: 10.1016/j.jorganchem.2014.10.050

Aminobenzimidazole‐based (η6‐p‐cymene)ruthenium (II) complexes as nascent anticancer chemotherapeutics: Synthesis, crystal structure, DFT studies, HSA interactions, molecular docking, and cytotoxicity
Rais Ahmad Khan, Amal AlFawaz, Nida N. Farshori, Anup Paul, Mohammed H. Jaafar and Ali Alsalme
Applied Organom Chemis, 2022, 36
DOI: 10.1002/aoc.6702

Newly Synthesized Heteronuclear Ruthenium(II)/Ferrocene Complexes Suppress the Growth of Mammary Carcinoma in 4T1-Treated BALB/c Mice by Promoting Activation of Antitumor Immunity
Milan M. Milutinović, Petar P. Čanović, Dragana Stevanović, Romana Masnikosa, Milan Vraneš, Aleksandar Tot, Milan M. Zarić, Bojana Simović Marković, Maja Misirkić Marjanović, Ljubica Vučićević, Maja Savić, Vladimir Jakovljević, Vladimir Trajković, Vladislav Volarević, Tatjana Kanjevac and Ana Rilak Simović
Organometallics, 2018, 37, 4250
DOI: 10.1021/acs.organomet.8b00604

Osmium(III) Analogues of KP1019: Electrochemical and Chemical Synthesis, Spectroscopic Characterization, X-ray Crystallography, Hydrolytic Stability, and Antiproliferative Activity
Paul-Steffen Kuhn, Gabriel E. Büchel, Katarina K. Jovanović, Lana Filipović, Siniša Radulović, Peter Rapta and Vladimir B. Arion
Inorg. Chem., 2014, 53, 11130
DOI: 10.1021/ic501710k

Synthesis, characterization, interactions with 9-MeG and cytotoxic activity of heterobimetallic RuII-PtII complexes bridged with 2, 2′-bipyrimidine
Theodoros Tsolis, Neofyta Nikolaou, Konstantinos Ypsilantis, Anastasia Kougioumtzi, Dimitrios Kordias, Angeliki Magklara and Achilleas Garoufis
Journal of Inorganic Biochemistry, 2021, 219, 111435
DOI: 10.1016/j.jinorgbio.2021.111435

Design, Synthesis, Characterization and Biological Evaluation of Ruthenium Complexes of Flavonethiosemicarbazones as Antiproliferative and Mycobacterial Activities
Ashok K. Singh, Gunjan Saxena, Ravindra K. Singh, Lovely Kumari, Rishabh Sharma, Sudheer K. Singh, Sahabzada and Mohamad Arshad
ChemistrySelect, 2018, 3, 12682
DOI: 10.1002/slct.201802929

Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy
Nilmadhab Roy and Priyankar Paira
ACS Omega, 2024, 9, 20670
DOI: 10.1021/acsomega.3c08890

(η6-Arene)ruthenium complexes with P-coordinated phosphinoferrocene amides bearing extended polar substituents at the amide nitrogen: Synthesis, characterization and cytotoxicity
Hana Charvátová, Tina Riedel, Ivana Císařová, Paul J. Dyson and Petr Štěpnička
Journal of Organometallic Chemistry, 2016, 802, 21
DOI: 10.1016/j.jorganchem.2015.11.009

Synthesis and Antiproliferative Insights of Lipophilic Ru(II)-Hydroxy Stearic Acid Hybrid Species
Giacomo Drius, Silvia Bordoni, Carla Boga, Magda Monari, Jessica Fiori, Erika Esposito, Chiara Zalambani, Luca Pincigher, Giovanna Farruggia, Natalia Calonghi and Gabriele Micheletti
Molecules, 2023, 28, 4051
DOI: 10.3390/molecules28104051

A comprehensive review on the sustainable synthesis of indole-derived Schiff base ligands and their metal complexes for biological studies
Palani Karthik, Chinnadurai Kalaivanan, Murugesan Sankarganesh and Jegathalaprathaban Rajesh
Inorganic Chemistry Communications, 2026, 188, 116397
DOI: 10.1016/j.inoche.2026.116397

Cytotoxic dimeric half‐sandwich Ru(II), Os(II) and Ir(III) complexes containing the 4,4′‐biphenyl‐based bridging ligands
Pavel Štarha, Jan Hošek, Zdeněk Trávníček and Zdeněk Dvořák
Applied Organom Chemis, 2020, 34
DOI: 10.1002/aoc.5785

Alteration of the HIF-1α/VEGF Signaling Pathway and Disruption of the Cell Cycle by Second Generation Carbosilan Dendrimers
Oscar Barrios, Belén G. Sánchez, Tamara Rodríguez-Prieto, Jesús Cano, Alicia Bort, Rafael Gómez and Inés Díaz-Laviada
Biomacromolecules, 2022, 23, 5043
DOI: 10.1021/acs.biomac.2c00899

Organoruthenated Nitroxoline Derivatives Impair Tumor Cell Invasion through Inhibition of Cathepsin B Activity
Ana Mitrović, Jakob Kljun, Izidor Sosič, Matija Uršič, Anton Meden, Stanislav Gobec, Janko Kos and Iztok Turel
Inorg. Chem., 2019, 58, 12334
DOI: 10.1021/acs.inorgchem.9b01882

Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD‐100/KP1339 in the Endoplasmic Reticulum
Benjamin Neuditschko, Anton A. Legin, Dina Baier, Arno Schintlmeister, Siegfried Reipert, Michael Wagner, Bernhard K. Keppler, Walter Berger, Samuel M. Meier‐Menches and Christopher Gerner
Angew Chem Int Ed, 2021, 60, 5063
DOI: 10.1002/anie.202015962

Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death
Gurunath Sahu, Sushree Aradhana Patra, Sudhir Lima, Sanchita Das, Helmar Görls, Winfried Plass and Rupam Dinda
Chemistry A European J, 2023, 29
DOI: 10.1002/chem.202202694

Recent development of transition metal complexes with in vivo antitumor activity
Jia-Xin Liang, Hai-Jing Zhong, Guanjun Yang, Kasipandi Vellaisamy, Dik-Lung Ma and Chung-Hang Leung
Journal of Inorganic Biochemistry, 2017, 177, 276
DOI: 10.1016/j.jinorgbio.2017.06.002

Recent advances in anticancer ruthenium Schiff base complexes
Shazia Parveen
Applied Organom Chemis, 2020, 34
DOI: 10.1002/aoc.5687

Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities
Zhishan Xu, Jie Huang, Deliang Kong, Yuliang Yang, Lihua Guo, Xianglei Jia, Genshen Zhong and Zhe Liu
European Journal of Medicinal Chemistry, 2020, 207, 112763
DOI: 10.1016/j.ejmech.2020.112763

Indazole scaffold: a generalist for marketed and clinical drugs
Yaquan Cao, Chunying Luo, Pu Yang, Pan Li and Chunli Wu
Med Chem Res, 2021, 30, 501
DOI: 10.1007/s00044-020-02665-7

Exploring the binding properties of DNA/BSA and cytotoxicity studies with new terpyridine-ester-based metal complexes (M = Fe(III), Ni(II), Cu(II) and Ru(III)) – A comparative analysis
Chayan Pandya and Akella Sivaramakrishna
International Journal of Biological Macromolecules, 2024, 274, 132792
DOI: 10.1016/j.ijbiomac.2024.132792

The complex-in-a-complex cation [Pt(acac)2⊂(p-cym)6Ru6(tpt)2(dhnq)3]6+: Its stability towards biological ligands
Lydia E.H. Paul, Bruno Therrien and Julien Furrer
Inorganica Chimica Acta, 2018, 469, 1
DOI: 10.1016/j.ica.2017.08.045

Mass spectrometry techniques for imaging and detection of metallodrugs
Sarah Theiner, Anna Schoeberl, Andreas Schweikert, Bernhard K. Keppler and Gunda Koellensperger
Current Opinion in Chemical Biology, 2021, 61, 123
DOI: 10.1016/j.cbpa.2020.12.005

Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo
Maja Savic, Aleksandar Arsenijevic, Jelena Milovanovic, Bojana Stojanovic, Vesna Stankovic, Ana Rilak Simovic, Dejan Lazic, Nebojsa Arsenijevic and Marija Milovanovic
Molecules, 2020, 25, 4699
DOI: 10.3390/molecules25204699

Synthesis, Modification, and Biological Evaluation of a Library of Novel Water‐Soluble Thiopyridone‐Based Organometallic Complexes and Their Unexpected (Biological) Behavior
Sophia Harringer, Barbara Happl, Marius Ozenil, Caroline Kast, Michaela Hejl, Debora Wernitznig, Anton A. Legin, Andreas Schweikert, Natalie Gajic, Alexander Roller, Gunda Koellensperger, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Chemistry A European J, 2020, 26, 5419
DOI: 10.1002/chem.201905546

Modulating the Anticancer Activity of Ruthenium(II)–Arene Complexes
Catherine M. Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska, Arjan W. Griffioen, Rosario Scopelliti and Paul J. Dyson
J. Med. Chem., 2015, 58, 3356
DOI: 10.1021/jm501655t

Bis(bipyridine)ruthenium(II) Ferrocenyl β‐Diketonate Complexes: Exhibiting Nanomolar Potency against Human Cancer Cell Lines
Matthew Allison, Pablo Caramés‐Méndez, Christopher M. Pask, Roger M. Phillips, Rianne M. Lord and Patrick C. McGowan
Chemistry A European J, 2021, 27, 3737
DOI: 10.1002/chem.202004024

Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway
Jian Zhao, Shuang Li, Xinyi Wang, Gang Xu and Shaohua Gou
Inorg. Chem., 2019, 58, 2208
DOI: 10.1021/acs.inorgchem.8b03447

A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
Upendarrao Golla, Swati Swagatika, Sakshi Chauhan and Raghuvir Singh Tomar
Oncotarget, 2017, 8, 98426
DOI: 10.18632/oncotarget.21416

A bis-indazolic ruthenium(II) complex: Reactivity and biological studies on cancer cells
Danilo K.S. Sales, Lílian M.T. Simplício, Carlos D.S. da Silva, Carolina M.B. Enju, Vanessa B. Silva, Tércio de F. Paulo, Ivanilson P. Santos, Helenita C. Quadros, Cássio S. Meira, Milena B.P. Soares, Luiz G. de F. Lopes, Eduardo H.S. de Sousa and Denise S. de Sá
Inorganica Chimica Acta, 2021, 516, 120125
DOI: 10.1016/j.ica.2020.120125

Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives
Yan-Ru Fan, Bo-Jin Wang, Deng-Guo Jia, Xin-Bin Yang and Yu Huang
Journal of Inorganic Biochemistry, 2021, 219, 111425
DOI: 10.1016/j.jinorgbio.2021.111425

Synthesis and Structural Evaluation of Organo-Ruthenium Complexes with β-Diketonates
Matija Uršič, Tanja Lipec, Anton Meden and Iztok Turel
Molecules, 2017, 22, 326
DOI: 10.3390/molecules22020326

Insights into the antineoplastic activity and mechanisms of action of coumarin-coordinated 8-hydroxyquinoline ruthenium(II/III) compounds
Ling-Qi Du, Yan Yang, Li Ruan, Song Sun, Dong-Yin Mo, Jin-Yuan Cai, Hong Liang, Sai Shu and Qi-Pin Qin
Journal of Inorganic Biochemistry, 2024, 259, 112659
DOI: 10.1016/j.jinorgbio.2024.112659

Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties
F. Battistin, F. Scaletti, G. Balducci, S. Pillozzi, A. Arcangeli, L. Messori and E. Alessio
Journal of Inorganic Biochemistry, 2016, 160, 180
DOI: 10.1016/j.jinorgbio.2016.02.009

Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Golara Golbaghi and Annie Castonguay
Molecules, 2020, 25, 265
DOI: 10.3390/molecules25020265

Antitumor Effect of Organometallic Half-Sandwich Ru(II)–Arene Complexes Bearing a Glutathione S-Transferase Inhibitor
Tianyu Han, Yuying Wu, Weinan Han, Kaiwen Yan, Jian Zhao and Yanyan Sun
Inorg. Chem., 2021, 60, 13051
DOI: 10.1021/acs.inorgchem.1c01482

Synthesis, photophysical properties and photo-induced cytotoxicity of novel tris(diazatriphenylene)ruthenium (II) complex
Srinivas Samala, Woojeong Lim, Dong Kyun You, Kang Mun Lee, Hongil Jo, Kang Min Ok, Jongmin Park and Chang-Hee Lee
Bioorganic Chemistry, 2022, 128, 106044
DOI: 10.1016/j.bioorg.2022.106044

Multinuclear Ir-BODIPY complexes: Synthesis and binding studies
Gajendra Gupta, Abhishek Das, Junseong Lee, Nripendranath Mandal and Chang Yeon Lee
Inorganic Chemistry Communications, 2020, 113, 107759
DOI: 10.1016/j.inoche.2019.107759

Critical assessment of different methods for quantitative measurement of metallodrug-protein associations
Luis Galvez, Sarah Theiner, Márkó Grabarics, Christian R. Kowol, Bernhard K. Keppler, Stephan Hann and Gunda Koellensperger
Anal Bioanal Chem, 2018, 410, 7211
DOI: 10.1007/s00216-018-1328-8

Ruthenium(II)-arene complexes with naphthalimide-tagged N,O- and N,N-chelating ligands: Synthesis and biological evaluation
Kesete Ghebreyessus, Ashley Peralta, Meena Katdare, Krishnan Prabhakaran and Shanthi Paranawithana
Inorganica Chimica Acta, 2015, 434, 239
DOI: 10.1016/j.ica.2015.05.025

Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies
Thallita Monteiro Teixeira, Isabela Gasparini Arraes, Davi Carvalho Abreu, Katia M. Oliveira, Rodrigo S. Correa, Alzir A. Batista, Thomas Braunbeck and Elisaângela de Paula Silveira Lacerda
European Journal of Medicinal Chemistry, 2021, 216, 113262
DOI: 10.1016/j.ejmech.2021.113262

Anticancer activity of a series of copper(II) complexes with tripodal ligands
Melanie Jopp, Jonathan Becker, Sabine Becker, Andreas Miska, Valentina Gandin, Cristina Marzano and Siegfried Schindler
European Journal of Medicinal Chemistry, 2017, 132, 274
DOI: 10.1016/j.ejmech.2017.03.019

Sensitivity towards the GRP78 inhibitor KP1339/IT-139 is characterized by apoptosis induction via caspase 8 upon disruption of ER homeostasis
Beatrix Schoenhacker-Alte, Thomas Mohr, Christine Pirker, Kushtrim Kryeziu, Paul-Steffen Kuhn, Alicia Buck, Thilo Hofmann, Christopher Gerner, Gerrit Hermann, Gunda Koellensperger, Bernhard K. Keppler, Walter Berger and Petra Heffeter
Cancer Letters, 2017, 404, 79
DOI: 10.1016/j.canlet.2017.07.009

Hypoxia-Targeting Organometallic Ru(II)–Arene Complexes with Enhanced Anticancer Activity in Hypoxic Cancer Cells
Jian Zhao, Wanchun Li, Shaohua Gou, Shuang Li, Shengqiu Lin, Qianhui Wei and Gang Xu
Inorg. Chem., 2018, 57, 8396
DOI: 10.1021/acs.inorgchem.8b01070

Evaluation of Perylene Bisimide‐Based RuII and IrIII Complexes as Photosensitizers for Photodynamic Therapy
Cristina Mari, Huaiyi Huang, Riccardo Rubbiani, Marcus Schulze, Frank Würthner, Hui Chao and Gilles Gasser
Eur J Inorg Chem, 2017, 2017, 1745
DOI: 10.1002/ejic.201600516

Homo‐ and Hetero‐dinuclear Arene‐Linked Osmium(II) and Ruthenium(II) Organometallics: Probing the Impact of Metal Variation on Reactivity and Biological Activity
Christopher S. Wilson, Timothy J. Prior, Jordon Sandland, Huguette Savoie, Ross W. Boyle and Benjamin S. Murray
Chemistry A European J, 2020, 26, 11593
DOI: 10.1002/chem.202002052

Versatile Impact of Serum Proteins on Ruthenium(II) Polypyridyl Complexes Properties - Opportunities and Obstacles
Olga Mazuryk, Przemysław Gajda-Morszewski and Małgorzata Brindell
CPPS, 2019, 20, 1052
DOI: 10.2174/1389203720666190513090851

Effect of an Imidazole-Containing Schiff Base of an Aromatic Sulfonamide on the Cytotoxic Efficacy of N,N-Coordinated Half-Sandwich Ruthenium(II) p-Cymene Complexes
Moumita Maji, Sourav Acharya, Indira Bhattacharya, Arnab Gupta and Arindam Mukherjee
Inorg. Chem., 2021, 60, 4744
DOI: 10.1021/acs.inorgchem.0c03706

Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group
Stephan Mokesch, Daniela Schwarz, Michaela Hejl, Matthias H. M. Klose, Alexander Roller, Michael A. Jakupec, Wolfgang Kandioller and Bernhard K. Keppler
Molecules, 2019, 24, 2373
DOI: 10.3390/molecules24132373

Hydrogen Bonding and Anticancer Properties of Water‐Soluble Chiral p‐Cymene RuII Compounds with Amino‐Oxime Ligands
Yosra Benabdelouahab, Laura Muñoz‐Moreno, Malgorzata Frik, Isabel de la Cueva‐Alique, Mohammed Amin El Amrani, María Contel, Ana M. Bajo, Tomás Cuenca and Eva Royo
Eur J Inorg Chem, 2015, 2015, 2295
DOI: 10.1002/ejic.201500097

Synthesis, Characterization, Cytotoxic Activity, and Interactions with CT-DNA and BSA of Cationic Ruthenium(II) Complexes Containing Dppm and Quinoline Carboxylates
Edinaldo N. da Silva, Paulo A. B. da Silva, Angélica E. Graminha, Pollyanna F. de Oliveira, Jaqueline L. Damasceno, Denise C. Tavares, Alzir A. Batista and Gustavo Von Poelhsitz
Bioinorganic Chemistry and Applications, 2017, 2017, 1
DOI: 10.1155/2017/2562780

Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems
Claudia Riccardi, Chiara Platella, Domenica Musumeci and Daniela Montesarchio
Molecules, 2023, 28, 5775
DOI: 10.3390/molecules28155775

Ruthenium(II) complexes of 1-(2-picolyl)-1,2,3-triazole-appended 2-arylbenzothiazoles: synthesis, characterization, in vitro and in silico evaluation of anti-proliferative activity
Silvio Jakopec, Napat Prompat, Lejla Ferhatovic Hamzic, Luka Bočkor, Mirela Sedić, Srećko I. Kirin, Dijana Jadreško and Silvana Raić-Malić
Inorganic Chemistry Communications, 2025, 182, 115627
DOI: 10.1016/j.inoche.2025.115627

Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
Ileana Dragutan, Valerian Dragutan and Albert Demonceau
Molecules, 2015, 20, 17244
DOI: 10.3390/molecules200917244

Ruthenium Carbonyl Complexes with Azole Heterocycles – Synthesis, X‐ray Diffraction Structures, DFT Calculations, Solution Behavior, and Antiproliferative Activity
Paul‐Steffen Kuhn, Samuel M. Meier, Katarina K. Jovanović, Isolde Sandler, Leon Freitag, Ghenadie Novitchi, Leticia González, Siniša Radulović and Vladimir B. Arion
Eur J Inorg Chem, 2016, 2016, 1566
DOI: 10.1002/ejic.201501393

Ruthenium(II)–Cyclopentadienyl-Derived Complexes as New Emerging Anti-Colorectal Cancer Drugs
Catarina Teixeira-Guedes, Ana Rita Brás, Ricardo G. Teixeira, Andreia Valente and Ana Preto
Pharmaceutics, 2022, 14, 1293
DOI: 10.3390/pharmaceutics14061293

Ruthenium(II) Polypyridyl Complexes as Photosensitizers for Antibacterial Photodynamic Therapy: A Structure–Activity Study on Clinical Bacterial Strains
Tony Le Gall, Gilles Lemercier, Sylviane Chevreux, Katrin‐Stephanie Tücking, Julian Ravel, Franck Thétiot, Ulrich Jonas, Holger Schönherr and Tristan Montier
ChemMedChem, 2018, 13, 2229
DOI: 10.1002/cmdc.201800392

Bioengineered lipophilic Ru(III) complexes as potential anticancer agents
Claudia Riccardi, Marialuisa Piccolo, Maria Grazia Ferraro, Raffaele Graziano, Domenica Musumeci, Marco Trifuoggi, Carlo Irace and Daniela Montesarchio
Biomaterials Advances, 2022, 139, 213016
DOI: 10.1016/j.bioadv.2022.213016

Synthesis, characterization and cancer cell growth inhibition activity of ruthenium(II) complexes bearing bidentate pyrrole-imine ligands
Guan-Hao Chen, Wohn-Jenn Leu, Jih-Hwa Guh, Chia-Her Lin and Jui-Hsien Huang
Journal of Organometallic Chemistry, 2018, 868, 122
DOI: 10.1016/j.jorganchem.2018.05.012

Cyclopentadienyl ruthenium(II) carbosilane metallodendrimers as a promising treatment against advanced prostate cancer
Natalia Sanz del Olmo, Ana M. Bajo, Maksim Ionov, Sandra García-Gallego, Maria Bryszewska, Rafael Gómez, Paula Ortega and F. Javier de la Mata
European Journal of Medicinal Chemistry, 2020, 199, 112414
DOI: 10.1016/j.ejmech.2020.112414